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Summary  
 
The term Prion (Proteinaceous infectious) was first described by Stanley Prusiner in 
1982. Prions are infectious proteins and are responsible for many neurodegenerative 
diseases, collectively termed as transmissible spongioform encephalopathies, including; 
BSE, vBSE, scrapie and CJD. Prions are also present in fungi. There have been a number 
of prion proteins discovered in the yeast Saccharomyces cerevisiae. Probably the most  
studied of these is the [PSI+], which is the prion form of the protein Sup35, which is 
required for the release of nascent polypeptide chains from the ribosome during 
translation termination. Studies indicate that the de novo formation and propagation of 
yeast prions require the function of protein chaperones and co-chaperones. The heat 
shock proteins (HSP) such as Hsp40, Hsp70 and Hsp104, are essential for prion 
propagation in yeast. Hsp70 is a highly conserved protein composed of an N-terminal 
ATPase domain, a peptide-binding domain (PBD) and a C-terminal domain. In this study 
we describe a genetic screen that identifies an array of mutants within different domains 
of the major cytosolic Hsp70 chaperones of yeast, Ssa1-4 which impair the propagation 
of [PSI+]. A majority of isolated mutants are located within the ATPase domain and have 
no significant affect on Hsp70 function. The PBD mutant Ssa1F475S, which impairs [PSI+] 
propagation also appears to make Ssa1 non-functional and may implicate Ssa1 in an array 
of cellular functions. We also highlight differences between the Hsp70 cytosolic Ssa 
family members with respect to prion propagation and Hsp70 function. 
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1.0 Mammalian prions  
The term Prion (Proteinaceous infectious) was first coined by Stanley Prusiner in 
1982 (Prusiner 1982a). Prions are responsible for a class of neurodegenerative 
diseases termed as transmissible spongiform encephalopathies (TSE) (Prusiner 
1982a). Bovine spongiform encephalopathy (BSE), Scrapie and Creutzfeldt-Jakob 
disease (CJD) are prion diseases that manifest in cows, sheep and humans, 
respectively (Prusiner 1998). The most prominent symptom of CJD is progressive 
dementia whereas Scrapie and BSE generally display ataxic symptoms. Strong 
evidence lead researchers to the conclusion that prions are proteinaceous infectious 
particles that are devoid of nucleic acid.  
  
1.1 PrP Protein 
The PRNP gene encodes the PrPc protein in mammals, which is expressed in the 
central nervous system (CNS). PrP is a cell membrane protein that is anchored by 
glycosyl phosphatidyl inositol (GPI) (Prusiner 1998). The normal function of this 
protein is not yet clear. Evidence suggests it may be involved in a range of functions 
such as sleep physiology, oxidative burst compensation, apoptosis, signal transduction 
and interactions with extracellular matrix (Mouillet et al., 2000). The PrPc protein can 
be converted to form the prion form of the protein; PrPsc (Prusiner 1998). PrPc is 
typically composed of α-helical structure, soluble and highly sensitive to protease 
digestion, when converted to the prion form (PrPsc) a portion of the α-helical structure 
is refolded into ß-sheet form and the protein becomes insoluble, is amyloid rich and 
becomes resistant to protease digestion (Prusiner 1998). These structural changes are 
also accompanied by physiochemical properties of PrP being altered. The amino acid 
sequence of PrPsc corresponds to that encoded by the PRNP gene. 
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1.1.1 Prion Transmission 
Prions can be established in three different ways.  They can arise spontaneously, be 
inherited by way of a predisposing mutation or may be contracted by infection 
(Prusiner 1998). Sporadic conversion of human CJD occurs rarely, affecting one in a 
million annually. There are more than twenty mutations of the PrP gene known to 
cause inherited human prion diseases. A common polymorphism at codon 129 of the 
human PrP gene (PRNP), where either methionine (M) or valine (V) can be encoded, 
is a key determinant of susceptibility to sporadic and acquired prion diseases (Asante 
et al., 2002). These mutations can lead to aberrant behavior of the PrP protein. A 
common way for prions to appear is by contraction through infection. This is when 
the host is infected by TSE agents; this is how vCJD is established. 
 
1.2 Fungal Prions 
Prions are not exclusive to mammals; they are also present in other eukaryotes such as 
fungi. Studies revealed that the yeast Saccharomyces cerevisiae contains proteins that 
can spontaneously convert to prions. This was first observed by Brian Cox when he 
discovered a non-mendelian factor which he termed [PSI+] (Cox 1965). Another non-
mendelian element, [URE3], was also discovered during a genetic screen to isolate 
nitrogen metabolism mutants (Lacroute 1971, Aigle and Lacroute, 1975). For years 
researchers postulated over the molecular mechanisms of these non-mendelian 
elements until Reed Wickner proposed that [PSI+] is the prion form of the Sup35 
(translation termination factor) and [URE3] is the prion form of the Ure2 (regulator in 
nitrogen catabolism) (Wickner 1994). Mammalian prions are known to cause 
neurodegenerative diseases, yet it was unclear whether the presence of fungal prions 
were detrimental, beneficial or neutral. The [HET-s] prion is present in the 
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filamentous fungus Podospora anserina, and is involved in controlling a fungal 
somatic allorecognition process called heterokaryon incompatibility. Filamentous 
fungi grow as an interconnected network of filaments forming a syncytial structure. 
Fusion of somatic cells occurs between strains, which then leads to the formation of 
vegetative heterokaryons (Glass and Kaneko, 2003). Organisms that form vegetative 
heterokaryons display genetic systems allowing them to recognize self from non-self. 
P. anserina possesses a set of genes termed het genes (Saupe 2000). The het-s gene is 
a member of this family and exists in two polymorphic variants; het-S and het-s and 
only heterokaryons in which both nuclear components have compatible het gene 
constitution are viable. The Het-s protein can convert into the prion [Het-s] and this 
incompatibility reaction only occurs when the protein is in its prion state. This 
suggests that the presence of fungal prions may be beneficial for carrying out natural 
cellular roles. 
 
It is debatable whether the presence of yeast prions are advantageous or a disease of 
yeast. Studies have proposed that the presence of [PSI+] is an advantage to cells when 
surviving stress (Eaglestone et al., 1999) and for evolvability (True et al., 2004, True 
and Lindquist, 2000). However these studies were all preformed by measuring 
growth, but yeast spends most of its time in stationary phase. Therefore, studies were 
undertaken  to examine the distribution of the prions [PSI+ and  [URE3] in seventy 
wild-yeast strains (Nakayashiki et al., 2005). It was postulated that even if prions 
were of a mild disadvantage they should be found in the wild. No wild-type strains 
were found to contain [PSI+] or [URE3], however the prion [PIN+] was isolated in 
eleven strains. Similarly previous studies found [PSI+] to be absent from nine clinical 
isolates (Resende et al., 2003) and two industrial strains of S. cerevisiae (Chernoff et 
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al.,, 2000). This may indicate that prions are detrimental to there host as if they were 
advantageous distribution in wild yeast would be expected. 
 
1.2.1 Properties of yeast prions 
Prions are infectious proteins and horizontal transmission in yeast and filamentous 
fungi occurs by cytoplasmic mixing, which occurs by mating parental strains even if 
nuclei do not fuse mating of filamentous fungi occurs when two colonies of 
filamentous fungi grow towards each other and their hyphae fuse to allow cytoplasmic 
mixing. Along with transmission of prions during cytoplasmic mixing, viruses may 
also be transferred. In order to distinguish prions from viruses, three genetic 
properties were assigned to self-inactivating prions that are not found in nucleic acid 
replicons (Wickner 1994). The first genetic property that a prion must possess is 
reversible curing. If a prion can be cured from a yeast strain, it should be able to arise 
again de novo as the protein capable of undergoing the prion change is still present 
and could spontaneously covert into the prion form. In contrast, if a virus is cured, it 
should not reappear again, unless reintroduced from the outside. The second genetic 
property prions must display is that the overproduction of the protein must increase 
the frequency with which the prion arises. One would expect that by simply 
increasing the concentration of the protein capable of undergoing the prion change, 
the frequency of which the prion forms de novo would also increase. In contrast there 
are no chromosomally encoded proteins whose overproduction will increase the 
frequency in which nucleic acid replicons arise de novo, in fact they will not arise de 
novo at all.  The third genetic criteria that a prion protein must possess is that the gene 
for the protein required for the propagation of the prion, and the phenotype when the 
prion is present is similar to that of a mutation of the gene for the protein. For prions 
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that simply inactivate the protein function, similarities in phenotypes between 
presence of the prion and mutations of that protein would be expected, for example, a 
null mutant for the protein should have the same phenotype as a strain that contains 
the prion form of protein (if the prion is an inactive form of the protein) (Wickner 
1994). Both [PSI+] and [URE3] both fit the genetic criteria needed to classify them as 
prions. 
 
1.2.2 The [PSI+] prion 
 As mentioned above [PSI+] is the prion form of the translation termination factor 
Sup35.Termination of protein synthesis occurs when the stop codons (TAA, TGA or 
TAG) of the mRNA enters the ribosomal A site. Stop codons are recognized by the 
class I release factors (RF), which also promote the hydrolysis of ester bonds in 
peptidyl t-RNA in the peptidyl transfer center of the large ribosomal subunit 
(Nakamura and Ito, 2003). In eukaryotes the eRF1, encoded by the SUP45 gene, 
recognizes all three stop codons (Kisselev et al. 2003). In eukaryotes translation 
termination also requires the eRF3 (Stansfield et al., 1995), which is encoded by the 
SUP35 gene. The GTPase activity of eRF3 couples codon recognition and a peptidyl 
RNA hydrolysis mediated by eRF1 to ensure rapid and efficient peptide release 
(Salas-Marco and Bedwell, 2004). The structure of Sup35 can be divided into three 
regions; the N-terminal, which is 130 amino acids long, which contains a prion 
domain (PrD), this domain is required for the formation and propagation of prions and 
is typically high in Glutamine and Aspargine residues, a highly charged middle 
domain and the C-terminus, which carries out the translation termination function. 
The PrD contains five imperfect regions of an octapeptide sequence YQQYNPQGG 
similar to the octapeptide PHGGGWGQ repeat present in the PrP protein. Deletion of 
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these repeats interferes with [PSI+]  propagation (Ter-Avanesyan et al., 1994) and 
addition of repeats leads to an increase in frequency of [PSI+]  appearance (Liu and 
Lindquist ,1999). Similarly, adding repeats in PrP can cause inherited CJD (Owen et 
al., 1989) but is not necessary for scrapie propagation (Flechsig et al., 2000). 
Aggregation of Sup35 in [PSI+] cells causes nonsense suppression due to the reduced 
pool of functional Sup35 (inefficient translation termination) (Figure 1.1). Strains 
containing the ade2-1 nonsense allele cannot grow without adenine and are red when 
grown on limiting amounts; this red color is due to the accumulation of a pigmented 
substrate of Ade2. Partial suppression of the ade2-1 nonsense allele by [PSI+], which 
also requires the weakly UAA suppressing tRNA SUQ5, allows growth on media 
lacking adenine and eliminates pigmentation (Cox 1965). In other words, this system 
allows the detection of the presence of [PSI+], if the prion is not present, the strain 
will grow as red colonies and if the prion is present cells will grow as white colonies 
on limiting adenine. 
 
1.2.3 [URE3] 
When yeast has good nitrogen source e.g. ammonia or glutamine, it turns off synthesis 
of enzymes and transporters needed for assimilating poor nitrogen sources such as 
proline and allonate. The Ure2 protein mediates this process, known as nitrogen 
catabolite repression. It represses genes that express enzymes and transporters needed 
by yeast cells in the utilization of poor nitrogen sources in the presence of a good 
nitrogen source by sequestering the transcription factor Gln3 and Gat3/Nil1 in the 
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cytoplasm (Beck and Hall, 1999, Cox et al., 2000), which prevent their entry into the 
 
 
Figure 1.1 Spontaneous formation of [PSI+]. In S.cerevisiae, the SUP35 gene 
encodes the protein Sup35, also known as eRF3 (eukaryotic release factor) (black 
squares). Under normal circumstances, eRF3 binds to another release factor (black 
triangle); eRF1 to form the termination complex. The termination complex is 
responsible for the correct release of nascent polypeptides from the ribosome post 
translation. However, the Sup35 protein can undergo spontaneous conversion to a 
prion form of the protein (yellow hexagon). Once the prion form is established, it can 
then recruit and convert native Sup35 into the prion form. The termination complex is 
unable to form, as the prion form of Sup35 is unable to find with eRF1, which results 
in insoluble non-functional Sup35 unable to assist in the release of nascent 
polypeptide chains from ribosome. 
 
nucleus. [URE3] is a nonchromosomal mutation that was isolated in a genetic screen, 
to identify nitrogen metabolite genes,  that gave rise to Ure2 mutants (Lacrout 
1971).The [URE3]element displays the three genetic criteria in order for it to be 
classified as a prion (Wickner 1994). Firstly it is cured by millimolar concentrations 
of guanidine hydrochloride, but  [URE3] can arise post curing, overproducing the 
Ure2 protein increases the frequency of [URE3]  de novo generation and the [URE3]  
SUP35 
eRF3 
UAA 
eRF1 
Functional Sup35 promotes 
termination 
Termination complex 
Prion form of Sup35 can 
self seed conversion to 
“abnormal” form 
UAA 
[psi-]: soluble functional Sup35 
[PSI+]: insoluble non-functional Sup35 
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phenotype is similar to that of loss of function mutations in Ure2 (Wickner 1994).  
Ure2 is a two-domain protein, containing an N-terminal (1-65 amino acids) and a C 
terminal (66-354 amino acids). Overproduction of the N-terminal alone is sufficient to 
induce [URE3] appearance at a rate of approximately 100-fold higher than 
overexpression of the full length Ure2 protein (Masison and Wickner, 1995). In 
contrast, the C-terminal domain is sufficient for carrying out nitrogen regulation 
(Masison et al., 1997). In addition, the prion domain (PrD) is sufficient to propagate 
[URE3]   in complete absence of the C-terminal domain (Masison et al., 1997). 
Similarly to Sup35, the Ure2 PrD is composed of 40% aspargine residues and deletion 
of a run of these residues diminishes the ability of overproduced Ure2 to induce prion 
formation (Maddelein and Wickner, 1999).  
 
1.2.4 [PIN+]  
Although Sup35 induces the de novo formation of the [PSI+] (Chernoff et al.,  1993), 
it was noted that this was a strain specific phenomenon (Derkatch et al., 1997). In fact 
the ability to overexpress Sup35 to induce [PSI+] appearance was proved to be 
dependent on a second nonchromosomal agent termed [PIN+] (PSI inducibility) 
(Derkatch et al., 1997). Subsequently, an examination to isolate potential prions by 
analyzing proteins containing regions rich in N/Q residues, resulted in the discovery 
of the Rnq1 protein, which can be found in an aggregated state in some strains and a 
soluble state in others (Sondheimer and Lindquist, 2000) 
 
The function of Rnq1 is unknown.  [PIN+] proved to be the prion form of the Rnq1 
protein; overexpression of Rnq1 increases the frequency  with which [PIN+]  arises 
and the propagation of [PIN+]  is dependent on the presence of Rnq1 (Derkatch et al., 
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2001). The [PIN+] prion is so far the only prion to be isolated in natural isolates of 
S.cerevisiae. Data so far suggests that [PIN+] prion aggregates act as an imperfect 
template on which Sup35 molecules misfold and assemble into infectious prion 
aggregates. This procedure, termed “cross-seeding”, occurs only at the initial step of 
de novo formation of [PSI+] and subsequently the two proteins stably co-aggregate 
(Bagriantsev and Liebman, 2004). There is also evidence for co-localization during 
initial cross-seeding (Derkatch et al.,2004, Salnikova et al., 2005). Furthermore, 
yeast-two hybrid studies and co-immunoprecipitation analysis have detected 
interactions between soluble forms of Rnq1 and Sup35 in vivo (Tuite et al., 2008). 
 
1.2.4 Discovery of new yeast prions 
Since the discovery of [PSI+], [URE3] and [PIN+] many genetic screens have gone 
underway to search for novel prions in yeast. Recently an unbiased screen  identified a 
possible ten new prions whose overexpression facilitated the de novo appearance of 
[PSI+] (Derkatch et al., 2001). As Ure2 was isolated in this screen as facilitating the 
de novo appearance of [PSI+], it was postulated that some of these proteins might in 
fact be prions themselves,  prions include Cyc8, New1 and Swi1 (Table 1.1). Further 
screens have identified twenty-four potential new yeast prions (Alberti et al., 2009). 
[OCT+] is the prion form of the protein Cyc8 (Patel et al., 2009).The cyc8-Tup1 
global transcriptional repressor complex (Smith and Johnson, 2000) forms one of the 
largest gene regulatory systems controlling over seven percent of yeast genes (Green 
and Johnson, 2004). Analogous to other yeast prions, overexpression of the 
glutamine-rich region induces a heritable dominant [OCT+] phenotype that is 
transmitted cytoplasmically and is dependent on the presence of the Cyc8 protein 
(Patel et al., 2009). The SWI/SNF evolutionary conserved ATP chromatin remodeling 
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complex plays an important role  in transcriptional regulation (Martens and Winston, 
2003). This complex regulates the expression of approximately 6% of total genes, 
either through gene activation or repression (Sudarsanam et al.2000).Similar to other 
prion proteins, Swi1 also contains an N-terminal domain rich in glutamine and 
aspargine residues. Swi1 aggregates in [SWI+] cells but not in non prion cells and cells 
containing [SWI+] show a partial loss of function phenotype (Du et al., 2008). The 
[SWI+] prion is eliminated by the presence of guanidine or loss of the Swi1 protein 
and is dominantly and cytoplasmically transmitted (Du et al., 2008).  The findings 
that the proteins Cyc8 and Snf1 can propagate as prions shows that prionization may 
lead to the mass activation or repression of yeast genes. The protein Mca1 is a 
metacaspase that regulates apoptosis in S.cerevisiae. Mca1 was isolated as a potential 
prion as it harbors a Q/N rich region in its N-terminal (Nemecek et al., 2009).  
Additionally, the prion forming domain of Mca1 contains several imperfect repeats of 
QQYG residues which is similar to repeats in the Sup35 protein (Nemecek et al., 
2009).  
 
1.3 Protein chaperones 
As polypeptide chains are released from the ribosome, it may change its conformation 
more than once, before reaching its functioning biologically active structure. Protein 
folding is a structured process and evolution has created a simplified pathway to 
achieve this. Protein chaperones catalyze protein folding and prevent protein 
misfolding; normally many chaperones will be involved in this process. Another 
function of protein chaperones is to recover proteins that have not correctly folded or 
have become aggregated. Misfolding of proteins may be a consequence of the cell 
being exposed to environmental stresses such as heat shock, osmolarity and acidity. 
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Table 1.1 Prions present in S.cerevisiae. There is strong genetic and biochemical 
data that the proteins Sup35, Ure2 and Rnq1 are capable of spontaneously converting 
into prion forms. According to strong genetic evidence, the more recently discovered 
Cyc8, Mca1, Swi1 and New1 are possible prion proteins, yet more biochemical 
analysis must be carried out. 
 
Genetic screens have uncovered protein chaperones and cochaperones such as Hsp70, 
Hsp104, Hsp40, Sse1 and Sti1 as having an essential role in the propagation of yeast 
prions.  
 
1.3.1 Hsp70 
The Hsp70 family of chaperones is highly conserved forming part of the ubiquitous 
protein folding system (Wegele et al., 2004). Hsp70 assists in protein folding and 
prevents aggregation of misfolded proteins due to heat shock.  Further functions of 
Hsp70 include translocation of polypeptides across membranes and it also plays a role 
Prion formNative protein Cellular function
Sup35 Efficient translation 
termination [PSI+]
Ure2 Utilisation of poor 
Nitrogen sources [URE3]
Rnq1 Unknown [PIN+]
Cyc8 Transcriptional co-
repressor/co-
activator
[OCT+]
Mca1 Regulation of 
apoptosis
[MCA]
Regulation  of  
transcription
Swi1 [SWI+]
Genetically and 
biochemically 
confirmed
Strong genetic proof
New1 Unknown [NU+]
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in macromolecule assembly e.g. clathrin coats (Schlossman et al., 1984). Hsp70 is a 
highly conserved protein, it is found in all organisms from archaebacteria to plants to 
humans. The bacterial Hsp70 (Dnak) shares fifty percent identity with eukaryotic 
Hsp70 proteins (Daugaard et al., 2007). Hsp70 also shows functional conservation 
e.g. Drosophila Hsp70 expressed in mammalian cells efficiently protects them against 
heat stress (Pelham 1984). S.cerevisiae encodes five organelle specific and nine 
cytosolic Hsp70’s (Table1.2). Kar2 is a lumenal Hsp70, which functions in 
conjunction with the transmembrane signal inducer Ire1 and the transcription factor 
Hac1 as part of the unfolded protein response in the endoplasmic reticulum. Yeast 
cytosolic Hsp70s are composed of the; Ssa (stress seventy subfamily a) (Ssa1, Ssa2, 
Ssa3, and Ssa4) and Ssb (Ssb1 and Ssb2), Sse1, Sse2 and Ssz1. 
 
 
1.3.1.1 Structure of Hsp70 
Hsp70 contains a conserved N-terminal ATPase (44-kDa), a peptide-binding domain 
(18-kDa) and a C-terminal domain lid domain (10-kDa). Functioning of Hsp70 
depends on the binding and hydrolysis of ATP; in an ATP bound state there is rapid 
substrate exchange between the chaperone and surrounding environment. When ATP 
is hydrolyzed to ADP, the chaperone is in a closed state, the substrate remains tightly 
bound to the peptide binding domain (Mayer et al., 2001) (Fig. 1.2). Optimal Hsp70 
function is achieved by communication between the peptide-binding domain and 
ATPase domain; binding of the substrate stimulates ATP hydrolysis in proportion to 
the proteins binding affinity (Mayer et al., 2000). The ATPase domain of Hsp70 is 
composed of two lobes, which consists of four subdomains (IA, IB, IIA and IIB), lobe 
one consists of IA and IB and the other lobe is comprised of IIA and IIB. The lobes  
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Gene 
name 
Location Function 
SSA1 Cytosol Constitutively expressed molecular chaperone, that binds 
newly-translated proteins to assist in proper folding and 
prevent aggregation/misfolding 
SSA2 Cytosol Constitutively expressed molecular chaperone, that binds 
newly-translated proteins to assist in proper folding and 
prevent aggregation/misfolding 
SSA3 Cytosol Heat induced molecular chaperone, that binds newly-
translated proteins to assist in proper folding and prevent 
aggregation/misfolding 
SSA4 Cytosol Heat induced molecular chaperone, that binds newly-
translated proteins to assist in proper folding and prevent 
aggregation/misfolding 
SSE1 Cytosol Nucleotide exchange factors (NEF) for Hsp70 chaperones 
during protein refolding. 
SSE2 Cytosol Nucleotide exchange factors (NEF) for Hsp70 chaperones 
during protein refolding. 
SSB1 Cytosol The chaperone activity of Ssb1 is localized to the ribosome 
as part of the ribosome-associated complex RAC. 
SSB2 Cytosol The chaperone activity of Ssb2 is localized to the ribosome 
as part of the ribosome-associated complex RAC. 
SSZ1 Cytosol The activity of Ssz1p is localized to the ribosome where it 
functions as part of the ribosome-associated complex 
(RAC), 
KAR2 Lumen of the 
ER 
Binds to secretory and transmembrane precursor proteins 
to prevent their misfolding 
LHS1 Lumen of the 
ER 
Lhs1 localizes to the ER and shares 24% amino acid 
identity with the other ER HSP70 protein, Kar2. These two 
proteins reciprocally regulate each other. Lhs1 only 
participates in post-translational import. 
SSC1 Mitochondria SSC1 encodes an essential chaperone that is the key 
component of the import motor sub-complex that mediates 
the transit of precursor proteins through the TIM23 
complex. 
SSQ1 Mitochondria Required for assembly of iron/sulfur clusters into proteins 
at a step after cluster synthesis, and for maturation of 
Yfh1p, which is a homolog of human frataxin implicated 
in Friedreich's ataxia, 
ECM10 Mitochondria Plays a role in protein translocation. 
 
Table 1.2 S.cerevisiae Hsp70 family: S.cerevisiae encodes five-organelle specific 
and nine cytosolic Hsp70’s 
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are connected at their bases through subdomains IA and IIA. ATP binds to the 
ATPase domain in a cleft between IB and IIB (O'Brien et al., 1996, Jiang et al., 
2005). The DnaK Hsp70 peptide-binding domain is composed of two anti-parallel ß-
sheets that are comprised of four ß-strands each, which forms a ß-sandwich structure. 
The first ß-sheet is comprised of ß3, ß6, ß7 and ß8 and the second ß-sheet is 
comprised of ß5, ß4, ß1 and ß2 with four upward protruding loops (Zhu et al., 1996). 
The peptide-binding cavity is formed by ß-sheets one and two and loops L12 and L34. 
The peptide-binding cavity
 
is primarily hydrophobic, but the surface potential around 
the cavity is mainly negative, therefore charges in the substrate also contribute to 
binding affinity. Hsp70 favours peptides that contain an interior hydrophobic core 
flanked with basic residues, with an optimal substrate length of eight residues for 
ATPase stimulation (Jordan and McMacken, 1995). The C-terminal domain (CTD) lid 
is linked to the ß-sandwich PBD through a network of Hydrogen bonds and ionic 
interactions between residues in the lid and residues present in loops L45 and L12. The 
CTD is not necessary for inter-domain communication but is necessary for peptide 
binding.    
 
1.3.1.2 Hsp70 mechanism of action 
The functioning of Hsp70 depends on the binding and hydrolysis of ATP. Information 
regarding the mechanism of action of Hsp70 is mostly acquired from studies utilizing 
E.coli Hsp70, DnaK, which has 50% identity to mammalian Hsp70 and thought to 
function in a similar manner. The function of Hsp70 is dependent on coordinated 
action from all three domains (ATPase, PBD and CTD). Substrate binding occurs in 
peptide binding cavity, which is formed by ß-sheets one and two and loops L12 and L34 
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the PBD, the binding affinity and kinetics is dependent on the presence or absence 
of ATP in the ATPase domain. In an ATP bound state there is rapid substrate 
exchange in the PBD, conversely when in an ADP bound state the PBD has a higher 
affinity for its substrates and displays slower exchange rates of peptides (Figure 1.2). 
The major structural difference between the ATP and ADP bound states of Hsp70 is 
the position of the CTD. In an ADP bound state the CTD lid is positioned over the 
peptide binding cavity, therefore reduces the release of substrates (Han and Christen, 
2003). Upon ATP hydrolysis, structural changes in the ATPase domain induce 
conformational changes in the PBD and CTD, which result in substrate trapping. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 “OPEN” form (rapid 
substrate exchange) 
“CLOSED” form (substrate 
tightly bound) 
ATP ADP 
Hsp40, Sti1, Cns1 
Fes1, Sse1 
Figure 1.2 Schematic diagram showing the Hsp70 binding cycle. In an ATP 
bound state Hsp70 is in an open conformation allowing rapid substrate exchange. 
ATP is hydrolyzed to ADP causing Hsp70 to become into a  closed state in which 
the substrate is tightly bound. The ATPase cycle is regulated by the presence of co-
chaperones such as Hsp40, that stimulates ATP hydrolysis. The nucleotide exchange 
factors Fes1 and Sse1 assist in returning the Hsp70 into the “open” conformation. 
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Correspondingly, substrate binding to the PBD alters its structure, which results in a 
signal being transmitted to the ATPase domain that stimulates ATP hydrolysis, 
therefore increasing substrate-binding affinity. Conversely, Hsp70 Nucleotide 
exchange factors (NEFs), promote the release of ADP, thereby facilitating the binding 
of ATP and reinstating the PBD to a low affinity state allowing rapid substrate 
exchange. The Hsp70 mechanism of action strongly suggests that inter-domain 
communication between the Hsp70 domains is critical for the correct functioning of 
Hsp70. 
 
 
1.3.1.3 Hsp70 cytosolic members of S.cerevisiae 
S.cerevisiae encodes nine cytosolic members of the Hsp70 family that are subdivided 
into classes Ssa (Ssa1, Ssa2, Ssa3, and Ssa4), Ssb (Ssb1 and Ssb2), Sse (Sse1 and 
Sse2) and Ssz1. The highly homologous Ssa proteins differ in their expression 
patterns, Ssa2 is constitutively expressed at high levels, SSA1 is also constitutively 
expressed but at lower levels than SSA2. However, SSA3 and SSA4 are not expressed 
under vegetative conditions but expression is dramatically increased when the cell 
encounters stress (Werner-Washburne et al., 1987, Boorstein and Craig 1990b, 
Boorstein and Craig, 1990a). The Ssa family consists of four proteins (Ssa1-Ssa4), 
and at least one of these is required for growth (Werner-Washburne et al., 1987). Ssa1 
and Ssa2 have 97% homology, the heat-inducible Ssa3/Ssa4 are 88% identical to one 
another and are 80% identical to Ssa1/2 (Table 1.3) (Sharma et al., 2009). Ssa1 
negatively regulates its own expression (Stone and Craig, 1990).  
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Table 1.3 Percent amino acid identity of Ssa proteins. Table adapted from (Sharma 
et al. 2009). 
  
The activity of cytosolic Hsp70 chaperones Ssb1, Ssb2 and Ssz1 are localized to the 
ribosome. They form part of a complex, ribosome-associated complex (RAC), which 
includes either Ssb1/2, Ssz1 and the DnaJ homologue Zuo1 (Pfund et al., 1998, 
Gautschi et al., 2001). This complex binds both the active ribosome and the 
associated nascent polypeptide chain to assist with translational fidelity and ensure 
correct protein folding (Gautschi et al., 2002, Rakwalska and Rospert, 2004). Both 
Ssb1/2 and Ssz1 are structurally similar to other Hsp70’s, containing an ATPase 
domain and a peptide-binding domain (Pfund et al., 1998). Unlike other heat shock 
genes in which expression is induced by heat, the expression of SSB1/2 is repressed 
(Craig and Jacobsen, 1985), instead the expression of SSB1/2 is coordinated with 
expression of ribosomal protein genes (Lopez et al., 1999). Ssz1 differs from other 
Hsp70’s as its ATPase domain and PBD activities do not appear to be necessary to 
carry out its functions (Hundley et al., 2002, Huang et al., 2005). It has been 
postulated that the function of Ssz1 is not to bind unfolded protein, but to assist in the 
ATPase stimulation of Ssb1/2 by the DnaJ protein Zuo1 (Huang et al., 2005). The Sse 
family of cytosolic Hsp70’s act as nucleotide exchange factors for Ssa1 (section 
1.3.2.3). 
 
 Ssa1 Ssa2 Ssa3 
Ssa2 97%   
Ssa3 79% 79%  
Ssa4 81% 81% 87% 
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1.3.2 Regulatory roles of Hsp70 co-factors 
Hsp70 is involved in many cellular functions and requires the activity of co-
chaperones and NEFs to carry out essential cellular functions and to regulate its own 
functions. Hsp70 functions in concert with the co-chaperones such as Hsp40 and 
Hsp90 and the ATPase cycle of Hsp70 is regulated by components that stimulate ATP 
hydrolysis and NEFs such as Sse1 and Fes1. 
 
1.3.2.1 Hsp40 
One important co-chaperone that plays a major role in regulating Hsp70 interaction 
with substrates is Hsp40. The Hsp40 is ubiquitous and is represented by multiple 
isoforms, with twenty-two being expressed in S.cerevisiae. The Hsp40 co-chaperone 
family (also known as J proteins) are defined by a conserved stretch of approximately 
seventy residues, which is known as the J domain (Craig et al., 2006, Walsh et al., 
2004). Hsp40 is the most abundant and is an obligatory regulator of Hsp70 in 
S.cerevisiae. The co-chaperone Hsp40 functions in two ways to assist the function of 
Hsp70; it can bind to unfolded substrates and present them to Hsp70 (Laufen et al., 
1999) and it can physically interact with Hsp70 and stimulate ATP hydrolysis (Cyr et 
al., 1992) (Figure1.2). Hsp40 can be defined as a chaperone itself as it binds specific 
hydrophobic peptide, which are also bound by Hsp70 and contributes to the 
prevention of protein aggregation, (Lian et al., 2007, Moriyama et al., 2000). Hsp40 
also binds directly to Hsp70, stimulating ATP hydrolysis by up to 1000-fold and 
functions to coordinate ATP hydrolysis in the PBD (Laufen et al., 1999, Liberek et 
al., 1991). Particular Hsp70s display specificity for a single J protein (Walsh et al., 
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2004, Sahi and Craig, 2007), e.g. in S.cerevisiae the cytosolic Hsp70 members Ssa1/2 
specifically interact with the hsp40 members; Sis1, Ydj1, Swa2, Hij1 and Djp1 
(Hettema et al., 1998, Horton et al., 2001, Kryndushkin et al., 2002). The specificity 
of the interaction between members of the Hsp70 family and the Hsp40 family, allows 
Hsp70 to perform various functions, e.g. a main function of Ssa1/2 is general protein 
folding in the cytosol. However, the Hsp40 member Sis1 assists Ssa1/2 on ribosomes 
(Horton et al., 2001) in translation and Ydj1 is involved in the recruitment of Ssa1/2 
to protein folding on ER membranes (Brodsky et al.,1998). The ability of Hsp40 to 
interact with various substrates and its ability to stimulate the ATPase cycle of Hsp70 
results in Hsp70 binding a wider range of substrates than it would independently 
(Misselwitz et al., 1998).  
 
1.3.2.2 Sti1 and Cns1 
Sti1 and Cns1 are both strong regulators of ATPase activity of the Hsp70 member 
Ssa1. Sti1 was originally discovered as a Hsp90 chaperone that inhibits the ATPase 
activity of Hsp90 by acting as a non-competitive inhibitor (Prodromou et al. 1999) 
(Richter et al. 2003). Sti1 has also been identified as a potent ATPase activator of the 
Hsp70 Ssa members (Wegele et al. 2003b). Hop1 is the mammalian homologue of 
Sti1 (Honoré et al. 1992, Smith et al. 1993) and binds to the C -termini of both Hsp70 
and Hsp90, providing a physical link between both chaperones (Brinker et al. 2002). 
Binding of Sti1 to Hsp70 and Hsp90 involves tetratricopeptide (TPR) domains, which 
consist of TPR motifs which are degenerate sequences that are thirty-four amino acid 
in length (Richter et al., 2003, Lamb et al., 1995), that form a structurally conserved 
tandem array of two anti- parallel α-helices.  Multiple TPR motifs adopt a right-
handed super helix structure, which creates a groove with a large surface area. Both 
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Hsp70/Ssa1 and Hsp90 contain the conserved C-terminus residues EEVD that 
mediates their interactions with the TPR domains of Sti1 (Scheufler et al., 2000). The 
Cns1 protein also contains a TPR domain and can activate basal Ssa1 ATPase activity 
by thirty-fold (Hainzl et al., 2004). 
 
1.3.2.3 Hsp70 NEFs Sse1 and Fes1 
When in an ADP bound state, Hsp70 has a weak interaction with its substrate, 
conversely, in an ADP bound state the Hsp70 substrate becomes tightly bound, 
therefore, the ADP-ATP exchange is critical for regulating the Hsp70 cycle. NEFs 
trigger substrate release by shifting the equilibrium towards an ATP bound state. Fes1 
and Sse1 are well known NEFs in S.cerevisiae (Kabani, et al., 2002a). Sse1 and Fes1 
exhibit functional redundancy as overexpression of FES1 recovers strains harboring a 
lethal ∆sse1 ∆sse2 double deletion (Raviol et al., 2006), although recovery seems to 
be strain specific (C. Moran, personal communication). 
Sse1 is also a member of the cytosolic Hsp70 family, comprised of an ATPase 
domain, a PBD containing an extended linker region separating the ß and α 
subdomains of the domain and an extended C-terminal region (Liu and Hendrickson, 
2007; Easton et al., 2000). Sse1 requires ATP for its activation and upon binding of 
ATP Sse1 adopts a conformation required for association with Ssa1. It is thought that 
the ATPase domains of Ssa1 and Sse1 associate assymetrically  so that lobe I of Ssa1 
contacts lobe II of Sse1 and the C-terminal α-helical domain of Sse1 plays a role in 
this interaction (Andréasson et al., 2008). Fes1 is also a NEF present in yeast (Kabani 
et al., 2002a), it is homologous to the mammalian HspBP1 which causes nucleotide 
dissociation in both Ssa1 and mammalian Hsc70 (Kabani et al., 2002b). Fes1 
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facilitates translation, a process in which Ssa1 and Ydj1 have been implicated in 
(Brodsky et al., 1998, Horton et al., 2001). 
 
1.3.3 Hsp90 
Hsp90 was originally identified as one of the several conserved heat shock proteins as 
it exhibits general protective properties, preventing aggregation of non-native proteins 
(Wiech et al., 1992). However, Hsp90 appears to be more selective than other heat 
shock proteins, reacting with only a specific subset of proteins (Picard 2002). Hsp90 
is a highly conserved protein and is extremely abundant in nearly all organisms and 
cell types prior to cellular stress. Budding yeast contain two Hsp90 genes which 
encode very similar isoforms of Hsp90; Hsc82 and Hsp82 which have 97% sequence 
identity . Hsc82 is constitutively expressed at high levels and is only slightly induced 
by heat shock, whereas Hsp82 is strongly induced by both heat and stress (Borkovich 
et al., 1989). 
 
1.3.3.1 Hsp90 structure 
Hsp90 is a flexible dimer, with each monomer consisting of three domains, each 
consisting of an N domain, connected by a long linker sequence to an M –domain that 
is followed by a C-terminal dimerization domain. The function of Hsp90 is dependent 
on ATP hydrolysis (Panaretou et al., 1998, Obermann et al., 1998); the N-terminal 
possesses a deep ATP binding pocket (Prodromou et al., 1997). The rate of ATP 
hydrolysis is slow (in yeast one molecule of ATP is hydrolyzed every one/two 
minutes) (Panaretou et al., 1998, Scheibel et al.,  1998). The slow rate of ATP 
hydrolysis suggests that Hsp90 undergoes a complex conformational rearrangement 
due to ATP binding. Upon ATP binding a short segment on the N-domain known as 
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the ATP lid, changes its position and flaps over the binding pocket. This releases a 
short N-terminal sequence from its original position (Richter et al. 2002). 
Subsequently this segment binds to the respective N-domain of other subunit in dimer 
producing a strand-swapped, transiently dimerized N-terminal conformation (Ali et 
al., 2006, Richter et al., 2006). This N-terminal rearrangement results in further 
conformational changes throughout the dimer leading to a twisted and compact 
structure.   
 
1.3.3.2 Hsp90 function and cofactors  
The Hsp90 chaperone differs from Hsp70 as its client proteins typically compose of 
kinase or transcription factors that rely on Hsp90 for correct signaling.  Hsp90 binds 
clients that are already considerably folded and induces structural changes and protein 
associations in order for clients to obtain their full activity. Hsp90 client folding 
pathway involves Hsp70 and co-chaperones involved in regulating Hsp90. Initially, 
client proteins interact with Hsp40 (Hernández et al., 2002ab), which targets them to 
Hsp70; proteins are transferred from Hsp70 to Hsp90 in order for folding to be 
completed. The co-chaperone Sti1 is thought to facilitate transfer by binding both 
Hsp70 and Hsp90 via TPR domains, forming a bridge on which proteins can be 
transferred (Smith et al., 1993, Chen et al., 1996, Chen and Smith, 1998). Sti1 
stimulates the ATPase activity of Hsp70 but inhibits the ATPase activity of Hsp90 
(Wegele et al., 2003b, Richter et al., 2003). It is thought that in addition to forming a 
physical link between Hsp70 and Hsp90, Sti1 may affect client folding through 
regulation of conformation and ATPase cycles of the two chaperones (Johnson et al., 
1998, Smith and Johnson, 2000, Hernández et al., 2002b).  
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An example of an Hsp90 client is the stress activated mitogen activated protein 
(MAP) kinase protein Slt2. MAPK modules consist of protein kinases that stimulate 
each other in series resulting in activation of a terminal MAPK. The Slt2 protein is 
part of the cell wall integrity (CWI) signaling pathway. The CWI signaling pathway is 
induced by cell wall damage caused by heat and chemical agents. Cell wall damage is 
transmitted by protein kinase C to a MAP kinase module terminating in the MAPK 
Slt2 (Paravicini et al., 1992, Torres et al., 1991, Lee and Levin, 1992). Slt2 
phosphorylates and activates two transcription factors, Rlm1 and the Swi4/6 cell-cycle 
box-binding factor (SBF). Rlm1 and SBF activate expression of distinct sets of genes 
with predicted roles in cell wall synthesis and repair (Lagorce et al., 2003). A Yeast-
two hybrid screen that was undertaken to isolate Hsp90 binding partners isolated Slt2 
as a Hsp90 binding partner (Millson et al., 2005) and further studies revealed that 
Hsp90 binds specifically to the dually Thr/Tyr-phosphorylated, stress activated 
form of Slt2p ((Y-P,T-P) Slt2) and also to the MAP kinase domain within this (Y-P,T-
P) Slt2 (Millson et al., 2005). Mutant analysis of Hsp90 revealed that the chaperones 
function for (Y-P,T-P) Slt2 to activate its downstream target; the transcription Rlm1 
(Millson et al., 2005), implicating Hsp90 as a component of the CWI signaling 
pathway. More recently the Hsp70 NEF Sse1 has also been implicated in the CWI 
signaling pathway, through a partnership with Hsp90 and Slt2 (Shaner et al., 2008).  
 
 
1.3.4 Hsp104 
Hsp104 is a member of the class1 Clp/Hsp100 family of hexameric AAA+ ATPases 
(ATPases associated with various cellular activities) protein superfamily (Neuwald et 
al., 1999). The clp/Hsp100 family is composed of Hsp100 proteins from bacteria, 
 24 
plants and fungi. Hsp104 is a protein disaggregase that recovers proteins that have 
becomes aggregated due to stresses such as heat shock, hydrogen peroxide (Godon et 
al., 1998), ethanol and near freezing cold shock (Kandror et al., 2004). Hsp104 
substrates include unfolded polypeptides and amorphous aggregates from various 
proteins. It is not required for cellular viability, as a ∆hsp104 strain shows no defect in 
normal cellular growth but exhibits severe defects at elevated temperatures exhibiting 
the importance of the chaperone in cellular thermotolerance.  
 
1.3.4.1 Structure and function of Hsp104  
Members of the class Clp/Hsp100 family, members of this family contain variable C 
and N-terminus domains and two highly conserved nucleotide binding domains 
(NBD1 and NBD2), that are separated by a variable middle domain. The highly 
conserved NBD domains are equipped with a multitude of accessory motifs and 
domains that grant different substrate specificities and functions (Hanson and 
Whiteheart, 2005), but are not identical to one another in structure or function. The 
active state of yeast Hsp104 and its bacterial homologue ClpB is typically a 
hexameric ring (Figure 1.3). Studies utilizing electron microscopy observing 
negatively stained Hsp104 revealed a barrel shaped hexamer of approximately 155 Å 
diameter (Parsell et al., 1994). The hexameric state of Hsp104 exhibits a higher 
ATPase rate than the monomer and is stabilized by high protein concentration, ATP 
or ADP and low ionic strength (Schirmer et al.1998, Schirmer et al. 2004). NBD1 
drives the major constitutive Hsp104 ATPase activity (Schirmer et al., 1998, 
Hattendorf and Lindquist, 2002), whereas oligomerization is dependent on NBD2 
(Parsell et al., 1994, Schirmer et al., 2004). ATPase activities of both domains is 
necessary for full protein remodeling activity and is dependent on allosteric 
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communication between and within domains of Hsp104 (Schirmer et al., 2001, 
Hattendorf and Lindquist, 2002, Cashikar et al., 2002, Doyle et al., 2007). In Hsp104 
communication between NBDs, is thought to be mediated by Arginine fingers (R334 
and R765) that extend into the ATPase binding site of adjacent subunits and 
participate in hydrolysis of ATP (Karata et al., 1999). Studies on the Hsp104 
homologue, ClpB of T.thermophilis, reveals the middle region is formed by two 
antiparallel coiled-coil motifs connected near the interface of NBD1 and NBD2 (Lee 
et al., 2003). The role of the coiled-coil region in Hsp104 is unclear, deletion of this 
region in ClpB results in inhibition of protein remodeling activities but 
hexamerization still occurs (Mogk et al., 2003). Single point mutations in a conserved 
eleven amino acid region (helix L3) of the coiled-coil domain of Hsp104 results in 
extremely diverse functional defects (Schirmer et al., 2004). A loss of function 
mutation in the equivalent region of the Arabidopsis Hsp101 is restored by suppressor 
mutations in both NBD1 and the axial channel loops of the hexamer, this result is 
indicative of a functional link between the coiled-coil and these regions (Lee et al., 
2005). The coiled-coil region of Hsp104 drives inter-domain communication between 
NBD1 and NBD2 in Hsp104 (Cashikar et al., 2002) and acts as a regulatory device in 
ClpB by coupling translocation activity to DnaK chaperone activity (Haslberger et al., 
2007). A mechanistic model of Hsp104  is that it operates by extracting polypeptide 
chains from aggregates and processing them through the central channel of Hsp100/ 
ClpB hexamer, a process which is dependent on ATP hydrolysis (Grimminger et al., 
2004). This process in conjunction with the Hsp70/Hsp40 chaperone system carries 
out the disaggregase function of Hsp104 (Fig 1.3). Recent studies indicate that the M 
domain is essential for protein dissaggregation but dispensable for ATPase and 
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substrate translocation activities and controls the Hsp104 remodeling activities in a 
Hsp70/Hsp40 dependent manner (Sielaff and Tsai, 2010).  
 
 
 
 
Figure 1.3 Mechanistic model of Hsp104. When the cell encounters stress, proteins 
become misfolded and aggregated. Hsp104 operates by extracting polypeptide chains 
from aggregates and processing them through the central channel of Hsp100/ Clpb 
hexamer, a process that is dependent on ATP hydrolysis. Hsp104 operates in concert 
with Hsp70 and Hsp40 to ensure correct folding of proteins. 
 
 
1.4 Factors affecting prion propagation in S.cerevisiae  
Propagation of yeast prions requires normal abundance and activity of many protein 
chaperones including Hsp70, Hsp40 and Hsp104. Hsp70 is regulated by many co-
chaperones whose affect on prion propagation is probably mediated through Hsp70 
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(Figure 1.4).  The Hsp70 NEFs, Sse1 and Fes1 have also been implicated as playing a 
role in prion propagation. Chaperones, co-chaperones and Hsp70 NEFs have been 
implicated in the maintenance and propagation of yeast prions.  
 
1.4.1 Affects of Hsp70 and co-chaperones on prion propagation  
Co-purification studies of the prion proteins Sup35 and Rnq1 showed that the 
cytosolic Hsp70 members; Ssa1 and Ssb1and their co-chaperones Ydj1, Sis1 and Sse1 
bind to the prion form of the Sup35 protein in yeast (Allen et al., 2005, Bagriantsev et 
al., 2008, Sondheimer et al., 2001). Ssa1/2 were the most abundant proteins to co-
purify with Sup35 from [PSI+] cells, which is indicative that Hsp70 directly interacts 
with the prion form of Sup35 in vivo and its co-chaperones may affect prion  
propagation in a Hsp70 mediated manner. Many groups have monitored the affects of 
chaperones on amyloid and the kinetics of Sup35 and Ure2 formation, or their prion 
determining regions into amyloid (Krzewska and Melki, 2006, Shorter and Lindquist, 
2008, Savistchenko et al., 2008). These studies concluded that fragmentation  
of amyloid or inhibition of amyloid assembly are consistent with binding interactions 
of the different chaperones with ex vivo soluble and prion forms of proteins. 
In addition to biochemical studies on the involvement of Hsp70 in prion propagation, 
numerous groups have carried out genetic studies. Overexpression of Ssa1 in yeast 
cells causes loss of [URE3] but not doe not cause loss of the [PSI+] prion (Schwimmer 
and Masison, 2002). Mutational analysis of Ssa1 and Ssa2 has further implicated 
Hsp70 as playing a role in prion propagation (Jung et al., 2000, Jones and Masison, 
2003, Loovers et al., 2007). Isolation of mutations in the PBD and ATPase domain 
highlight the importance of the ATPase cycle and inter-domain communication of 
Hsp70 in prion  
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propagation. The Ssa1 dominant mutation L483W, designated the name SSA1-21 
(Jung et al., 2000) and the G481D (Loovers et al., 2007) mutants are the only isolated 
mutations present in the PBD of Ssa1 that impair [PSI+] propagation in yeast. These 
mutations have no detectable effects on stress tolerance or cell growth suggesting the  
 
 
 
Figure 1.4 Involvement of protein chaperones in prion propagation. In yeast, 
specific native proteins such as Sup35 can spontaneously convert into the prion form. 
Once the prion form has been established, it can then recruit and convert native 
protein into the prion form, forming aggregates which enlarge and form amyloid 
fibrils. In order for prions to propagate, they must be passed on to daughter cells. This 
is achieved by the fragmentation of amyloid fibrils into prion seeds, which are then 
passed on to daughter cells during cell division. Protein chaperones such as Hsp40, 
Hsp70 and Hsp104 play a crucial role in this process. 
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affects are specific and do not affect functions of Hsp70 (Jung et al., 2000, Loovers et 
al., 2007). To gain further insight into how Ssa1 affects prion propagation, further 
mutagenesis screens were carried out, a majority of mutations that impaired prion 
propagation were located in the ATPase domain of Ssa1 and Ssa2 (Jones and 
Masison, 2003, Loovers et al., 2007). This is indicative that regulation of chaperone 
activity was more important than direct substrate interactions for the inhibitory effect. 
A further genetic screen to isolate second-site suppressors of the SSA1-21, isolated 
mutations that suppress anti prion effects of SSA1-21 and a number of ATPase 
mutants (Jones and Masison, 2003, Loovers et al., 2007). The location of these second 
-site mutants suggests that they suppress anti-prion affects of mutants by reducing 
ATP hydrolysis through interaction with Hsp40 or TPR co-chaperones or through 
weakening substrate trapping. 
 
Subsequent analysis confirmed that altering the ATPase cycle has an affect on prion 
propagation (Jones et al., 2004), e.g. for example, either increasing ATPase activity 
by overexpressing  Sti1 or decreasing ADP release by deleting the NEF Fes1 weakens 
the [PSI+] phenotype (Jones et al., 2004). This is indicative that shifting the ATPase 
cycle of Hsp70 to favor an ADP bound state appears to impair [PSI+] propagation.  
Despite their high levels of conservation, different Ssa members appear to have 
different affects on prion propagation. Overexpression of Ssa1 but not Ssa2 cures 
[URE3], additionally [URE3] is weaker in cells lacking Ssa1 but not in cells lacking in 
Ssa2 (Roberts et al., 2004; Sharma and Masison, 2008; Sharma et al., 2009). Other 
members of the cytosolic Hsp70’s also have an affect on prion propagation; Ssb1 and 
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Ssb2 were found to antagonize the de novo formation of [PSI+] (Chernoff et al., 1999; 
Allen et al., 2005).  
Another member of the cytosolic Hsp70 family, Sse1 is also thought to play a role in 
prion propagation (Fan et al., 2007, Sadlish et al., 2008, Kryndushkin and Wickner, 
2007). In addition to its role in prion propagation, recent studies have shown that the 
Ssa1 and Ssb1 NEF is also required for the de novo formation of [PSI+] and also prion 
variant determination (Fan et al., 2007). Studies show that overproduction of Sse1 
dramatically enhances [PSI+] formation, whereas deletion of Sse1 severely inhibits 
[PSI+] formation ( Fan et al., 2007; Shaner et al., 2008; Sadlish et al., 2008,). The 
abundance of Sse1 also has an affect on the [URE3] prion; overproduction of Sse1 can 
efficiently cure [URE3] whereas deletion of Sse1 blocks [URE3] propagation 
(Kryndushkin and Wickner ,2007). Results from these studies are indicative that Sse1 
affects propagation of prions through Ssa1 function. It has been suggested that the 
NEF function of Sse1 is necessary for maintaining sufficient levels of substrate free 
Ssa1 (Sadlish et al., 2008). However, Sse1 also exhibits NEF independent activity in 
relation to prion propagation; stimulation of in vitro nucleation of the Sup35NM 
(prion forming domain of Sup35) (Sadlish et al., 2008). The above information 
suggests that propagation of different prions relies on different Hsp70 functions. 
 
1.4.2 Affects of Hsp40 on prion propagation  
Studies utilizing both [PSI+] and [URE3] have identified complex roles for Hsp40 co-
chaperones in prion propagation and assembly of amyloid-like fibrils. The Sis1 and 
Ydj1 members of the Hsp40 family have been found to physically interact with large 
Sup35 aggregates (Bagriantsev et al., 2008) and [PSI+] propagation has been shown 
to be dependent on Sis1 (Higurashi et al., 2008, Tipton et al., 2008), whereas Ydj1 in 
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combination with cognate Hsp70 destabilizes weak variants of [PSI+] (Kushnirov et 
al., 2000). Apj1 is another member of the Hsp40 family in yeast, and overexpression 
of this co-chaperone cures certain variants of [PSI+] (Kryndushkin et al., 2002). Apj1 
shares high homology with Ydj1 but its cellular function remains unclear. Hsp40 has 
also been directly implicated with Sup35 fibril assembly in vitro ( Krzewska and 
Melki, 2006; Shorter and Lindquist, 2008).  
Hsp40s also play a role in the propagation of the [URE3] prion, Sis1 is required for 
[URE3] propagation (Higurashi et al. 2008), while overexpression of Ydj1 cures yeast 
of [URE3] (Moriyama et al., 2000). Ydj1 binds to soluble Ure2 in the presence or 
absence of its prion domain and when added to purified Ure2 it inhibits formation of 
amyloid in a concentration dependent manner, indicating Ydj1 binds to Ure2 and 
prevents fibril formation (Savistchenko et al., 2008, Lian et al., 2007). However, the 
addition of Ydj1 to Ure2 after polymerization begins, does not affect amyloid 
formation and additionally, cells over producing Ydj1 have longer prion polymers 
(Kryndushkin and Wickner, 2007), indicating that Ydj1 may interfere with polymer 
fragmentation rather than polymer assembly. Studies have also revealed that the J 
domain of Ydj1 is sufficient for the elimination of [URE3], the J domain of Ydj1 
mediates interaction with Hsp70 and is responsible for stimulating ATPase activity, 
suggesting that the regulation of Ssa1 by Ydj1 is crucial for the [URE3] curing 
process (Sharma et al., 2009; Masison et al., 2009). 
 
The Hsp40 cytosolic member, Sis1, was discovered to be essential for prion 
propagation through its association with the Rnq1 protein in [PIN+] cells (Sondheimer 
et al., 2001). Sis1 is the only member of the Hsp40 family that is required for the 
propagation of [PSI+], [URE3] and [PIN+] (Aron et al., 2007, Higurashi et al., 2008). 
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The Sis1 protein binds specifically to Rnq1, to a region outside of the prion 
determining domain, and this binding is important for [PIN+] propagation  (Lopez et 
al., 2003, Douglas et al. 2008). Ssa1 also interacts with Rnq1, and the Sis1pG/F 
region is believed to aid cooperation between Sis1 and Ssa1 in substrate interactions. 
The interaction of Sis1 and Ssa1 with Rnq1 occurs only in [PIN+] cells (Sondheimer 
et al., 2001), and inhibition of the ability of Sis1 to stimulate ATPase activity of Ssa1 
also impairs [PIN+] propagation, suggesting Sis1 acts as a Hsp70 co-chaperone with 
respect to [PIN+] propagation (Higurashi et al., 2008, Lopez et al., 2003, Aron et al., 
2007). In cells depleted of Sis1 and Hsp104, there is an increase in Rnq1 polymers 
size and the number of [PIN+] seeds decreases (Aron et al., 2007). Both these effects 
appear to be due to altered Sis1 interactions with both Hsp70 and Hsp104 and 
indicates that Sis1 is necessary for fragmentation of Rnq1 polymers which is required 
for [PIN+] prion propagation (Aron et al., 2007). Sup35 polymers also increase in size 
in the absence of Sis1 or due to the inhibition of Hsp104 
(Kryndushkin et al., 2003, Higurashi et al., 2008). These results suggest that Sis1 may 
work in conjunction with Hsp70 to deliver prion substrates to Hsp104 (Tipton et al., 
2008). 
 
1.4.3 Affects of Hsp104 on prion propagation  
In yeast, prions are passed from generation to generation by transmitting aggregated 
prion seeds in cytoplasm from mother to daughter cells. Prion seeds can recruit and 
convert native proteins of identical amino acid sequence into the prion form, thus 
propagating the prion (Figure 1.4). Abundance of the protein chaperone Hsp104 is 
critical in the propagation of [PSI+] prion (Chernoff et al.,1995), deletion or 
overexpression results in the loss of the prion and the appearance of [psi-] cells. Intact 
 33 
Hsp104 is also required for the propagation of other yeast prions although unlike 
[PSI+] they are not cured by Hsp104 overproduction.  
Decreased production or inactivation of Hsp104 results in an increased size and 
number of Sup35 aggregates (Wegrzyn et al., 2001). Treatment of cells by GdnHCl, a 
chemical known to cure yeast prions via Hsp104 inactivation (Ferreira et al., 2001), or 
down regulation of its production, also exhibit an increased size of Sup35 aggregates. 
The increase in polymer size and decrease in polymer number can be explained by the 
assumption that Hsp104 breaks down prion polymers into smaller oligomers, 
therefore deletion or inhibition of Hsp104 results in the generation of larger polymers 
and therefore a smaller number of seeds (Kushnirov and Ter-Avanesyan, 1998). The 
decrease in polymer levels per cell results in the decreased efficiency of prion 
conversion, resulting in loss of the [PSI+] prion during cellular divisions (Cox et al., 
2003). 
 
The dissaggregation-based model of Hsp104 may also explain how overproduction of 
the chaperone cures the [PSI+] prion. There is a high possibility that high abundance 
of the Hsp104 chaperone eliminates [PSI+] by shearing Sup35 polymers into 
monomers, although direct evidence is lacking. Studies utilizing fluorescent 
microscopy analyzed the affects of Hsp104 overproduction on a Sup35-GFP 
aggregated structure (Wegrzyn et al.,2001). Diffusion of the structure was visible in 
[PSI+] cells; however, it is not clear whether the diffusion reflects monomerization or 
a decrease in the Sup35-GFP aggregate size. Biochemical analysis confirm that [PSI+] 
cells overexpressing Hsp104 accumulate a larger proportion of soluble Sup35 
(Paushkin et al.,1996), that behaves as a monomeric protein in semi denaturing 
conditions (Kryndushkin et al., 2003). However, it is not clear whether monomeric 
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Sup35 present in cells overproducing Hsp104 originates from prion aggregates or is 
synthesized de novo when prion propagation is inhibited, although it is thought that 
monomers originating from prion aggregates are likely to be misfolded. 
 
 However, there is also an alternative hypothesis on how excess Hsp104 cures cells of 
the [PSI+] prion. In cells overexpressing Hsp104 in which monomers were detected, 
the remaining Sup35 polymers were larger in comparison to extracts from the same 
strain expressing normal levels of Hsp104 (Kryndushkin et al., 2003). Fluorescent 
microscopy studies of overproduced Sup35-GFP in the presence of excess Hsp104 
formed large filaments in [PSI+] cells (Zhou et al., 2001), such filaments have no been 
observed in [PSI+] cells expressing normal abundance of Hsp104, but have been 
observed in [psi-] cultures overproducing Sup35-GFP (Zhou et al.,, 2001). Further 
studies showed that these filaments are associated with some cytoskeletal components 
of the endocytic/vacuolar network and are interpreted as intermediates in the prion de 
novo formation pathway (Ganusova et al., 2006). 
 
Further studies on the mechanism of how overproducing Hsp104 cures the [PSI+] 
prion, the Masison group proposed that the amino terminal domain (NTD), is 
necessary for this process (Hung and Masison, 2006). The NTD is a highly conserved 
domain among Hsp100 proteins and contains two structurally similar repeats R1 and 
R2 (Lo et al., 2001), the function of this domain in unknown. Mutations of the 
Hsp104 NTD were isolated that improved [PSI+] propagation and removal of the 
NTD also supported [PSI+], thermotolerance and protein dissaggregation, yet 
overexpression of this construct failed to cure [PSI+]  (Hung and Masison, 2006). This 
suggests that an intact NTD is required for curing by Hsp104 overexpression, despite 
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having both normal thermotolerance and protein dissaggregation function increasing 
these activities is not sufficient for curing. These results imply that the mechanism by 
which excess Hsp104 cures the [PSI+]  prion is not dependent on Hsp104’s function 
of disaggregating of proteins (Hung and Masison, 2006). It also implies that the NTD 
of Hsp104 is not required for interacting with Hsp104 substrates such as Sup35. 
However, overexpression of the NTD alone is not sufficient to cure [PSI+], suggesting 
that the dissaggregation function of Hsp104 may still be necessary for this process. 
One possibility is that the NTD directs Hsp104 function to subcellular locations 
required for eliminating [PSI+]. The exact mechanism by which overexpression of 
Hsp104 cures [PSI+] remains to be uncovered. 
 
It also appears that Hsp104 does not function independently in curing of the [PSI+] 
prion by its overexpression. Recent studies have indicated that the Hsp70 and Hsp90 
co-chaperones Sti1 and Cpr7 may be involved in this process (Moosavi et al., 2010). 
The N-terminal of Hsp104 contains a TPR motif required for interactions with TPR 
containing co-chaperones. The Hsp104 TPR motif is dispensable for curing, however 
cells expressing Sti1 defective in Hsp70 and Hsp90 interaction cured less efficiently. 
Also the presence of the Hsp90 inhibitor radicicol  abolishes curing, implying Sti1 
acts in curing through Hsp70 and Hsp90 interactions (Reidy and Masison, 2010). 
Similar results were also observed by another study, deletion of the Hsp70 and Hsp90 
co-chaperones lead to a significant reduction in the generation of [psi-] cells by 
Hsp104 overexpression. Deletion of the Sti1 and Cpr7 genes does not modify curing 
of [PSI+] by guanidine, which inhibits the ATPase activity of Hsp104, but does not 
block the elimination  of [PSI+] by overexpression of either a Hsp104 mutant deficient 
in ATPase activity or a trap mutant that binds substrate and does not release it 
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(Moosavi et al., 2010). These results support the hypothesis that Hsp104 
overexpression elimination of [PSI+] is not simply a consequence of complete 
dissolution of prion aggregates but rather through a consequence of a mechanism 
distinct from remodeling of Hsp104. 
 
It is unclear whether Hsp104 recognizes specific regions of prion proteins. Some  
reports implicate the Sup35 prion domain (PrD), which is located between residues 40 
and 97, which includes 5.5 imperfect copies of the oligopeptide repeat (OR) as a 
possible element responsible for [PSI+] transmission to daughter cells (Chernoff 2004, 
Osherovich et al., 2004). As prion propagation is dependent on Hsp104, it is 
conceivable to think that the ORs may acts as a site of interaction for Hsp104. 
However, studies carried out using Sup35 derivatives with a shuffled PrD (maintained 
amino acid sequence but lacked repetitive order of ), are still able to propagate as 
prions in a Hsp104 dependent manner (Ross et al., 2005).  Further to this not all 
prions contain the OR regions, e.g. it is absent in Ure2. Conversely, some data suggest 
that the middle domain of Sup35, which is located outside the PrD, influence effects 
of Hsp104 on prion (Liu et al., 2002). Collectively, this information suggests that the 
Hsp104 chaperone may recognize a variety of sequences in amyloid conformation or 
the role of the ORs is to make amyloid accessible to Hsp104 rather than interacting 
with the chaperone directly.  
 
Mutational analysis of the Hsp104 gene suggests that the chaperone may have 
different mechanisms for dissaggregation of prion polymers and dissaggregation of 
heat-damaged proteins (Lee et al., 2003, Cashikar et al., 2002, Kurahashi and 
Nakamura 2007). Mutations were isolated in Hsp104 that affected prion propagation 
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but not thermotolerance, all theses mutations were situated near the lateral channel of 
the Hsp104 hexamer (Figure 1.3), according to an alignment with the T.thermophilus  
ClpB sequence (Kurahashi and Nakamura 2007). This channels ~10-to-30 Å wide, 
thus it was proposed that this channel could be able to thread amyloid fibers, pointing 
to the possible ability of Hsp104 to use the lateral channels for dissaggregation of 
prion polymers, while the central pore is used for disaggregating heat damaged 
proteins (Lee et al., 2003, Cashikar et al., 2002, Kurahashi and Nakamura, 2007).  
 
1.5.0 Other factors affecting prion propagation in S.cerevisiae  
In addition to effects of protein chaperones on propagation in yeast, it is possible that 
other cellular components or processes may also have an effect. 
 
1.5.1 Sup45 (eRF1) 
As discussed in section 1.2.2, Sup45 physically and functionally interacts with Sup35 
to form a release factor complex that is essential for the release of nascent peptides 
from the ribosome during translation termination. The Sup35 protein interacts with 
the C-terminal of Sup45 (Eurwilaichitr et al., 1999). Presumably once Sup45 forms a 
complex with Sup35, the Sup35 molecule is not available to undergo conversion into  
[PSI+]. Studies analyzing the affects of overexpression of Sup45 on prion propagation 
found that overexpression significantly reduced the frequency of the induced de novo 
formation of [PSI+] but did not affect prion propagation (Derkatch et al.,1998).  It is 
possible that this interaction between Sup35 and Sup45 stabilizes Sup35 conformation 
enough to prevent imperfect seeding by the [PIN+] but not to prevent polymerization 
once seeds are established. Alternatively, Sup45 could interact directly with other 
chaperones or could interact with the Rnq1 protein directly.  
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1.5.2 The ubiquitin-proteosome system (UPS) 
One mechanism in yeast cells to eliminate damaged, misfolded or defective proteins 
that may cause damage to the cell, is the ubiquitin-proteosome system (UPS) 
(Hershko and Ciechanover, 1998). Once a protein has become damaged, it is targeted 
for degradation by binding a 76-amino acid protein named ubiquiton (UB) through the 
sequential action of many enzymes, including UB conjugating enzymes (Ubc). This 
can be reversed  by various deubiquitinating enzymes, that include UB specific 
proteases (UBP) that take apart UB conjugates and release free UB (Wilkinson 2000). 
It has been shown that alterations to the UPS can affect the de novo appearance of  
[PSI+] (Allen et al., 2007). As previously discussed overproduction of Hsp104 
eliminates the [PSI+] prion. Studies have demonstrated that deletion of genes (UBC4 
and UBC6), involved in the UPS has a decreased affect on [PSI+] elimination by 
Hsp104 overproduction (Allen et al., 2007). Furthermore, it was found that in the 
presence of Rnq1, ∆Ubc4 facilitates the spontaneous de novo formation of [PSI+] 
(Allen et al., 2007). The deletion of Ubc4 had a slight increase on the induction of 
Hsps but this increase was not sufficient to explain effects on [PSI+] (Allen et al., 
2007).  It was also observed that in strains containing the Ubc4 deletion there was an 
increase in the abundance of Ssa bound Sup35, which may suggest that misfolded 
Sup35 is more abundant or more accessible in the absence of Ubc4 (Allen et al., 
2007). Furthermore, it was found that  there was an increase in the proportion of 
[PSI+] cells containing large aggregated Sup35 structures (Allen et al.,, 2007). It was 
hypothesized that alterations to the UPS induce an adaptive response that results in the 
accumulation of large aggresome-like aggregates that promote the de novo formation 
of prions and prion recovery by chaperone treatment (Allen et al., 2007). However, it 
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is important to note that there is no evidence that Sup35 is ubiquitinated and therefore 
these affects may be indirect.    
 
1.5.3 NatA acetyltransferases  
The Natα –acetyltransferases; NatA, NatB and NAtC are involved in the N-terminal 
acetylation of approximately 50% yeast protesome, which is critical for the normal 
cellular functions of  many proteins (Polevoda et al., 1999). It is believed that 
mutations to the Natα –acetyltransferases reduces the affinity of their substrates to 
protein binding partners.  In order to explore cellular regulation of prion proteins, the 
interaction between the [PSI+] prion and the three Natα –acetyltransferases; NatA, 
NatB and NAtC was analyzed. In strains lacking NatB and NatC there was no effect 
on [PSI+] propagation, however in cells lacking NatA the [PSI+] phenotype is lost. 
Despite the change in phenotype, NatA mutants continue to propagate  heritable 
[PSI+], suggesting that strains lacking NatA function the [PSI+] complex were 
uncoupled from their phenotypic effects (Pezza et al., 2009). It was found that this 
change in stability was due to failure to establish the translational termination defect 
which is observed upon [PSI+] formation (Pezza et al., 2009). This effect was not a 
result of impaired direct acetylation of Sup35 as it is not a substrate of NatA. 
Furthermore, it appears other factors that affect the de novo formation and 
propagation of [PSI+] such as Hsp70, Hsp104 and other co-chaperones are not crucial 
targets of NatA (Pezza et al., 2009). Substrates of NatA include the ubiquitin-
conjugating enzyme Ubc4 and the cytosolic Hsp70 members Ssb1 and Ssb2 are 
proven substrates of the NatA (Huang et al., 1987, Polevoda et al., 1999), modify the 
prion cycle (Chernoff et al., 1999, Allen et al., 2007) and have demonstrated synthetic 
reactions with NatA (Gautschi et al., 2003, Pan et al., 2006). Despite these 
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connections, cells lacking Ubc4, Ssb1 and Ssb2 display the [PSI+] nonsense 
suppression phenotypes, making them unlikely crucial targets of NatA. As Sup35 or 
none of the main factors involved in the de novo formation and propagation of [PSI+]  
appear to be crucial targets of NatA, it was hypothesized that the affects of NatA on 
prion propagation may be due to the binding of a trans-factor(s) to Sup35, which 
facilitates the establishment of the translation termination defect in [PSI+] (Pezza et 
al., 2009).    
 
1.5.4 Polarisome transport of aggregated proteins 
It has previously been shown that damaged protein aggregates accumulate in mother 
cells but are absent in daughter cells (Aguilaniu et al., 2003). A new mechanistic basis 
has been uncovered for this process in yeast (Liu et al., 2010). Previous findings’ 
involving asymmetric segregation of damaged proteins between the mother and 
daughter cells suggests this process is dependent on the anti-aging gene SIR2 
(Aguilaniu et al., 2003) . This gene encodes a NAD dependent deacetylase that retards 
aging in organisms ranging from yeast to mammals (Finkel et al., 2009). Analysis 
carried out, using synthetic gene arrays, looking for genes required for survival in the 
presence of sir2 mutants, resulted in a large number of genes encoding components of 
the polarisome being observed  (Liu et al., 2010). The polarisome is a structure 
located at the distal end of the yeast bud that forms a focal point for polymerization of 
actin monomers into cables that extend from bud tip to mother cell. The function of 
these actin cables is the transportation of cargo from mother to daughter cell and to 
support growth. In sir2 mutant strains, there is a substantial amount of unfolded actin 
monomers and additionally the chaperone required for actin folding is relatively 
inactive in sir2 mutants. Previous work has shown that SIR2 functions in 
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asymmetrical segregation through Hsp104 (Erjavec et al., 2007). Studies showed the 
application of heat shock caused formation of aggregates in the mother and bud, 
however aggregates were transferred back to mother via the actin cables were they 
fused to protein aggregates in mother (Liu et al., 2010). Although this is a novel 
mechanism and further studies will be necessary, this process may affect prion 
propagation. As previously discussed, Hsp104 acts as a disaggregase to break down 
prion aggregates into seeds, which are passed onto  the daughter cell during cell 
division in order for prions to propagate. Overexpressing Hsp104 may lead to 
increases in shipping of aggregates from daughter cells back to mother cells, which 
would explain why overproduction of Hsp104 impairs prion propagation. In addition, 
larger Sup35 polymers were observed in strains over expressing Hsp104, this could be 
due to aggregates from daughter cell binding to previously formed aggregates in 
mother cell. However, at present this is just a theory. 
 
1.5.5 Involvement of Sla1 in prion propagation 
Similarities between cytoskeletal assembly and nucleated polymerization of prion 
proteins  is suggestive that similar overlapping proteins may assist in both processes 
(Lansbury and Caughey, 1995). By carrying out yeast two-hybrid studies, it was 
found that the C-terminal domain of the cytoskeletal assembly protein Sla1 interacts 
with the N-terminal prion-forming domain of Sup35 (Bailleul et al., 1999). This 
interaction is inhibited by alterations to the Sup35 PrD that makes Sup35 unable to 
propagate as [PSI+] and by the absence of Hsp104 (Bailleul et al., 1999). In cells 
lacking the Sla1 protein curing of [PSI+] by Hsp104 overexpression is increased 
whilst translational readthrough and the de novo formation of [PSI+] induced by 
overexpression of Sup35 or Sup35 PrD is decreased (Bailleul et al., 1999). It was 
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hypothesized that Sla1 assists in prion propagation but further analysis of sla1 
mutants revealed that cells were sensitive to translational inhibitors suggesting that the 
Sla1/Sup35 interaction may play a role in the functional translation apparatus 
(Bailleul et al., 1999). 
 
The presence of prion proteins in yeast is a powerful tool for studying the factors that 
affect the de novo appearance and the propagation of prions. Yeast contain many 
proteins that are highly conserved and present in mammals, indicating that proteins 
and cellular process regulating prion propagation in yeast may be transferable to the 
mammalian system which maybe useful in therapeutics and drug development. 
However further studies are needed to decipher the exact mechanisms of prion 
propagation in yeast. 
 
1.6 Objectives of this project 
The aim of this project is to gain further insight into the involvement of Hsp70 in 
[PSI+] prion propagation. We propose to achieve this by carrying out mutational 
analysis on the Hsp70 cytosolic members Ssa1-4, which have already been implicated 
as playing a crucial role in [PSI+] propagation (Jung et al., 2000; Jones and Masison, 
2003; Loovers et al., 2007; Sharma and Masison, 2008). We also will carry out 
further analysis on previously isolated mutants located in the ATPase domain of Ssa1 
(Loovers et al. 2007) and investigate the role of Ssa1’s C-terminal domain in prion 
propagation and Hsp70 function. Furthermore, we also aim to investigate functional 
specialization within the cytosolic Hsp70 Ssa family. 
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2.1.0 Fungal and bacterial growth media 
All Chemicals from Sigma-Aldrich Chemical Co. Ltd. U.K, unless otherwise stated. 
2.1.1 Yeast peptone dextrose (YPD) 
  Bacto-yeast extract (10g) (BD), Bacto-peptone (20g) (BD) and glucose (20g) were 
added to 1000ml of distilled water, and dissolved. The solution was autoclaved and 
stored at room temperature. 
 
2.1.2 YPD Agar 
  Bacto- yeast extract (10g) (BD), Bacto-peptone (20g) (BD), glucose (20g) and bacto-
agar (20g)  were added to 1000ml of distilled water, and dissolved. The solution was 
then autoclaved and allowed cool. Agar was poured into Petri dishes, under sterile 
conditions. The plates were allowed set and were stored at 4oC. 
 
2.1.3 Yeast Peptone Glycerol (YPG) 
  Bacto- yeast extract (10g) (BD), Bacto-peptone (20g) (BD), glycerol (30ml) (Sigma-
Aldrich Chemical CO. Ltd. U.K.) and bacto-agar (20g)  were added to 1000ml of 
distilled water, and dissolved. The solution was then autoclaved and allowed cool. 
Agar was poured into Petri dishes, under sterile conditions. The plates were allowed 
set and were stored at 4oC. 
 
2.1.4 Yeast peptone Galactose (YPGAl) 
Bacto- yeast extract (10g) (BD), Bacto-peptone (20g) (BD), Galactose (20g) and 
Bacto-agar (20g) were added to 1000ml of distilled water, and dissolved. The solution 
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was then autoclaved and allowed cool. Agar was then poured into Petri dishes, under 
sterile conditions. The plates were allowed set and were stored at 4oC. 
2.1.5 YPD (G418) 
  Bacto- yeast extract (10g) (BD), Bacto-peptone (20g) (BD), Glucose (20g) and 
Bacto-agar (20g) were added to 1000ml of distilled water, and dissolved.  The 
solution was then autoclaved and allowed to cool. Geneticin (20mg/ml) was added. 
Agar was poured into Petri dishes and allowed cool. The plates were poured and 
stored at 4oC. 
 
2.1.6 YPD-Copper Sulphate 
Bacto- yeast extract (10g) (BD), Bacto-peptone (20g) (BD), Glucose (20g) and Bacto-
agar (20g) were added to 1000ml of distilled water, and dissolved. The solution was 
then autoclaved and allowed to cool. 10mM,
 
12mM and 14mM of CuSO4 was added 
to agar, poured into petri dishes under sterile conditions, and stored at 4oC. 
 
2.1.7 YPD-Iron Sulphate 
Bacto- yeast extract (10g) (BD), Bacto-peptone (20g) (BD), Glucose (20g) and Bacto-
agar (20g) were added to 1000ml of distilled water, and dissolved. The solution was 
then autoclaved and allowed to cool, 2mM, 3mM and 4mM of FeSO4 was added to 
agar and poured into petri dishes under sterile conditions and stored at 4oC. 
 
2.1.8 YPD-Sorbitol  
  Bacto-yeast extract (10g) (BD), Bacto-peptone (20g) (BD), glucose (20g) and 1M 
sorbitol were added to 1000ml of distilled water, and dissolved. The solution was 
autoclaved and stored at room temperature.  
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2.1.9 YPD-Sorbitol (Agar)  
Bacto- yeast extract (10g) (BD), Bacto-peptone (20g) (BD), Glucose (20g), Bacto-
agar (20g) and 1M Sorbitol were added to 1000ml of distilled water, and dissolved. 
The solution was then autoclaved and allowed to cool and poured into petri dishes 
under sterile conditions, and stored at 4oC. 
 
2.1.10 Drop out mixture 
 Two grams of Alanine, Arginine, Aspargine, Aspartic Acid, Cysteine, Glutamic 
Acid, Glutamine, Glycine, Isoleucine, Lysine, Methionine, Phenylalanine, Proline, 
Serine, Threonine, Tyrosine and Valine were ground in a mortar and pestle. This 
mixture was stored at room temperature. 
 
2.1.11 Amino Acid stocks 
     Stock solution of the following amino acids were made by adding the amino acid 
at the following concentrations into distilled water; Adenine sulphate (0.2g/100ml), 
Uracil (0.2g/100ml), L-Tryptophan (1g/100ml), L-Histidine HCL (1g/100ml) and L-
Leucine (1g/100ml). The amino acid stocks were dissolved and filter sterilized using 
0.22µm Millex filter units (Millipore Corporation) into sterile tubes. Adenine sulphate 
and Uracil were stored at room temperature. L-Tryptophan, L-Histidine and L-
Leucine were stored at 4oC. 
 
 
2.1.12 Synthetic complete (SC) and dropout media 
        Bacto-yeast Nitrogen Base without amino acids or ammonium sulfate (6.7g) 
(BD), Glucose (20g) and drop out mixture (2g) were added and dissolved in 1000ml 
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of distilled water. This mixture could then be supplemented with Adenine sulphate 
(10ml), L-Histidine (2ml), L-Leucine (2ml), L-Trpytophan (2ml) or Uracil (10ml). 
The solution was autoclaved and allowed to cool and stored at room temperature. 
 
2.1.13 SD 
       Bacto-yeast Nitrogen Base without amino acids or ammonium sulfate (6.7g) 
(BD), Glucose (20g), drop out mixture (2g) and Bacto agar (20g) were added to 
1000ml of distilled water. The solution was autoclaved and allowed cool. This 
mixture could then be supplemented with Adenine sulphate(10ml), L-Histidine (2ml), 
L-Leucine (2ml), L-Trpytophan (2ml) or Uracil (10ml). Agar was poured into Petri 
dishes, under sterile conditions and plates were stored at 4oC. 
  
2.1.14 5-Fluoro-orotic acid medium 
  Bacto-yeast Nitrogen Base  without amino acids or ammonium sulfate (6.7g) (BD),  
Dropout mix (2g), Glucose (20g) (Sigma-Aldrich Chemical CO. Ltd. U.K.),  Adenine 
(10ml), Histidine (2ml), Leucine (10ml), Tryptophan (2ml), Uracil (50mg) and 5-
FOA were dissolved in 500ml of distilled water. This solution was filter sterilized. 
Bacto-agar (20g) (BD) was added to 500ml of distilled water and autoclaved. Agar 
was allowed cool and then mixed with the above mixture.  Agar was poured into Petri 
dishes, under sterile conditions. The plates were stored at 4oC. 
 
 
2.1.15 Sporulation medium 
 Potassium acetate (10g) (Fluka), Bacto-yeast extract (1g) (BD), Glucose (.5g), Bacto-
agar (20g) (BD) were dissolved in 1000ml of distilled water. The solution was 
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autoclaved and allowed cool.  The agar was then poured into Petri dishes and allowed 
cool. Plates were stored at 4oC 
2.1.16 Minimal sporulation medium 
 Potassium acetate (10g) (Fluka) and Bacto-agar (20g) (BD) were dissolved in 1000ml 
of distilled water. The solution was autoclaved and allowed cool.  Agar was then 
poured under sterile conditions and allowed to cool. Plates were stored at 4oC. 
 
2.1.17 LB 
  LB (25g) (BD) was dissolved in 1000ml of distilled water. The solution was 
autoclaved, and stored at room temperature. 
 
2.1.18 Ampicillin 
Sodium salt of Ampicillin (25mg) was dissolved in 1ml deionised water. The solution 
was stored at  -20oC. 
 
2.1.19 LB Ampicillan Agar 
  LB (25g) (BD) and Bacto-agar (20g) (BD) was dissolved in 1000ml of distilled 
water. The solution was autoclaved and cooled to room temperature. Ampicillin 
(50mg/ml) was added. Agar was poured into Petri dishes under sterile conditions. The 
plates were allowed set and stored at 4oC. 
 
 
2.1.20 2YT 
 Yeast extract (10g) (Oxoid Ltd., Hampshire, England), Tryptone (16g) (Oxoid Ltd., 
Hampshire, England) and NaCl (5g) (Beijing, Shiji) was dissolved in 1000ml of 
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distilled water. The solution was autoclaved and cooled  and stored at room 
temperature. 
 
 
2.1.21 Chloramphenicol stock 
 Chloramphenicol (30µg/ml) (Inalco spa, milano, Italy) was made as 4000x stock, 
chloramphenicol (0.15g) was dissolved in molecular EtOH (1.2ml) (Beijing chemical 
works). Solution was stored at -20oC. 
 
2.1.22 2YT agar Chloramphenicol Ampicillin  
 Yeast extract (10g) (Oxoid Ltd., Hampshire, England), Tryptone (16g) (Oxoid Ltd., 
Hampshire, England) and NaCl (5g) (Beijing, Shiji) and agar (20g) was dissolved in 
1000ml of distilled water. The solution was autoclaved and allowed cool to room 
temperature. Chloramphenicol (30µg/ml) and ampicillin (100µg/ml) were added to 
solution. Agar was pored under sterile conditions into Petri dishes, which were 
allowed to cool and stored at 4oC. 
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2.2 Bacterial and yeast Plasmids and strains 
2.2.1 Bacterial Plasmids 
Plasmid Description Origin Name 
pPROEX-HTb SSA1 Bacterial expression.Contains SSA1 
fused cleavable His(6X) Tag. 
ADEgene PRO-SSA1 
pPROEX-HTb- SSA1G73D Bacterial expression. Contains 
SSA1G73D His(6X). Mutation 
introduced by SDM. 
This study PRO-SSA1 G73D 
pPROEX-HTb- SSA1G287D Bacterial expression. Contains 
SSA1 G287DHis(6X). Mutation 
introduced by SDM. 
This study PRO-SSA1G287D 
pPROEX-HTb -SSA1 T295I Bacterial expression. Contains 
SSA1 T295IHis(6X). Mutation 
introduced by SDM. 
This study PRO-SSA1 T295I 
pPROEX-HTb -SSA1 F475S Bacterial expression. Contains 
SSA1 F475SHis(6X). Mutation 
introduced by SDM. 
This study PRO-SSA1 F475S 
pPROEX-HTB-SSA1- ∆20 Bacterial expression.Contains 
SSA1-His(6X) (∆623-642). 
Perret group PRO- ∆20 
pPROEX-HTB-SSA1- ∆40 Bacterial expression.Contains 
SSA1-His(6X) (∆603-642). 
Perret group PRO- ∆40 
pPROEX-HTB-SSA1- ∆60 Bacterial expression.Contains 
SSA1-His(6X) (∆583-642). 
Perret group PRO- ∆60 
pPROEX-HTB-SSA1- ∆A Bacterial expression.Contains 
SSA1-His(6X) (∆1-380). 
Perret group PRO- ∆A 
pPROEX-HTB-SSA1- ∆C Bacterial expression.Contains 
SSA1-His(6X) (∆525-642). 
Perret group PRO- ∆C 
pPROEX-HTB-SSA1- ∆AC Bacterial expression.Contains 
SSA1-His(6X) (∆1-380 + ∆525-
642). 
Perret group PRO- ∆AC 
 
 
 
 
 
 
 
 
 
Table 2.1: Bacterial plasmids 
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 2.2.2 SSA1 and mutant plasmids 
Plasmid Description Origin Name 
pC210-SSA1 pRS315 carrying SSA1 under SSA2 
promoter- LEU2 selection. 
YG pC210-SSA1 
pDCM64  pDCM64 is pRS313 carrying SSA2 
gene- LEU2 selection 
Daniel C. Masison pC210-SSA2 
pC210-SSA3 pRS315 carrying SSA3 under SSA2 
promoter LEU2 selection 
This study pC210-SSA3 
PA4 pRS315 carrying SSA4 under SSA2 
promoter LEU2 selection 
Daniel C. Masison pC210-SSA4 
pJ120  pRS315 carrying SSA1 with 500bp 5’ 
and 3’ flanking regions LEU2 selection 
Jung et al. 2000 pJ120 
pJ120 G73D G73D  introduced by Random 
mutagenesis- LEU2 selection 
Loovers et al pJ120 G73D 
pJ120 G287D G287D introduced by Random 
mutagenesis- LEU2 selection 
Loovers et al pJ120 G287D 
pJ120 T295I T295I  introduced by random 
mutagenesis- LEU2 selection 
Loovers et al pJ120 T295I 
pJ120 F475S F475S  introduced by Random 
mutagenesis- LEU2 selection 
Loovers et al pJ120 F475S 
pJ120 F475S+A394V A394V introduced by random 
mutagenesis- LEU2 selection 
This study pJ120 F+A394V 
pJ120 F475S+P432S P432S introduced by random 
mutagenesis- LEU2 selection 
This study pJ120 F+P432S 
pJ120 F475S+V477I V477I  introduced by random 
mutagenesis- LEU2 selection 
This study pJ120 F+V477I 
 pJ120 F475S+A519T A519T mutation introduced by SDM- 
LEU2 selection 
This study pJ120 F+A519T 
pJ120 F475S+E540K E540K mutation introduced by SDM- 
LEU2 selection 
This study pJ120 F+E540K 
pJ120 F475S+P636S P636S mutation introduced by SDM- 
LEU2 selection 
This study pJ120 F+P636S 
pJ121  pJ120  carrying SSA1 L483W  introduced 
by random mutagenesis LEU2 selection 
Daniel C. Masison pJ120 L483W 
pJ121 A519T A519T introduced by random 
mutagenesis- LEU2 selection 
Daniel C. Masison pJ120 L+A519T 
pJ121 E540K E540K introduced by random 
mutagenesis- LEU2 selection 
Daniel C. Masison pJ120 L+E540K 
pJ121 P636s P636S introduced by random 
mutagenesis- LEU2 selection 
Daniel C. Masison pJ120 L+P636S 
pC210-SSA1-His(6X) SSA1-His(6X) amplified from PRO-
SSA1 and cloned into pC210- LEU2 
selection 
This study pC210-SSA1-H 
pC210 
-SSA1-His(6X) G73D 
 
G73D mutation introduced by SDM- 
LEU2 selection 
This study pC210-SSA1-H G73D 
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Plasmid Description Origin Name 
pC210-SSA1-His(6X) G287D G287D mutation introduced by 
SDM- LEU2 selection 
This study pC210-SSA1-H G287D 
pC210-SSA1-His(6X) T295I T295I mutation introduced by SDM- 
LEU2 selection 
This study pC210-SSA1-H T295I 
pC210-SSA1-His(6X) F475S F475S mutation introduced by SDM 
LEU2 selection 
This study pC210-SSA1-H F475S 
SSA2 G73D G73D mutation introduced into 
pDCM64 by SDM 
This study  
SSA2 G287D G287D mutation introduced into 
pDCM64 by SDM 
This study  
SSA2 T295I T95I mutation introduced into 
pDCM64 by SDM 
This study  
SSA2 F475S F475S mutation introduced into 
pDCM64 by SDM 
This study SSA2 F475S 
pC210-SSA3 G73D G73D mutation introduced into 
SSA3-pC210 by SDM 
This study SSA3 G73D 
pC210-SSA3 G287D G287D mutation introduced into 
SSA3-pC210 by SDM 
This study SSA3 G287D 
pC210-SSA3 T295I T95I mutation introduced into SSA3-
pC210 by SDM 
This study SSA3 T295I 
pC210-SSA3 F475S F475S mutation introduced into 
SSA3-pC210 by SDM 
This study SSA3 F475S 
pC210-SSA4 G73D G73D mutation introduced into PA4 
by SDM 
This study SSA4 G73D 
pC210-SSA4 G287D G287D mutation introduced into PA4 
by SDM 
This study SSA4 G287D 
pC210-SSA4 T295I T95I mutation introduced into PA4 
by SDM 
This study SSA4 T295I 
pC210-SSA4 F475S F475S mutation introduced into PA4 
by SDM 
This study SSA4 F475S 
pRDW10 YCp50 carrying SSA1 with 500bp 3’ 
and 5’  flanking DNA-URA3 
selection 
Daniel C. 
Masison 
pRDW10 
 
 
 
 
 
 
 
 
 
 
Table 2.2 SSA1 and mutant plasmids 
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2.2.3 Truncated SSA1 Mutants 
Plasmid Description Origin Name 
pJ120-∆20 pJ120-SSA1 containing a 20 Amino Acid 
deletion at C-terminus-- LEU2 selection 
Jones 
group 
∆20 
pJ120-∆40 pJ120-SSA1 containing a 40 Amino Acid 
deletion at C-terminus- LEU2 selection 
Jones 
group 
∆40 
pJ120-∆60 pJ120-SSA1 containing a 60 Amino Acid 
deletion at C-terminus- LEU2 selection 
Jones 
group 
∆60 
pC210- ∆20- His(6X) ∆20- His(6X) amplified from PRO- ∆20 and 
cloned into pC210 - LEU2 selection 
This 
study 
∆20-H 
pC210- ∆40- His(6X) ∆40- His(6X) amplified from PRO- ∆40 and 
cloned into pC210 - LEU2 selection 
This 
study 
∆40-H 
pC210- ∆60- His(6X) ∆60- His(6X) amplified from PRO- ∆60 and 
cloned into pC210 - LEU2 selection 
This 
study 
∆60-H 
pC210- ∆A- His(6X) ∆A- His(6X) amplified from PRO- ∆A and 
cloned into pC210 - LEU2 selection 
This 
study 
∆A-H 
pC210- ∆C- His(6X) ∆C- His(6X) amplified from PRO- ∆C and 
cloned into pC210 - LEU2 selection 
This 
study 
∆C-H 
pC210- ∆AC- His(6X) ∆AC- His(6X) amplified from PRO- ∆AC and 
cloned into pC210 - LEU2 selection 
This 
study 
∆AC-H 
 
 
2.2.4 Other Plasmids 
Plasmid Description Origin/Reference Name 
Pzfo YCp50-based plasmid containing the SSA1 
promoter and the first 30 bases of SSA1 coding 
DNA fused in frame to E.coli lacZ gene. 
Stone and 
Craig.1990. 
pZFO 
PUPR Plasmid containing UPRE promoter fused in 
frame to E.coli lacZ gene. 
J. Brodsky, 
University of 
Pittsburgh 
pUPR 
pPDR5 Plasmid containing PDR5 promoter fused in 
frame to E.coli lacZ gene. 
Gift from Scott 
Moye-Rowly, 
University of 
Iowa 
pPDR5 
pDCM90 URA3-based single-copy plasmid containing 
a gene for expression of a thermolabile bacterial 
luciferase 
Daniel C. Masison pDM90 
pRS315 Yeast CEN plasmid containing LEU2 selection Sikorski and Hieter 
1989 
pRS315 
BCK Plasmid constitutively expressing BCK1 Levin BCK 
PKC Plasmid constitutively expressing PKC1 Levin PKC 
 
Table 2.4 Other plasmids used in study 
Table 2.3: Truncated SSA1 mutants 
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2.2.5 Bacterial Strains  
Bacterial strain Genotype 
DH5α fhuA2 ∆(argF-lacZ)U169 phoA glnV44 Φ80 
∆(lacZ)M15 gyrA96 recA1 relA1 endA1 thi-1 
hsdR17  
 
BL21 (DE3) pLysS B F– dcm ompT hsdS (rB-m B-) gal λ(DE3) 
[pLysS Camr] 
BL21 (DE3) pLysS- PRO-SSA1 B F– dcm ompT hsdS (rB-m B-) gal λ(DE3) 
[pLysS Camr]/ PRO-SSA1 
BL21 (DE3) pLysS- PRO-SSA1 G73D B F– dcm ompT hsdS (rB-m B-) gal λ(DE3) 
[pLysS Camr]/ PRO-SSA1G73D 
BL21 (DE3) pLysS- PRO-SSA1 G287D B F– dcm ompT hsdS (rB-m B-) gal λ(DE3) 
[pLysS Camr]/ PRO-SSA1G287D 
BL21 (DE3) pLysS- PRO-SSA1T295I B F– dcm ompT hsdS (rB-m B-) gal λ(DE3) 
[pLysS Camr]/ PRO-SSA1T295I 
BL21 (DE3) pLysS- PRO-SSA1F475S B F– dcm ompT hsdS (rB-m B-) gal λ(DE3) 
[pLysS Camr]/ PRO-SSA1F475S 
C41 (DE3) F- ompT hsdSB (rB- mB-) gal dcm (DE3) 
 
 
C41 (DE3)-YDJ1 F- ompT hsdSB (rB- mB-) gal dcm (DE3)-Ydj1 
 
 
 
Table 2.5 Bacterial strains. Bacterial strains and genotypes listed that were utilized 
in this study. The DH5α strain was used to amplify plasmid stocks. The BL21 (DE3) 
and C41 (DE3) were used for purifying Ssa1 and Ydj1 respectively. 
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2.2.6 Yeast Strains  
Strain name Genotype 
G600 (MATA ade2-1 SUQ5 kar1-1 his3 leu2 lys2 trp1 ura3) 
G402 (MATa ade2-1 SUQ5 kar1-1 his3 leu2 lys2 trp1 ura3 ssa1::KanMX, 
ssa2::HIS3, ssa3::TRP1, ssa4::URA3-1f/pRDW10 
G402-pJ120 (MATa ade2-1 SUQ5 kar1-1 his3 leu2 lys2 trp1 ura3 ssa1::KanMX, 
ssa2::HIS3, ssa3::TRP1, ssa4::URA3-1f/pJ120 
G402-315 (MATa ade2-1 SUQ5 kar1-1 his3 leu2 lys2 trp1 ura3 ssa1::KanMX, 
ssa2::HIS3, ssa3::TRP1, ssa4::URA3-1f/pRS315 
Ssa1 (MATa ade2-1 SUQ5 kar1-1 his3 leu2 lys2 trp1 ura3 ssa1::KanMX, 
ssa2::HIS3, ssa3::TRP1, ssa4::URA3-1f/pC210 
Ssa2 (MATa ade2-1 SUQ5 kar1-1 his3 leu2 lys2 trp1 ura3 ssa1::KanMX, 
ssa2::HIS3, ssa3::TRP1, ssa4::URA3-1f/pDCM64 
Ssa3 (MATa ade2-1 SUQ5 kar1-1 his3 leu2 lys2 trp1 ura3 ssa1::KanMX, 
ssa2::HIS3, ssa3::TRP1, ssa4::URA3-1f/pC210-SSA3 
Ssa4 (MATa ade2-1 SUQ5 kar1-1 his3 leu2 lys2 trp1 ura3 ssa1::KanMX, 
ssa2::HIS3, ssa3::TRP1, ssa4::URA3-1f/PA4 
Ssa1G73D 
 
(MATa ade2-1 SUQ5 kar1-1 his3 leu2 lys2 trp1 ura3 ssa1::KanMX, 
ssa2::HIS3, ssa3::TRP1, ssa4::URA3-1f/ pJ120G73D 
Ssa1G287D 
 
(MATa ade2-1 SUQ5 kar1-1 his3 leu2 lys2 trp1 ura3 ssa1::KanMX, 
ssa2::HIS3, ssa3::TRP1, ssa4::URA3-1f/ pJ120G2877D 
Ssa1T295I 
 
(MATa ade2-1 SUQ5 kar1-1 his3 leu2 lys2 trp1 ura3 ssa1::KanMX, 
ssa2::HIS3, ssa3::TRP1, ssa4::URA3-1f/ pJ120T295I 
Ssa1V439I 
 
(MATa ade2-1 SUQ5 kar1-1 his3 leu2 lys2 trp1 ura3 ssa1::KanMX, 
ssa2::HIS3, ssa3::TRP1, ssa4::URA3-1f/ pJ120V439I 
Ssa1F475S 
 
(MATa ade2-1 SUQ5 kar1-1 his3 leu2 lys2 trp1 ura3 ssa1::KanMX, 
ssa2::HIS3, ssa3::TRP1, ssa4::URA3-1f/ pJ120F475S 
Ssa1G481D 
 
(MATa ade2-1 SUQ5 kar1-1 his3 leu2 lys2 trp1 ura3 ssa1::KanMX, 
ssa2::HIS3, ssa3::TRP1, ssa4::URA3-1f/ pJ120G481D 
Ssa1L483W 
 
(MATa ade2-1 SUQ5 kar1-1 his3 leu2 lys2 trp1 ura3 ssa1::KanMX, 
ssa2::HIS3, ssa3::TRP1, ssa4::URA3-1f/ pJ120L483W 
Ssa1M515I 
 
(MATa ade2-1 SUQ5 kar1-1 his3 leu2 lys2 trp1 ura3 ssa1::KanMX, 
ssa2::HIS3, ssa3::TRP1, ssa4::URA3-1f/ pJ120M515I 
Ssa1S545F 
 
(MATa ade2-1 SUQ5 kar1-1 his3 leu2 lys2 trp1 ura3 ssa1::KanMX, 
ssa2::HIS3, ssa3::TRP1, ssa4::URA3-1f/ pJ120S545F 
Ssa1 L+A519T (MATa ade2-1 SUQ5 kar1-1 his3 leu2 lys2 trp1 ura3 ssa1::KanMX, 
ssa2::HIS3, ssa3::TRP1, ssa4::URA3-1f/ pJ120 L+A519T 
Ssa1 L+E540K (MATa ade2-1 SUQ5 kar1-1 his3 leu2 lys2 trp1 ura3 ssa1::KanMX, 
ssa2::HIS3, ssa3::TRP1, ssa4::URA3-1f/ pJ120 L+E540K 
Ssa1 L+P636S (MATa ade2-1 SUQ5 kar1-1 his3 leu2 lys2 trp1 ura3 ssa1::KanMX, 
ssa2::HIS3, ssa3::TRP1, ssa4::URA3-1f/ pJ120 L+P636S 
Ssa1 F+A394V (MATa ade2-1 SUQ5 kar1-1 his3 leu2 lys2 trp1 ura3 ssa1::KanMX, 
ssa2::HIS3, ssa3::TRP1, ssa4::URA3-1f/ pJ120 F+A394V 
Ssa1 F+P433S (MATa ade2-1 SUQ5 kar1-1 his3 leu2 lys2 trp1 ura3 ssa1::KanMX, 
ssa2::HIS3, ssa3::TRP1, ssa4::URA3-1f/ pJ120 F+P433S 
Ssa1 F+V477I (MATa ade2-1 SUQ5 kar1-1 his3 leu2 lys2 trp1 ura3 ssa1::KanMX, 
ssa2::HIS3, ssa3::TRP1, ssa4::URA3-1f/ pJ120 F+V477I 
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Ssa1 F+P636S (MATa ade2-1 SUQ5 kar1-1 his3 leu2 lys2 trp1 ura3 ssa1::KanMX, 
ssa2::HIS3, ssa3::TRP1, ssa4::URA3-1f/ pJ120 F+P636s 
Ssa2 G73D (MATa ade2-1 SUQ5 kar1-1 his3 leu2 lys2 trp1 ura3 ssa1::KanMX, 
ssa2::HIS3, ssa3::TRP1, ssa4::URA3-1f/ pDCM64 G73D 
Ssa2 G287D (MATa ade2-1 SUQ5 kar1-1 his3 leu2 lys2 trp1 ura3 ssa1::KanMX, 
ssa2::HIS3, ssa3::TRP1, ssa4::URA3-1f/ pDCM64 G287D 
Ssa2 T295I (MATa ade2-1 SUQ5 kar1-1 his3 leu2 lys2 trp1 ura3 ssa1::KanMX, 
ssa2::HIS3, ssa3::TRP1, ssa4::URA3-1f/ pDCM64 T295I 
Ssa2 F475S (MATa ade2-1 SUQ5 kar1-1 his3 leu2 lys2 trp1 ura3 ssa1::KanMX, 
ssa2::HIS3, ssa3::TRP1, ssa4::URA3-1f/ pDCM64 F475S 
Ssa3 G73D (MATa ade2-1 SUQ5 kar1-1 his3 leu2 lys2 trp1 ura3 ssa1::KanMX, 
ssa2::HIS3, ssa3::TRP1, ssa4::URA3-1f/ pC210-Ssa3 G73D 
Ssa3 G287D (MATa ade2-1 SUQ5 kar1-1 his3 leu2 lys2 trp1 ura3 ssa1::KanMX, 
ssa2::HIS3, ssa3::TRP1, ssa4::URA3-1f/ pC210-Ssa3 G287D 
Ssa3 T295I (MATa ade2-1 SUQ5 kar1-1 his3 leu2 lys2 trp1 ura3 ssa1::KanMX, 
ssa2::HIS3, ssa3::TRP1, ssa4::URA3-1f/ pC210-Ssa3 T295I 
Ssa3 F475S (MATa ade2-1 SUQ5 kar1-1 his3 leu2 lys2 trp1 ura3 ssa1::KanMX, 
ssa2::HIS3, ssa3::TRP1, ssa4::URA3-1f/ pC210-Ssa3 F475S 
Ssa4 G73D (MATa ade2-1 SUQ5 kar1-1 his3 leu2 lys2 trp1 ura3 ssa1::KanMX, 
ssa2::HIS3, ssa3::TRP1, ssa4::URA3-1f/ PA4 G73D 
Ssa4 G287D (MATa ade2-1 SUQ5 kar1-1 his3 leu2 lys2 trp1 ura3 ssa1::KanMX, 
ssa2::HIS3, ssa3::TRP1, ssa4::URA3-1f/ PA4 G287D 
Ssa4 T295I (MATa ade2-1 SUQ5 kar1-1 his3 leu2 lys2 trp1 ura3 ssa1::KanMX, 
ssa2::HIS3, ssa3::TRP1, ssa4::URA3-1f/ PA4 T295I 
Ssa4 F475S (MATa ade2-1 SUQ5 kar1-1 his3 leu2 lys2 trp1 ura3 ssa1::KanMX, 
ssa2::HIS3, ssa3::TRP1, ssa4::URA3-1f/ PA4 F475S 
∆20-pre (MATa ade2-1 SUQ5 kar1-1 his3 leu2 lys2 trp1 ura3 ssa1::KanMX, 
ssa2::HIS3, ssa3::TRP1, ssa4::URA3-1f/ pRDW10/ pJ120- ∆20  
∆40-pre MATa ade2-1 SUQ5 kar1-1 his3 leu2 lys2 trp1 ura3 ssa1::KanMX, 
ssa2::HIS3, ssa3::TRP1, ssa4::URA3-1f/ pRDW10/ pJ120- ∆40 
∆60-pre MATa ade2-1 SUQ5 kar1-1 his3 leu2 lys2 trp1 ura3 ssa1::KanMX, 
ssa2::HIS3, ssa3::TRP1, ssa4::URA3-1f/ pRDW10/ pJ120- ∆60 
∆20 (MATa ade2-1 SUQ5 kar1-1 his3 leu2 lys2 trp1 ura3 ssa1::KanMX, 
ssa2::HIS3, ssa3::TRP1, ssa4::URA3-1f/ pJ120- ∆20  
∆40 MATa ade2-1 SUQ5 kar1-1 his3 leu2 lys2 trp1 ura3 ssa1::KanMX, 
ssa2::HIS3, ssa3::TRP1, ssa4::URA3-1f/ pJ120- ∆40 
∆20-His (MATa ade2-1 SUQ5 kar1-1 his3 leu2 lys2 trp1 ura3 ssa1::KanMX, 
ssa2::HIS3, ssa3::TRP1, ssa4::URA3-1f/ pJ120- ∆20-His 
∆40-His MATa ade2-1 SUQ5 kar1-1 his3 leu2 lys2 trp1 ura3 ssa1::KanMX, 
ssa2::HIS3, ssa3::TRP1, ssa4::URA3-1f/ pJ120- ∆40-His 
∆60-His MATa ade2-1 SUQ5 kar1-1 his3 leu2 lys2 trp1 ura3 ssa1::KanMX, 
ssa2::HIS3, ssa3::TRP1, ssa4::URA3-1f/ pJ120- ∆60-His 
Ssa1-His MATa ade2-1 SUQ5 kar1-1 his3 leu2 lys2 trp1 ura3 ssa1::KanMX, 
ssa2::HIS3, ssa3::TRP1, ssa4::URA3-1f/ pC210-SSA1-H 
Ssa1-His G73D MATa ade2-1 SUQ5 kar1-1 his3 leu2 lys2 trp1 ura3 ssa1::KanMX, 
ssa2::HIS3, ssa3::TRP1, ssa4::URA3-1f/ pC210-SSA1-H G73D 
Ssa1-His T295I MATa ade2-1 SUQ5 kar1-1 his3 leu2 lys2 trp1 ura3 ssa1::KanMX, 
ssa2::HIS3, ssa3::TRP1, ssa4::URA3-1f/ pC210-SSA1-H T295I 
Ssa1-His F475S MATa ade2-1 SUQ5 kar1-1 his3 leu2 lys2 trp1 ura3 ssa1::KanMX, 
ssa2::HIS3, ssa3::TRP1, ssa4::URA3-1f/ pC210-SSA1-H F475S 
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PDR5-Ssa1 G73D MATa ade2-1 SUQ5 kar1-1 his3 leu2 lys2 trp1 ura3 ssa1::KanMX, 
ssa2::HIS3, ssa3::TRP1, ssa4::URA3-1f/ pJ120G73D /PDR5 
PZFO- Ssa1 G73D MATa ade2-1 SUQ5 kar1-1 his3 leu2 lys2 trp1 ura3 ssa1::KanMX, 
ssa2::HIS3, ssa3::TRP1, ssa4::URA3-1f/ pJ120 G73D /pZFO 
UPR- Ssa1 G73D MATa ade2-1 SUQ5 kar1-1 his3 leu2 lys2 trp1 ura3 ssa1::KanMX, 
ssa2::HIS3, ssa3::TRP1, ssa4::URA3-1f/ pJ120 G73D /pUPR 
PDR5-Ssa1 G287D MATa ade2-1 SUQ5 kar1-1 his3 leu2 lys2 trp1 ura3 ssa1::KanMX, 
ssa2::HIS3, ssa3::TRP1, ssa4::URA3-1f/ pJ120G287D /PDR5 
PZFO- Ssa1 G287D MATa ade2-1 SUQ5 kar1-1 his3 leu2 lys2 trp1 ura3 ssa1::KanMX, 
ssa2::HIS3, ssa3::TRP1, ssa4::URA3-1f/ pJ120 G287D /pZFO 
UPR- Ssa1 G287D MATa ade2-1 SUQ5 kar1-1 his3 leu2 lys2 trp1 ura3 ssa1::KanMX, 
ssa2::HIS3, ssa3::TRP1, ssa4::URA3-1f/ pJ120 G287D /pUPR 
PDR5-Ssa1 T295I MATa ade2-1 SUQ5 kar1-1 his3 leu2 lys2 trp1 ura3 ssa1::KanMX, 
ssa2::HIS3, ssa3::TRP1, ssa4::URA3-1f/ pJ120T295I /PDR5 
PZFO- Ssa1 T295I MATa ade2-1 SUQ5 kar1-1 his3 leu2 lys2 trp1 ura3 ssa1::KanMX, 
ssa2::HIS3, ssa3::TRP1, ssa4::URA3-1f/ pJ120 T295I /pZFO 
UPR- Ssa1 T295I MATa ade2-1 SUQ5 kar1-1 his3 leu2 lys2 trp1 ura3 ssa1::KanMX, 
ssa2::HIS3, ssa3::TRP1, ssa4::URA3-1f/ pJ120T295I /pUPR 
PDR5-Ssa1F475S MATa ade2-1 SUQ5 kar1-1 his3 leu2 lys2 trp1 ura3 ssa1::KanMX, 
ssa2::HIS3, ssa3::TRP1, ssa4::URA3-1f/ pJ120F475S /PDR5 
PZFO- Ssa1F475S MATa ade2-1 SUQ5 kar1-1 his3 leu2 lys2 trp1 ura3 ssa1::KanMX, 
ssa2::HIS3, ssa3::TRP1, ssa4::URA3-1f/ pJ120 F475S/pZFO 
UPR- Ssa1F475S MATa ade2-1 SUQ5 kar1-1 his3 leu2 lys2 trp1 ura3 ssa1::KanMX, 
ssa2::HIS3, ssa3::TRP1, ssa4::URA3-1f/ pJ120F475S /pUPR 
Ssa1-Luc MATa ade2-1 SUQ5 kar1-1 his3 leu2 lys2 trp1 ura3 ssa1::KanMX, 
ssa2::HIS3, ssa3::TRP1, ssa4::URA3-1f/pC210/pDM90 
Ssa2-Luc MATa ade2-1 SUQ5 kar1-1 his3 leu2 lys2 trp1 ura3 ssa1::KanMX, 
ssa2::HIS3, ssa3::TRP1, ssa4::URA3-1f/pDCM64/pDM90 
Ssa3-Luc MATa ade2-1 SUQ5 kar1-1 his3 leu2 lys2 trp1 ura3 ssa1::KanMX, 
ssa2::HIS3, ssa3::TRP1, ssa4::URA3-1f/pC210-SSA3/pDM90 
Ssa4-Luc MATa ade2-1 SUQ5 kar1-1 his3 leu2 lys2 trp1 ura3 ssa1::KanMX, 
ssa2::HIS3, ssa3::TRP1, ssa4::URA3-1f/PA4/pDM90 
Ssa1F475S -Luc MATa ade2-1 SUQ5 kar1-1 his3 leu2 lys2 trp1 ura3 ssa1::KanMX, 
ssa2::HIS3, ssa3::TRP1, ssa4::URA3-1f/pJ120 F475S /pDM90 
Ssa1-BCK MATa ade2-1 SUQ5 kar1-1 his3 leu2 lys2 trp1 ura3 ssa1::KanMX, 
ssa2::HIS3, ssa3::TRP1, ssa4::URA3-1f/pC210 /BCK 
Ssa1-PKC1 MATa ade2-1 SUQ5 kar1-1 his3 leu2 lys2 trp1 ura3 ssa1::KanMX, 
ssa2::HIS3, ssa3::TRP1, ssa4::URA3-1f/pC210 /PKC1 
Ssa1F475S- BCK MATa ade2-1 SUQ5 kar1-1 his3 leu2 lys2 trp1 ura3 ssa1::KanMX, 
ssa2::HIS3, ssa3::TRP1, ssa4::URA3-1f/pJ120 F475S /BCK 
Ssa1F475S- PKC1 MATa ade2-1 SUQ5 kar1-1 his3 leu2 lys2 trp1 ura3 ssa1::KanMX, 
ssa2::HIS3, ssa3::TRP1, ssa4::URA3-1f/pJ120 F475S /PKC1 
 
Table 2.6 Yeast strains. List of all yeast strains and their genotypes used in this 
study. All Ssa mutant analysis was carried out in the G402 strain 
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2.3.0 Fungal and bacterial culture conditions 
2.3.1 Fungal culture conditions 
  All yeast stocks were stored in a sterile mixture of 85% YPD and 15% glycerol at -
70oC. Working stocks of strains were restreaked onto fresh YPD agar every 3 weeks, 
grown at 30oC for forty-eight hours and stored at 4oC. For liquid culturing, yeast 
strains were grown overnight at 30oC in a conical flask to the cell density required, at 
200 RPM (Innova 4000) using appropriate media. 
 
2.3.2 Bacterial growth conditions 
 All DH5α bacterial strains were incubated at 37oC on LB AMP agar for 16 hours and 
stored at 4oC. For liquid culture, DH5α bacterial strains were cultured overnight in LB 
AMP media at 37oC in a shaking incubator (Innova 44). All BL21 strains were 
incubated at 37oC on 2YT agar with chloramphenicol (30µg/ml) and ampicillin 
(50mg/ml) for 16 hours and stored at 4oC. For liquid culture, BL21bacterial strains 
were cultured in 2YT media overnight at 37oC in a shaking incubator (Innova 44) 
 
2.4.0 Preparation of component and transformation of Bacterial and Yeast cells 
2.4.1 Preparation of competent E.coli (DH5α) 
 20ml of LB was inoculated with a single colony of DH5α. E.coli was incubated at 
37oC overnight in shaking incubator (Innova 44) at 250 RPM. Cells were transferred 
to one liter of LB and grown until culture reached an OD600 between 0.6-1.0 (≈ three 
hours). The culture was transferred to 250ml centrifuge tubes and  bacterial cells were 
pelleted at 3913Xg for ten minutes at 4oC. Pellet was resuspended in 10ml of RF1 
(KAc 30mM, CaCl2.2H2O 10mM, glycerol 15% and adjust to pH 5.92 with 0.2M 
acetic acid and RbCl 100mM and MnCl2.4H2O 50mM was added) and incubated on 
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ice for thirty minutes.  E.coli was pelleted at 3170Xg for fifteen minutes at 4oC. Pellet 
was resuspended in 2mlsRF2 (RbCl 100mM and CaCl2.2H2O 75mM) and incubated 
on ice. Transfer component E.coli to pre chilled 1.5ml microfuge tubes in 50µl 
aliquots, snap freeze using liquid Nitrogen and store at -80oC. 
 
2.4.2 Transformation of competent DH5α 
To amplify plasmids; LB-Amp plates were incubated at 37oC for one hour. 
Component cells (50µl) were defrosted on ice and 1µl of DNA was added. Cells were 
incubated on ice for five minutes and were immediately plated onto warm LB-Amp 
plate under sterile conditions and incubated at 37oC overnight. Transformation of 
plasmids for site-directed mutagenesis and yeast plasmid preps were carried out by 
adding 8µl of DNA to 100µl of component cells and incubated on ice for thirty 
minutes. Cells were then heat shocked at 42oC for fifty seconds and placed on ice for 
a further two minutes. LB (400µl) was added and cells were incubated at 37oC 
shaking for one hour. Cells were plated on LB-Amp under sterile conditions and 
incubated at 37oC overnight. 
 
2.4.3 Preparation of elecrto-competent DH5α 
Inoculated 20ml of LB with a single colony of DH5α and incubated at 37oC shaking 
overnight.  Overnight culture was transferred to 1 liter of LB and grown at 37oC 
shaking until an OD600 of 0.8 was reached. Cells were chilled on ice for thirty 
minutes. Cells were harvested in a GSA rotor at 3913Xg for ten minutes at 4oC. Pellet 
was resuspended in one liter of ice-cold dH20 and centrifuged at 3913Xg for ten 
minutes at 4oC. Pellet was resuspended in 500ml of ice-cold dH20 and centrifuged at 
3913Xg  for ten minutes at 4oC. Pellet was resuspended in 250ml of ice-cold dH20 
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and centrifuged at 3913Xg for ten minutes at 4oC. Pellet resuspended in 100ml of ice 
cold dH20 and centrifuged at 3170Xg  for fifteen minutes at 4oC. Pellet resuspended in 
1ml 10% glycerol (chilled). Electro-competent cells were transferred to 1.5ml 
microfuge tubes as 40µl aliquots and stored at -80oC. 
 
2.4.4 Transformation of electro-competent DH5α 
Electro-competent DH5α were thawed on ice. Electroporation cuvette (Gene pulser 
cuvettes, Bio Rad) were chilled on ice. 20µl of cells and 20µl of DNA 
(concentration)/stH20 were pipetted into chilled cuvette.  Cuvettes were chilled on ice 
for thirty minutes and then placed in cuvette holder of the MicroPulser electroporator 
(Bio Rad) which was set to EC2 and cells were pulsed for approximately 3-4 seconds. 
LB (600µl) was immediately added to cuvette and cells were transferred to microfuge 
tube and incubated at 37oC shaking for one hour. Following the one hour recovery 
incubation, cells were plated on LB-AMP under sterile conditions and placed at 37oC 
overnight. 
 
2.4.5 Preparation of competent BL21 and C41 cells 
2YT(50ml) was inoculated (plus chloramphenicol 30µg/ml for BL21) with a single 
colony of E.coli. Cells were grown at 37oC shaking until an OD600 of 0.5 is reached. 
Spin cells at 3913Xg for ten minutes at 4oC. Keep cells on ice. Resuspend in 15ml of 
0.1M CaCl2 and centrifuge at 3913Xg for ten minutes at 4oC. Resuspend pellet in 
15ml of 0.1M CaCl2 and incubate on ice for twenty minutes. Resuspend pellet in 5ml 
of 20% glycerol, transfer to pre chilled 1.5ml microfuge tube in 50µl aliquots, snap 
freeze and store at -80oC. 
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2.4.6 Transformation of competent BL21 and C41 cells 
Competent cells (50µl) were defrosted on ice. DNA (1µl) was added and cells were 
incubated on ice for thirty minutes. Cells were then placed at 42oC for ninety seconds 
and immediately plated onto 2YT-Amp- chloramphenicol (BL21) or 2YT-AMP (C41) 
under sterile conditions. Plate was incubated at 37oC overnight. 
 
2.4.7 Preparation of competent Yeast cells 
Inoculated 5ml of YPD or selective media with appropriate yeast strain. Cells were 
incubated at 30oC shaking overnight. Overnight culture was diluted to a concentration 
of 5x106 cells/ml in 50ml of YPD. Culture was grown until a concentration of 1x107-
2x107 was reached. Cells were pelleted at 978Xg  for five minutes and resuspended in 
25ml of dH20 and spun at 978Xg  for 5 minutes. Pellet was resuspended in 1ml of 
100mM LiAc and transferred to 1.5ml microfuge tube. Cells pelleted at 17,900 x g for 
5 seconds, supernatant was discarded. Pellet resuspended in 500µl of 100mM LiAc. 
Component cells can be used immediately or stored for up to two weeks at 4oC. 
 
2.4.8 Transformation of competent Yeast cells 
Component yeast cells (50µl) were centrifuged at 17,900 x g and supernatant was 
discarded. The following reagents were added in the order; 240µl 50% PEG, 36µl 1M 
LiAc, 25µl carrier DNA, DNA mix (200ng DNA mixed with sterile H20 to a final 
volume of 50µl). Cells and transformation reagents were mixed thoroughly and placed 
at 30oC static for thirty minutes. Cells were then placed at 42oC for twenty minutes 
and then pelleted at 7669Xg for fifteen seconds. Transformed cells were then plated 
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on appropriate selective media under sterile conditions and incubated at 30oC for 
forty-eight hours 
2.4.8.1 Plasmid shuffle technique 
To express mutants of Ssa1 as the sole source of the Ssa family in S.cerevisiae, the 
plasmid shuffle technique was employed. The G402 strain contains the plasmid 
pRDW10, which contains a Uracil marker and is the sole source of Ssa in the strain. 
To analyze the affects of mutations in Ssa1 that are expressed from plasmids that 
contain alternative marker to Uracil, mutant plasmids are transformed into G402 
(2.4.8) on media for sufficient selection of mutant plasmid. Transformants were 
restreaked onto media for sufficient selection of mutant plasmid, and incubated at 
30oC for forty-eight hours. The pRDW10 plasmid was eliminated from the strain by 
replicating transformants onto 5-FOA (2.1.14), which selected against plasmids with 
Uracil markers. 
 
2.5 Molecular techniques 
2.5.1 Preparation of Agarose Gel 
Agarose gels (0.8% ), were prepared by adding 0.8g of agarose to 50ml of 1XTAE 
buffer (diluted from 50X TAE buffer; 242g Tris, 100ml 0.5M EDTA ph 8.0 and acetic 
acid and bring to a final volume of 1000ml with stH20).  Solution was heated for 
approximately one minute until agarose was completely dissolved and poured into gel 
casting tray. Gel was allowed to cool slightly, 1µl of ethidium bromide was added and 
mixed with a yellow tip. Comb was placed in gel and gel was allowed set. All gels 
were run in 1X TAE buffer at 90V for approximately thirty minutes. 
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2.5.2 Restriction Digestion 
All restriction digests were carried out using enzymes and reagents from New 
England Biolabs inc. A typical digest to prepare pC210 for cloning would be carried 
out by adding 40µl pC210, 2µl Nde1, 2µl Sph1, 6µl Buffer 2 (10X) and 10µl 
molecular H20. Digestion was incubated at 37oC for three hours. Diagnostic digests 
were preformed by adding 5µl of potential clone, 0.5µl Nde1, 0.5µl Sph1 and 2µl 
Buffer 2 (10X) and 12µl molecular H20. Digestions run on a 0.8% agarose gel. 
 
2.5.3 Site-Directed Mutagenesis (SDM) 
 Mutant alleles were introduced using the appropriate primers with DNA base pair 
mismatch (Table 2.8). PFU Ultra (Stratagene, La Jolla, CA, USA) was used to 
amplify the mutant plasmid under the cycle conditions [95oC for 1 min, 95oC for 
30secs, 55oC for 1 min, 68oC extension, 68oC for 7min, cycle repeated 12 times]. The 
parental plasmid was digested by 1µl dpn1 (Invitrogen) and potential mutant plasmids 
are transformed into component DH5α (section 2.4.2), mutation confirmed by 
sequencing (Agowa, LGC) 
Primer Name Primer Sequence 5’-3’ 
SSA1 G73D- F 
                      R 
CTAAGCGTTTGATTCGGTAGAAACTTCAACGAC 
GTCGTTGAAGTTTCTACCGAATCAAACGCTTAG 
SSA1 G287D F 
                       R 
GACTCTTTGTTCGAAGGTATCGATTTCTACACT 
AGTGTAGAAATCGATACCTTCGAACAAAGAGTC 
SSA1 T295I   F 
                       R 
TTCTACACTTCCATCACCAGAGCCAGATTCGAAG 
CTTCGAATCTGGCTCTGGTGATGGAAGTGTAGAA 
SSA1  F475S F 
                       R 
 TGTCCCACAAATTGAAGTCACTTCCGATGTCGACTCTAACGG  
 CCGTTAGAGTCGACATCGGAAGTGACTTCAATTTGTGGGACA 
SSA1 A519T-F 
                      R         
GAAAGAGTGGTTGCTGAAGCCGAAAAATTCAAGGAAG 
CTTCCTTGAATTTTTCGGCTTCAGCAACCACTCTTTC 
SSA1-E540K-F 
                       R          
CTTCCAAGAACCAATTGGAATCCATTGCTTACTC 
GAGTAAGCAATGGATTCCAATTGGTTCTTGGAAG 
SSA1- P636S-F 
                        R            
CCAGAGGCTGAAGGTTCAACCGTTGAAGAAGTTG 
CAACTTCTTCAACGGTTGAACCTTCAGCCTCTGG 
Table 2.7 SDM primers. Primers designed to insert single base mutations into SSA1. 
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Primer name Primer Sequence 5’-3’ 
SSA2-G73D-F 
SSA2-G73D-R 
GCTAAGCGTTTGATCGATAGAAACTTTCAATGAC 
GTCATTGAAAGTTTCTATCGATCAAACGCTTAGC 
SSA2-F475S-F 
SSA2-F475S-R 
CAAATTGAAGTCACTTCCGATGTCGACTCTAAC 
GTTAGAGTCGACATCGGAAGTGACTTCAATTTG 
SSA3- G73D- F 
SSA3-G73D-R 
AAGCGGTTAATTGATCGTAAATTTGATG 
CATCAAATTTACGATCAATTAACCGCTT 
SSA3- G287D- F 
SSA3-G287D-R 
GATTCTTTATTTGAAGATATGGATTTCTACACT 
AGTGTAGAAATCCATATCTTCAAATAAAGAATC 
SSA3- T295I- F 
SSA3-T295I-R 
TTCTACACTTCGTTAATAAGGGCAAGGTTTGAA 
TTCAAACCTTGCCCTTATTAACGAATGTAGAA 
SSA3- F475S- F 
SSA3-F475S-R 
CAAATTGATGTTACCTCTGATATCGACGCTAAT 
ATTAGCGTCGATATCAGAGGTAACATCAATTTG 
SSA4- G73D- F 
SSA4-G73D-R 
GCTAAGCGTCTGATCGATCGTAAATTCGATGATC 
GATCATCGAATTTACGATCGATCAGACGCTTAGC 
SSA4- G287D- F 
SSA4-G287D-R 
GATTCATTATTTGAGGATATCGATTTCTATACTTC 
GAAGTATAGAAATCGATATCCTCAAATAATGAATC 
SSA4- T295I- F 
SSA4-T295I-R 
GGTATCGATTTCTATATTTCCATTACAAGGGCAAG 
CTTGCCCTTGTAATGGAAATATAGAAATCGATACC 
SSA4- F475S- F 
SSA4-F475SR 
CAAATTGAAGTTACATCTGATATCGATGCAAATG 
CATTTGCATCGATATCAGATGTAACTTCAATTTG 
 
Table 2.8 SDM primers. Primers designed to insert single base mutations into SSA2, 
SSA3 and SSA4. 
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2.5.4 Homologous recombination 
2.5.4.1 PCR 
DNA was amplified to include flanking regions that are homologous to regions of 
plasmid/region of genome in which DNA will integrate. Primers were designed to 
allow for this (Table 2.9) and may include diagnostic restriction sites. The PCR 
reaction was carried out using High-Fidelity Taq (Invitrogen) under recommended 
cycling conditions. 
 
 
Table 2.9 Homologous recombination primers. Primers containing 5’ and 3’ pC210 
flanking regions designed to amplify gene of interest. 
 
2.5.4.2 Cloning by homologous recombination 
A restriction digest was carried out on pC210 (section 2.5.2) and incubated at 37oC 
for three hours. Restriction digest was run on an agarose gel (0.8%) and digested 
plasmid was extracted according to manufacturers’ recommendations (Qiagen Gel 
extraction kit). Yeast transformation preformed as in section 2.4.4 except DNA mix 
Primer 
name 
Primer Sequence 5’-3’ 
SSA1-his-F 
SSA1-his-R 
CAAGCAGATTTTATACAGAAATATTTATACATATGCTCGAGCATCACCATCACCATCAC 
CTTCCTGATTAAACAGGAAGACAAAGCATGCGGATCCTTAATCAACTTCTTCAACGG 
SSA1-China-F CAAGCAGATTAAACAGGAAGACAAATTAACCGCCTGGAGCACCACCTGCAGC 
SSA1-∆20HR-R CTTCCTGATTAAACAGGAAGACAAATTAACCGCCTGGAGCACCACCTGCAGC 
SSA1-∆40HR-R CTTCCTGATTAAACAGGAAGACAAATTACATCATTGGGTTGGCAATGTCTTG 
SSA1-∆60HR-R CTTCCTGATTAAACAGGAAGACAAATTAGGCAGTGGTGTTGCTGTCTAACC 
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consists of 45µl PCR products and 5µl of digested pC210. Transformants were 
screened on selective media. Yeast plasmids were extracted as in section 2.6.1, 
diagnostic digests and sequencing confirmed successful clones.  
2.5.5 Sequencing primers 
Sequencing of plasmids was carried out using Agowa genomics sequencing services  
(100ng DNA, 4µl primer, xµl molecular H20 made to a total volume of 15µl). Primers 
were designed to cover complete sequences of SSA1, SSA2, SSA3 and SSA4 (Table 
2.10). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Primer name Primer sequence 5’-3’ 
SP1 CTCATTATACCCAGATCA 
SP2 CTTTTCGACGGCGGAAAC 
SP3 CATCGACTTGAGATTTG 
SP4 CAGCGATTGACCTTGGC 
SP5 CGAGAAGGATTGAGTTG 
SP6 GGTCTTGGGTAAGATG 
SP7 CAGATCTACTTTGGACCC 
SP8 CAAAGGCGTGTCCAC 
SSA2-1  CCTGTGTTGCTCAC 
SSA2-2 CACTTCATCCAAGAATTC 
SSA2-3 CTACTTATGCTGACAAC 
SSA3-1 GATGATCCTGAAGTGACG 
SSA3-2 GATTCGAAGCTGGACAAGTC 
SSA3-3 GTAGGCTCTCGAAGGATG 
SSA3-7 CTTGTATGTCAATGTTTG 
SSA3-8 GACACTCATTTAGGTG 
SSA3-9 GGTAGAGAAGGTTTCCG 
SSA4-1 GAACGATGCTAAGCATTACC 
SSA4-2 GATCTACATTGGAGCCAG 
SSA4-3 GAACGTATCTGCCGTTGA 
SSA4-4 GCGAAGCATCTAACCAAT 
SSA4-5 GTTAAGATGGCAGCCTGTAC 
SSA4-6 GATACGAAGAACGTTCAAGC 
Table 2.10 Sequencing primers 
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2.5.6 Random Mutagenesis of pJ120F475S 
pJ120F475S was incubated in the mutagen hydroxylamine (20µl EDTA 200mM, 200µl 
NaCl 1M, 138.98mg of hydroxylamine, 44.6mg of Sodium Pyrophosphate added to 
1.8ml of dH2O) at 70oC for one hour. This reaction was stopped by placing microfuge 
tube on ice. Excess hydroxylamine was removed from pJ120F475S by performing PCR 
purification according to manufacturer’s recommendations (Qiagen, PCR purification 
kit). Mutagenized plasmid library was transformed into competent DH5α by 
electroporation (section 2.4.4). Approximately 20,000 cells are required for this 
process; therefore, electroporation was repeated twenty times with approximately 
1000 colonies on each plate. Mutagenized plasmids were retrieved from E.coli by 
pipetting 1ml of LB onto LB-AMP plates containing mutagenised colonies. Cells 
were scrapped from plate using a yellow tip into 1ml LB, LB containing cells was 
removed from plate by pipetting, and added to next plate were the process was 
repeated twenty times. Plasmid library retrieved from 1ml of LB by carrying out 
miniprep by manufacturer’s recommendations (Qiagen, miniprep kit). 
 
2.5.6.1 Isolation of second-site suppressors of pJ120F475S 
The yeast strain G402 was transformed with pJ120F475S mutagenised plasmid library. 
Second-site suppressors of F475S were screened for by selecting  plasmids on media 
lacking leucine followed by using plasmid-shuffle technique. 5-FOA plates were 
incubated at 37oC for 48 hours. Colonies with growth at 37oC were selected and 
restreaked onto media lacking leucine and then replicated onto media lacking Uracil 
to ensure pRDW10 was not present. Yeast plasmids were retrieved as described in 
section 2.6.1 and second-site suppressor mutations were located by sequencing 
analysis (section 2.5.6) 
 67 
 
2.5.7 RT-PCR 
RNA was extracted from strains using the RNAeasy kit (Sigma) following 
manufacturers recommendations (section 2.6.3). To ensure that sample was DNA 
free, samples were treated using the Sigma DNase kit. 1µg of RNA was added to 1µ   
l of 10X buffer and 1µl of DNase, and the reaction was brought to a final 
concentration of 10µl using stH20. The reaction was left at room temperature for 
fifteen minutes and digestion was stopped by adding 1µl of EDTA and incubating at 
70oC for ten minutes. To synthesize cDNA, 8µl of the digestion was added to 1µl of 
50µM oligo dT and 1µl 10mM dNTPs and incubate at 65oC for five minutes and then 
for one minute on ice. Reaction mixture was prepared by adding 2µl 10RT buffer, 4µl 
25mM MgCL2, 2µl 0.1M DTT, 1µl RNase out and 1µl Superscript II . 10µl of 
reaction mixture was added to 10µl RNA mixture and was mixture was incubated at 
50oC for minutes. Reaction was stopped by incubating mixture at 85oC for five 
minutes and chilling it on ice.1µl RNaseH was added to solution and incubated at 37 
oC for twenty minutes. cDNA was then transferred to a PCR reaction containing 2.5µl 
of forward and reverse primer (Table 2.8), 2.5µl of PFU ultra buffer (10X) (Agilent 
technologies), 1µl dNTPS (Promega) and 1µl of PFU ultra (Agilent technologies). 
RT-PCR was preformed using the PFU cycling conditions; [95oC for 1 min, 95oC for 
30secs, 55oC for 1 min, 68oC extension 2 mins per kb, , 68oC for 7min,repeated 12 
times]. 
 
 
Primer name Primer sequence 5’-3’ 
PDR5    F 
             R 
CATCGGTTTCACTTTCTTC 
GCTGCAGACGCGTTGGAG 
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PDR10  F 
             R 
GAGTTGGACTGGATGGAAGG 
GATGGCCTTTCTCTAGCTTC 
PDR15  F 
             R 
GCAAAGGGATTTGTATGAG 
CCATATGTGCCGCTGTTTC 
ACT1    F 
              R 
GGGTTTGGAATCTGCC 
CCACCAATCCAGACGGAG 
 
2.6 DNA and RNA extraction from yeast cells 
2.6.1 Yeast plasmid prep 
Yeast strains containing a specific plasmid were grown in 5ml of YPD or selective 
growth media overnight. Yeast cells were pelleted at 978Xg  for five minutes and 
resuspended in 250µl of buffer P1 (Miniprep Kit, Qiagen) and transferred to 
microfuge tube. Approximately half the volumes of 0.5mm soda lime glass beads 
(Biospec products Inc,) were added, and vortexed at max speed for five minutes 
(vortex-2 gene, Scientific industries). Liquid was removed and transferred to new 
eppendorf. 250µl of lysis buffer (P2) and 350µl of Neutralization buffer (N3) 
(Miniprep Kit, Qiagen) was added to solution and gently mixed and centrifuges at 
17,900 x g  for ten minutes. Supernatant was removed and transferred to DNA 
binding column (Miniprep Kit, Qiagen). DNA binding column was centrifuged at 
17,900 x g  for one minute and flow through was discarded. Wash (750µl) solution 
was added and column was centrifuged at 17,900 x g for one minute. Flow through 
was discarded and columns were centrifuged for an additional minute to remove any 
residual buffer from the binding column. 50µl of elution buffer (Miniprep Kit, 
Qiagen) was added to column and allowed sit for two minutes. The binding column 
was transferred to fresh eppendorfs and plasmid DNA was isolated by a final one-
minute centrifugation at 17, 900 x g.  
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To increase the plasmid concentration, 17µl of plasmid, retrieved from yeast was 
transformed into to E.coli as described in section 2.4.2. Plasmids were retrieved from 
E.coli using Qiagen miniprep kit by manufacturer’s recommendations.  
 
 
2.6.2 Isolation of Yeast genomic DNA  
Yeast cells cultured in 1.5ml of YPD at 30oC shaking overnight. Cells pelleted at 
978Xg  for five minutes. Pellets were resuspended in 1M Sorbitol/100mM EDTA.  
12µl of Zymolase (5mg/ml) was added and eppendorfs were incubated at 37oC for 
one hour. The cells were pelleted at 17,900 x g  for five seconds and resuspended in 
1M Tris/100mM EDTA. SDS 10% (15µl)  was added and mixture was incubated at 
65oC for thirty minutes. KAc 5M (60µl) was added to and solution was incubated on 
ice for one hour. The mixture was then centrifuged at 17,900 x g for five minutes. 
Supernatant was retained, 195µl of 100% Isopropanol was added, and mixture was 
incubated at room temperature for five minutes DNA pellet was obtained by 
centrifugation of mixture at 17,900 x g for ten seconds. DNA pellet was resuspended 
in 45µl of molecular H20 and stored at -20oC. 
 
 
2.6.3 RNA extraction 
RNA extraction was preformed by using the Sigma RNAeasy kit. Yeast cells cultured 
in 5mls of YPD overnight. 1.5ml of the overnight culture was removed and 
transferred onto an eppendorf tube. Cells were centrifuged at 978 x g for five minutes 
at 4oC and supernatant was removed. The pellet was resuspended in 600µl of buffer 
RLT. The same volume of glass beads (0.5mm soda lime) (Biospec products) were 
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added to resuspended cells and cells were vortexed for thirty seconds followed by 
thirty seconds on ice, five times. Cell lysates were centrifuged at 1308 x g for three 
minutes and supernatant was transferred into a new sterile tube. One volume of 70% 
EtOH was added to lysates and mixed well by pipetting, Lysates were then transferred 
to spin column and centrifuged and spun at 15,652 x g for fifteen seconds. 
Supernatant was discarded and 700µl of buffer RW1 was added to column, and 
centrifuged at 15,652 x g for fifteen seconds. Supernatant was discarded and 500µl of 
buffer RPE was added to column and spun at 15,652 x g for fifteen seconds. 
Supernatant was discarded and a further 500µl of buffer RPE was added to column 
and was centrifuged at 15,652 x g for two minutes. Column was then transferred into 
a new collection tube and spun at 15,652 x g for a further two minutes. Column was 
transferred into a new sterile 1.5ml tube and 40µl of stH20 was added. Column was 
spun at 15,652 x g for one minute. RNA concentrations were determined by using the 
nanodrop (Nanodrop 1000, Mason). 
 
2.7 Yeast growth assays 
2.7.1 Yeast growth curve 
Yeast strains were cultured overnight in 5ml of YPD or appropriate selective media at 
30oC shaking. Following incubation, the yeast cultures were diluted into 10ml of YPD 
at OD600 of 0.1. OD600 measurements were taken every two hours for approximately 
ten hours.  Log values for OD600 values were obtained using excel  and were plotted 
against time; the time points which gave the most linear point on graph were used in 
the following formula to calculate the mean generation time for each yeast strain; 
(Time (mins) /(LOG T1- LOG T0)/(LOG2). Mean generation times were plotted as 
minutes on excel graph. 
 71 
 
2.7.2 Dot growth assay 
Yeast strains were cultured overnight in 5ml of YPD or appropriate selective media at 
30oC shaking. Following incubation, the yeast cultures were diluted into 5ml of fresh 
media at an OD600 of 0.15. Cells were grown until they reached a final concentration 
of 5X106 cells/ml; concentration was determined by counting cells on 
haemocytometer. Cells were pelleted at 978 x g  for five minutes and resuspended at a 
concentration of 3 X106 cells/ml. A 1/5 serial dilution was performed on strains in a 
96 well plate under sterile conditions. Using a cell replicator cells were plated onto 
YPD or appropriate media and incubated at appropriate temperature (25oC, 30oC, 
37oC or 39oC) for forty-eight hours. 
 
2.7.3 Thermotolerance assay 
Yeast strains were cultured overnight in 5ml of YPD at 30oC shaking. Following 
incubation, the yeast cultures were diluted into 5ml of fresh media at an OD600 of 
0.15. Cells were grown until they reached a final concentration of 5X106 cells/ml. 
Cells were transferred to 37oC shaking for one hour, 1ml of cells was then removed 
from culture and placed on ice. Cells were transferred to 52oC shaking, after fifteen 
minutes 1ml of cells were removed and stored on ice and after thirty minutes this 
process was repeated.  Dot growth assays (2.7.2) was carried out on aliquots and cells 
were plated on YPD at 30oC for 48 hours. 
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2.8 Western Blot 
2.8.1 Preparation of cell lysates 
Appropriate yeast strain inoculated in 5ml of YPD or selective media at 30oC shaking 
overnight. Cells were diluted into 25ml of fresh YPD to an OD600 between 0.1-0.2 and 
incubated until an OD600 0.6-0.8 was reached. Cells were harvested by centrifugation 
at 978Xg  for five minutes at 4oC and pellets were immediately placed on ice. Pellet 
was resuspended in 1ml of  lysis buffer (Tris-Hcl pH 7.5 (250 µl), 1M Kcl (125µl), 
1M MgCl2 (50µl), 1.25M DTT (4µl), RNase A 10µg/ml (100µl), 100mM PMSF 
(50µl), PIC (10µl) were added to 9.46ml sterile water and stored on ice) and 
transferred to a 2ml screw cap tube. Glass beads were added to approximately 75% of 
2ml tube. Cells were then vortexed (vortex-2 gene, Scientific industries) for twenty 
seconds and placed on ice, vortexed again and then centrifuged at 7669 x g for ten 
minutes. Supernatant was then transferred to a pre-chilled 1.5ml microfuge tube. 
Protein concentrations determined by adding 10µl of protein to 900µl of Bradford 
reagent (Quickstart Bradford dry reagent 1X, Biorad) and concentrations measured on 
nanodrop (Nanodrop 1000, Mason) following manufacturer’s recommendations. 
Protein samples (80µl) were mixed with 20µl 4X protein sample buffer (Tris-HCL 
(0.25M)  adjusted to pH 6.8, SDS (1g) , Glycerol (5ml) Bromophenol blue (5mg) and 
DTT (755mg) dissolved in 10ml of sterile water and stored at room temperature).  
Samples were boiled on heat block at 100oC for five minutes. 
 
2.8.2 Preparation of SDS-PAGE gels 
The reagents used for making 12.5% SDS-PAGE gels are listed in Tables 2.12 and 
2.13.  Gels were prepared by adding various components and mixing gently, running 
gel was pipetted between two clean glass plates to about 70% capacity of glass plate.  
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Isopropanol (100%) was pipetted on top of running gel to 100% capacity of glass 
plates. Running gel was allowed to set and isopropanol was discarded. Stacking gel 
components were mixed and pipetted on top of running gel to 100% capacity of glass 
plates. Comb was placed and stacking gel was allowed set. 
 
 
Table 2.12 Composition of polyacrylamide running gel. All components of running 
gel stored at room temperature with the exception of 10% APS (4oC).  
 
 
 
 
 
No. of gels 1 2 
Volume 10ml 15ml 
4X Running Buffer(34.75g Tris base and 4g SDS dissolved in 
500ml distilled H20 and adjusted to pH8) 
2.5ml 3.75ml 
stH20 3.3ml 4.95ml 
Protogel 4.15ml 6.225ml 
10% APS 100µl 150µl 
TeMed 10µl 15µl 
No. of gels 1 2 
Volume 10mls 15mls 
2X Stacking buffer (15g Tris Base and .2g SDS dissolved in 
500ml d H20 and adjust to pH 6.8 
3.3ml 4.95ml 
H20 0.825
ml 
1.65ml 
Protogel 0.4ml 0.8ml 
10% APS 25µl 50µl 
TeMed 2.5µl 5µl 
Table 2.13 Composition of polyacrylamide stacking gel. All components of 
stacking gel stored at room temperature with the exception of 10% APS (4oC) 
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2.8.3 SDS-PAGE  
 Protein gels placed in electrophoresis tank and which was filled to appropriate level 
with 1X protein gel buffer (10X protein gel buffer; Tris Base (30.2g), Glycine for 
electrophoresis (18.8g), and 10% SDS (100ml) dissolved in 1000ml of distilled water 
and stored at room temperature). Comb was gently removed from gel and protein 
samples (10µg/lane) were loaded onto gel along with protein ladder (Bioline, 
hyperladder I). Electric current (100V for 15minutes and 200V one hour) was applied 
to gels. 
 
2.8.4 Transfer to PVDF membrane 
PVDF membrane and four sheets of whatman paper were cut to a similar size of 
protein gel. PVDF membrane was soaked in MeOH for a few seconds and then 
soaked in dH20 for one minute. Membrane, whatman paper and sponges were all 
soaked in Transfer buffer (Tris (3.03g) , Glycine  for electrophoresis (14.4g) and 
200ml of Methanol were added to 800ml of distilled water and stored at -20oC for 
approximately one hour) for approximately five minutes.  Sponges were placed on 
each side of transfer case, followed by two sheets of Whatman paper on each side, 
membrane was placed on clear side of transfer case and gel was placed on top of 
membrane. Transfer case was closed, ensuring that no air bubbles were present and 
placed in transfer tank, with clear side of transfer tank facing red side of transfer 
apparatus; tank was filled with transfer buffer, an ice block and a magnetic stirrer bar. 
Transfers were run at 200V/ 400mA for one hour exactly on a magnetic stirrer. 
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2.8.5 Blocking  
Membranes were transferred to blocking solution (Marvel (1.25g) was dissolved in 
25ml of 1X TBS-T (10X TBS; Tris (100mM) and NaCl (1M)  and 1ml of tween-20, 
dissolved in distilled water), for approximately one hour shaking at room temperature. 
 
2.8.6 Primary Antibody and secondary Antibody 
Primary antibodies were diluted in 10ml of TBS-T according to manufacturer’s 
recommendations (Table 2.14). The PVDF membrane was probed with primary 
antibody overnight shaking at room temperature. Membrane was then washed with 
5ml TBS-T for 5 minutes three times. Alkaline phosphatase labeled secondary 
antibodies were diluted in 10ml of TBS-T according to manufacturer’s 
recommendations (Table 2.15). Membrane was probed with secondary antibody for 
approximately one-two hours hour shaking at room temperature. Following this, the 
membrane was washed with 5ml TBS-T for 5 minutes three times. 
 
Primary Antibody 
name 
Animal of 
origin 
Source Dilution 
SPA-822 Mouse Stressgen (Victoria, BC, Canada) 1/2000 
Ssa1/2 (yT-14) Goat Santa Cruz, biotechnology, inc. 1/200 
Ssa3/4 (60591) Mouse Elizabeth Craig (University of 
Wisconsin) 
1/5000 
Hsp104 Rabbit John Glover (University 
of Toronto) 
1/150,000 
Anti-His Rabbit Santa Cruz, biotechnology, inc 1/200 
 
Table 2.14 Primary antibodies. Primary antibodies diluted in 10ml of TBS-T and 
incubated overnight at room temperature. 
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Secondary Antibody  Animal of 
origin 
Source Dilution 
Anti-Mouse IgG (Fab specific)–
Alkaline Phosphatase antibody  
 
Goat Sigma-Aldrich 
Chemical CO. Ltd. 
U.K 
1/2000 
Anti-Goat IgG (whole molecule)–
Alkaline Phosphatase antibody  
Rabbit Sigma-Aldrich 
Chemical CO. Ltd. 
U.K 
1/200 
Anti –Rabbit- Alkaline Phosphatase 
antibody 
Mouse Sigma-Aldrich 
Chemical CO. Ltd. 
U.K 
1/2000 
 
Table 2.15 Secondary antibodies. Secondary antibodies diluted in 10ml of TBS-T 
and incubated for two hours at room temperature. 
 
  
2.8.7 Chemiluminescence and developing blot 
The membrane was covered in 5ml of Chemiluminescence substrate CDP-star 
(PerkinElmer), for five minutes at room temperature. Membrane was placed between 
two acetate sheets and air bubbles were removed. The remainder of the developing 
process was carried out in dark room. Membrane was placed on X-ray cassette and 
film was placed on top Kodak film (PerkinElmer). X-ray cassette was shut for varying 
times depending on Antibody. Film was immediately transferred to developer (25ml 
Kodak developer and 100ml of dH20) for ten seconds. Film was then washed in H20 
and transferred to fixer (25ml Kodak fixing solution and 100ml of dH20) for 
approximately thirty seconds. Film was washed in H20 and then allowed to dry.   
 
2.8.8 Stripping membrane 
Membranes were firstly washed twice for five minutes with 5ml of dH20, followed by 
5ml of TBS-T. The membrane was stripped by adding it to 0.2M Sodium hydroxide 
for five minutes, shaking at room temperature. Sodium hydroxide was removed by 
washing in 5ml of dH20 for five minutes. 
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2.8.9 Coomassie staining of protein gels  
Following electrophoresis polyacrylamide gels were transferred to Coomassie brilliant 
blue stain shaking, overnight at room temperature. Gels were washed with dH20 and 
then in destain solution (10% Ethanol, 10% Acetic acid and 80% dH20) for 
approximately four hours. 
 
2.8.10 Amido black staining of membrane 
PVDF membranes stained in 10ml of Amido black (0.1% Naphtol blue black 
dissolved in 2% acetic acid and 45% MeOH for one minute. Membrane was then 
washed with stH20 and washed with destain (2% acetic acid and 45% Methanol) 
 
2.9 Hsp70 protein purification 
2.9.1 Transformation of BL21 
BL21 cells were transformed with the plasmids pPRO-SSA1, pPRO-SSA1G73D, pPRO-
SSA1G287D, pPRO-SSA1T295I and pPRO-SSA1F475S.  BL21 component cells were 
defrosted on ice. The plasmid (1µl) was added to 100µl BL21 component cells and 
this was incubated on ice for thirty minutes. Cells were then heat shocked at 42oC for 
ninety seconds and under sterile conditions plated on 2YT-AMP-CHL- agar and 
incubated at 37oC for sixteen hours.  
 
 
2.9.2 Scaling of BL21 
One single colony from BL21 transformants was added to 4ml 2YT-AMP-CHL and 
grown at 37oC in a shaking incubator for four hours until an OD600 of 0.8 is reached. 
Culture is diluted (1/100) into 50ml of 2YT-AMP-CHL and grown at 37oC in a 
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shaking incubator for three hours until an OD600 of 0.8 is achieved. Culture was then 
diluted (1/100) into 1000ml (x4) of 2YT-AMP-CHL and grown for four hours at 37oC 
in a shaking incubator for three hours until an OD600 of 0.8nm is reached. To induce 
protein expression, 200µM of IPTG was added and culture is incubated at 16oC in a 
shaking incubator for 14 hours. 
 
2.9.3 Cell collection 
 Collect cells by centrifugation at 3170 x g for 30 mins at 4oC. Resuspend pellet in 
35ml of dH20 by vortexing and transfer to 50ml falcon tube (pellets from 2 liters/ 
falcon). Centrifuge at 3170 x g  for one hour at 4oC. Discard supernatant and store 
pellets at -80oC. 
 
2.9.4 Protein extraction and Nickel column purification 
Buffers prepared for Nickel column purification; MCAC-0 (Metal-Chelate Affinity 
Chromatography) (50mM Na 2HP04, 50mM NaH2P04, 0,2M Kcl and 5% Glycerol) 
this should be approximately pH 7.4 and MCAC-500 (50mM Na 2HP04, 50mM 
NaH2P04, 0,2M Kcl, 5% Glycerol and 500mM Imidazole) adjust to same pH as 
MCAC-0 and store at 4oC. E. coli pellets thawed on ice and resuspended in 40ml of 
MCAC-10 (490ml MCAC-0 and 10ml MCAC-500).  E. coli cells were disrupted by 
using a high-pressure homogenizer and cell crusher (JNBIO- JN3000). Cells were 
then centrifuged at 17, 562 x g  for thirty mins at 4oC (Sorvall), supernatant 
transferred to sterile falcon and stored on ice. Nickel column (chelating sepharose fast 
flow, GE healthcare) washed with approximately 100ml molecular H20, column is 
then washed with MCAC-10 (250ml/sample). Supernatant was run through Nickel 
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column. Column is then washed with MCAC-10, followed by washing with MCAC-
100. Protein was eluted by washing with MCAC-350. 
 
2.9.5 Dialysis 
Supernatant collected from MCAC-350 elution is transferred to Dialysis bag 
(www.biodee.net). Dialysis bag is then transferred to 2 liters of Dialysis buffer (Tris 
Base 2.36g, Tris Hcl 12.7g, 150mM Kcl, 5mM MgCl2, 5% glycerol and 1mM DTT 
dissolved in 2 liters of molecular H20) stored at 4oC stirring overnight. Supernatant is 
then transferred to protein condensing tubes (Millipore) to condense volume  
to less than 2.2ml. 
 
 
2.9.6 Gel Filtration 
Gel filtration column (HiLoad superDex 200pg, GE Health care) stored in 20% 
Ethanol. Using ACTA, column washed with approximately 150ml filter sterilized 
molecular H20. Column then equilibrated with 150ml Dialysis buffer (RT). Sample 
applied to column,   and fractions 1 (aggregated Ssa1) and fractions 2 (purified Ssa1) 
were collected and applied to a 12.5% SDS-PAGE gel. 
2.10 YDJ1 protein purification 
2.10.1 Transformation of C41 E.coli 
YDJ1 plasmid was transformed to C41 as described in section 2.4.6. 
 
2.10.2 Scaling of transformed C41 E.coli 
One single colony from C41 transformants is added to 4ml 2YT-AMP and grown at 
37oC in a shaking incubator for four hours until an OD600 of 0.8 is reached. Culture is 
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diluted (1/100) into 50ml of 2YT-AMP and grown at 37oC in a shaking incubator for 
three hours until an OD600 of 0.8 is achieved. Culture is then diluted (1/100) into 
1000ml (x2) of 2YT-AMP and grown for four hours at 37oC in a shaking incubator 
for three hours until an OD600 of 0.8 is reached. To induce protein expression, 200µM 
of IPTG is added and culture is incubated at 16oC in a shaking incubator for fourteen 
hours. 
 
2.10.3 Cell collection 
 Collect cells by centrifugation at 3170Xg for thirty minutes at 4oC. Resuspend pellet 
in 35ml of dH20 by vortexing and transfer to 50ml falcon tube (pellets from 2 liters/ 
falcon). Centrifuge at 3170 x g for one hour at 4oC. Discard supernatant and store 
pellets at -80oC. 
 
2.10.4 Protein extraction and Nickel column purification 
Buffers prepared for Nickel column purification; MCAC-0 (Metal-Chelate Affinity 
Chromatography) (50mMTris-base, 0.3M NaCl and 5% Glycerol) this should be 
approximately pH 7.5 and MCAC-200 (50mM Tris-base, 0.3M NaCl, 5% Glycerol 
and 200mM Imidazole) adjust to same pH as MCAC-0 and store at 4oC. E. coli pellets 
thawed on ice and resuspended in 40ml of MCAC-10 (490ml MCAC-0 and 10ml 
MCAC-500).  E. coli cells were disrupted by using a high-pressure homogenizer and 
cell crusher (JNBIO- JN3000). Cells were then centrifuged at 17,800 x g for thirty 
mins at 4oC (Sorvall), supernatant transferred to sterile falcon and stored on ice. 
Nickel column (chelating sepharose fast flow, GE healthcare) washed with 
approximately 100ml molecular H20, column is then washed with MCAC-10 
(250ml/sample). Supernatant is run through Nickel column. Column was washed with 
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MCAC-10, followed by washing with MCAC-70. Protein is eluted by washing with 
MCAC-200. 
 
2.10.5 Dialysis 
Supernatant collected from MCAC-200 elution is transferred to Dialysis bag 
(www.biodee.net). Dialysis bag is then transferred to 1 liter of Dialysis buffer (Tris 
Base 2.36g, Tris Hcl 12.7g, 150mM Kcl, 5mM MgCl2, 5% glycerol and 1mM DTT 
dissolved in 2 liters of molecular H20), after four hours sample was transferred to 1 
liter of fresh dialysis buffer stored at 4oC stirring overnight. Supernatant is then stored 
at -80oC. 
 
2.11 ATPase assay 
Measuring ATPase activity depends on a coupled enzyme assay, which is based on 
the conversion of phosphoenolpyruvate (PEP) to pyruvate by pyruvate kinase (PK); 
this depends on the hydrolysis of ATP to ADP. This reaction is coupled to the 
conversion of pyruvate to lactate by lactate dehydrogenase (LDH), which requires 
NADH being oxidized to NAD+. NADH is strongly absorbed at OD340 but NAD+ is 
not. This enables reduction of NADH over time to be monitored by decrease in 
absorbance value. Assay carried out with Dialysis buffer, PK (2U/ml), LDH 
(10U/ml), PEP (4mM), NADH (0.15mM), ATP (1mM) and 2µM of purified protein 
in a total volume of 900µl. Dialysis buffer, PK, LDH, PEP, NADH and ATP 
incubated at 30oC for 10 minutes. Mixture is then transferred to a cuvette and 
measured at 340nm, after 40 seconds 2µM of protein is added to cuvette and mixed 
and absorbance is read for a further six minutes. Rate (min-1) is calculated by the 
formula; slope*60/Є (3440)/ protein concentration (0.000002).  
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2.12 Circular dichroism spectroscopy  
Spectra were recorded over the range 200–250 nm in a Pistar-180 Spectrometer 
(Applied Photophysics). Spectra of 4µM native Ssa1 and mutants were measured in 
dialysis buffer in a 0.1mm path length thermostatted cuvette. 
 
2.13.0 Assay of ß-Galactosidase in yeast 
 
2.13.1 Preparation of crude extracts 
  
 A 5ml culture of yeast was grown overnight in YPD. The culture was diluted to a 
concentration of 5x106 (cells/ml) in 5ml of YPD and were then grown to a 
concentration of 1x107-2x107 (cells/ml).  Cells were chilled on ice and then harvested 
at 4oC and kept on ice for remainder of the experiment. Supernatant was discarded 
and pellet was resuspended in breaking buffer (100mM Tris-CL pH8, 1mM 
dithiothreitol and 20% Glycerol) and transferred into a 1.5ml microfuge tubes. Glass 
beads (0.5mm soda lime) (Biospec products) were added until the beads reached a 
level just below meniscus of the liquid. 12.5µl of PMSF stock solution (40mM PMSF 
in 100% isopropanol) was then added to liquid. Cells were then vortexed six times at 
top speed in fifteen second bursts, and chilled on ice between bursts. 250µl of 
breaking buffer was added to liquid and mixed well. The liquid is then clarified by 
centrifuging for fifteen minutes at 17,900 x g in a microfuge. Supernatant was then 
transferred into a sterile 1.5ml microfuge tube. 
 
2.13.2 ß-Galactosidase assay 
 To perform ß-Gal assay, 100µl of extract was added to 900µl Z buffer (16.1g 
Na2HPO4 .7H20, 5.5g of NaH2PO4. H20, 0.75g KCL, 0.246g MgSO4.7H20, 2.7ml ß-
mercaptoethanol made up to one liter with distilled H20. The buffer was adjusted to 
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pH 7.0 and was stored at 4oC). The mixture was then incubated at 28oC for five 
minutes. The reaction was initiated by adding 200µl of o-nitrophenyl- ß-D-galactoside 
(ONPG) (4mg/ml in Z Buffer and stored at -20oC). The time was noted at the exact 
moment ONPG was added into mixture. The mixture was then watched until a pale 
yellow color was observed. The reaction was terminated by adding 500µl of Na2CO3 
stock solution (1M Na2CO3 in distilled water). The precise time of adding Na2CO3 
was noted. The optical density of solution was measured at OD420. 
        
2.13.3 Determination of protein concentration 
 
 The extract (10µl) was added to 1ml of Bradford solution (Quickstart Bradford dry 
reagent 1X, Biorad). This was left at room temperature for twenty minutes. Protein 
concentration was read on a nanodrop (nanodrop 1000, Mason) at OD595. A standard 
curve was prepared by using several dilutions (0.125µg-2000µg/ml) of BSA (New 
England Biolabs) 
 
2.13.4 Expressing specific activity of extract 
  ß-Gal units of each extract were determined by using the formula; (OD420 x 1.7) / 
(.0045x protein concentration x extract volume x time). OD420 is the optical density of 
the product, σ-nitrophenol, at 420nm. The factor 1.7 corrects for the reaction volume. 
The factor 0.0045 is the optical density of a 1 nmole/ml solution of σ-nitrophenol.  
Protein concentration is expressed as mg/ml. Extract volume is the volume assayed in 
a ml. Time is in minutes. Specific activity is expresses as nmoles/minute/mg of 
protein.  
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2.14 Luciferase assay 
Yeast cultures containing the pDCM90 plasmid, that were grown overnight in SD 
media lacking Uracil at 30oC, were diluted to an OD600 of 0.2. Diluted cultures were 
incubated at 37oC shaking for thirty minutes to induce expression of heat shock 
proteins. Luciferase activity of three 200µl aliquots was measured to get a reading for 
100% activity. Cells were then shifted to 42oC and incubated with shaking for one 
hour. Cycloheximide was added to culture fifty minutes after shifting to 42oC to 
prevent synthesis of new luciferase, activity of luciferase was measured of three 200µl 
aliquots. To allow recovery, cells were shifted to 25 oC for thirty minutes; luciferase 
activity of three 200µl aliquots was measured. Luciferase recovery was calculated as a 
percentage of the 100% activity.  
 
 
2.15 Structural analysis 
Carried out by Dr. Gemma Kinsella (The Marie Curie Laboratory for Membrane 
Proteins, National University of Ireland, Maynooth).  The models created are based on 
the bovine Hsc70 (PDB: 3C7N chain B, 3.12 Å) (Schuermann. et al., 2008) which 
was the top BlastP hit (sequence identity ~76%). However, only residues 3-557 were 
modeled. 
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2.16 Next Generation Sequencing  
Next Generation sequencing was carried out on the Illumina GAII.  Yeast genomic 
DNA was isolated from the strains; G600, G402 and S288C as in section 2.6.2. 
Strains were sequenced by the Trinity sequencing group. 
 
2.17 Microarray analysis 
A 3-DTM competition award was granted by Toray industries, Inc. Japan to enable 
microarray analysis to be carried out. RNA was isolated (2.6.3), from [psi-] yeast 
strains Ssa1, Ssa2, Ssa3, Ssa4, ∆20 and Ssa1F475S. Microarray analysis was carried out 
by Toray industries in Japan. 
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3.0 Introduction 
 
The aim of this chapter is to provide insight into the influence of the Hsp70s peptide 
binding domain (PBD) on [PSI+] propagation and determine its importance with 
regards to other cellular functions. We generated mutants in the PBD of SSA1 that 
have impaired [PSI+] propagation. Propagation of yeast prions requires the activity of 
molecular chaperones. Heat shock proteins (HSPs) are a group of molecular 
chaperones that are involved in protein folding and dissaggregation.  
 
Hsp70 is a ubiquitous and essential protein chaperone involved in many processes 
such as protein folding and is a critical component of chaperone machinery. It is 
highly conserved in archaea, eubacteria, eukaryotes and organelles (mitochondria, 
chloroplasts) (Karlin and Brocchieri, 1998). Hsp70 proteins are abundant under 
cellular stress such as heat shock, osmolarity and acidity. In yeast, the Hsp70 family 
comprises of many 70 kDa chaperones, which exist in various compartments of the 
cell. The main member of Hsp70 family in yeast cytosol is the Ssa family (stress 
seventy subfamily A), which comprises of Ssa1-4, which collectively provide 
essential cellular functions. The function of Hsp70 depends on the binding and 
hydrolysis of ATP. Hsp70 contains a conserved N-terminal ATPase (44-kDa), a 
peptide-binding domain (18-kDa) and a C-terminal domain lid domain (10-kDa). ATP 
binds to the ATPase domain in a cleft, which is between two lobes (Flaherty et al.,  
1990). Most of the structural and biochemical analysis on Hsp70 has been carried out 
using the E.coli Hsp70 homologue DnaK (Mayer and Bukau, 2005). Structural 
analysis of the DnaK PBD highlights the importance of three elements for binding of 
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substrates; the α-helical lid, the arch enclosing the substrate peptide and the central 
hydrophobic pocket (Mayer and Bukau, 2005). 
 
The function of Hsp70 relies on many co-chaperones and other factors involved in the 
regulation of the ATPase cycle. The Hsp40 chaperone binds unfolded proteins and 
presents them to Hsp70, which then refolds them into the correct confirmation. The 
Hsp70 family member, Hsp110 (Sse1), acts as a nucleotide exchange factor, peptide 
release can be triggered by NEF’s, by helping liberate bound ADP and there 
facilitating ATP rebinding. The Hsp104 chaperone also works in conjunction with 
Hsp70; it is a member of the Hsp/100ClpB family of hexameric AAA+ ATPases. 
Hsp104 acts as a protein disaggregase; it shears high molecular weight proteins into 
smaller aggregates that are then dealt with by the Hsp70/40 system. 
 
Recent studies have implicated many of these chaperones as having an essential role 
in the propagation of [PSI+]. Overexpression or deletion of Hsp104 causes loss of the 
[PSI] in yeast cells, this is thought to happen due to the prion remodeling activities of 
Hsp104 (Shorter 2008). Recent studies have found Sse1 is required for de novo [PSI+] 
formation and efficient prion propagation (Kryndushkin and Wickner, 2007); Fan. et 
al., 2007). Biochemical studies using Sup35 show that the most abundant proteins to 
co-purify with [PSI+] cells are Ssa1 and Ssa2 (Bagrianstsev et al., 2008). The 
isolation of SSA1 mutants that impair [PSI+] propagation has also implicated Hsp70 as 
having an essential role in prion propagation. The SSA1 mutant L483W (Ssa1-21), 
located in the PBD, shows impairment of prion propagation but exhibits no effect on 
stress tolerance or cell growth (Jung et al., 2000). The majority of SSA1 mutants, that 
affect prion propagation (approximately ninety percent), are located in the ATPase 
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domain of Ssa1 (Jones and Masison, 2002; Loovers. et al., 2007), which suggests the 
regulation of chaperone activity may be more important than direct binding with 
substrates in relation to [PSI+] propagation. 
The main objective of this chapter was to: 
• Isolate mutants in the PBD of Ssa1 that impair [PSI+] propagation. 
• Genetically and biochemically characterize isolated mutants. 
• Investigate mutants with respect to other cellular functions 
• Isolate second -site suppressors of any PBD mutants, which may provide 
further insight into Ssa1’s role in prion propagation. 
 
3.1 Strategy for isolating Ssa1 PBD mutants that impair [PSI+] propagation. 
Random mutagenesis of Ssa1 to isolate mutations that affect [PSI+]  propagation has 
resulted in a predominance of mutations being located in the ATPase domain of Ssa1 
(Jones and Masison, 2002; Loovers. et al., 2007). Therefore, we employed a strategy 
that would yield mutants located in the PBD or C-terminal domain that affect [PSI+] 
propagation. To isolate PBD mutants we employed a modified version of the plasmid 
shuffle technique (Figure 3.1). Colonies harboring potential PBD mutants that impair 
[PSI+] had plasmids isolated and were transformed back into G402 to verify 
phenotype, mutant plasmids were isolated and sent for sequencing (Figure 3.1).To 
isolate mutants located in the PBD, a slightly modified version of plasmid shuffle 
technique was employed. The pJ120 plasmid was subjected to hydroxylamine 
treatment for one hour at 70oC, the PBD and C-terminal were amplified from plasmid 
library and cloned in vivo into a SexA1 and Sph1 digested pJ120 by transforming 
G402 yeast cells with the PCR product and digested vector on SD media lacking 
leucine (Figure 3.2). Transformants were replicated onto 5-FOA to select against the 
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pRDW10 plasmid which expresses wildtype Ssa1. To determine whether colonies 
appearing red or dark pink were harboring a SSA1 PBD mutant allele that impairs 
[PSI+] propagation and supports growth, the potential mutant plasmids were isolated 
and re-transformed into G402 to verify phenotypes. Plasmids were extracted and 
sequenced; mutations were located by aligning sequencing results with wildtype Ssa1 
sequence by BLAST analysis. 
 
 
 
SSA1* 
LEU 
*=SSA1 containing randomly mutagenised 
PBD 
SSA1* 
URA 
∆ssa1,2,3,4  
ade2-1  
[PSI+] 
5-FOA  
SSA1* 
Leu 
∆ssa1,2,3,4  
ade2-1  
[PSI+] 
 
 
 Screen for [psi-] colonies on 5-FOA 
 
 
 Mutations confirmed by sequencing 
analysis 
 
 
Figure 3.1 Proposed Strategy for isolating SSA1 mutations. To create a mutant library, 
SSA1 was mutagenized by hydroxylamine at 70oC for one hour. The mutant library was 
amplified by transformation to E.coli and the plasmid library was isolated and transformed 
into the [PSI+] yeast strain G402 onto SD media lacking leucine. The transformants were 
replicated on to 5-FOA to eliminate the pRDW10 plasmid which contains wildtype SSA1. 
Mutant plasmids were retrieved from [psi-] colonies and sequenced. 
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Figure 3.2 Strategy for isolation of PBD mutants. SSA1 was randomly mutagenized by 
hydroxylamine at 70oC for one hour. The potentially mutagenized PBD and C-terminal of 
SSA1 was amplified using the primers ZHssa1-1-1 and Sp9. A restriction digest was 
preformed on the pJ120 PBD plasmid using SexA1 and Sph1. The digested plasmid and 
PCR fragment were transformed simultaneously into the yeast strain G402 in which the 
PCR fragment ligated into the digested plasmid by homologous recombination. Mutant 
plasmids were identified as described in Figure 3.1. 
Selection of red colonies on 5-FOA 
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3.1.1 Isolation of SSA1 PBD mutants that impair [PSI+] propagation. 
To isolate potential cells harboring mutations of SSA1 that impair [PSI+] propagation, 
the plasmids from colonies that appeared red on 5-FOA were isolated. A secondary 
screen to confirm [psi-] phenotypes was preformed by retransforming mutant plasmids 
into the [PSI+] strain G402. SSA1 mutations were confirmed by sequencing and 
BLAST analysis (Table 3.1).The Ssa1 mutagenesis screen revealed four novel and 
two previously categorized Ssa1 PBD mutations that impair prion propagation. Color 
of mutants in G402 was scored subjectively by applying a numerical scale, zero being 
[PSI+] (white) and ten being [psi-] (red).  The novel mutant F475S and previously 
categorized mutant L483W (Jung. et al., 2000) appear to have the strongest [psi-] 
phenotypes  
 
Plasmid 
name 
SSA1 nucleotide 
change 
Amino Acid 
change 
Times 
isolated 
Color in 
G402 
V439I Position 1315- G-A V439I 2 7 
F475S Position 1424- T-C F475S 3 9 
G481D* Position 1442-G-A G481D* 1 9 
L483W* Position 1448- T-G L483W* 1 9 
M515I Position 1545 G-C M515I 1 6 
S545F Position 1634 C-T S545F 1 5 
 
Table 3.1 Ssa1 PBD mutants that impair [PSI+] propagation. The screen identifies 
four novel PBD; V439I, F475S, M515I and S545F and two previously characterized 
mutants G481D (Loovers et al. 2007) and L483W (Jung et al. 2000). This Table also 
shows how many times each PBD mutant was isolated in genetic screen and also  
numerically categorizes mutants subjectively according to their color, zero 
representing white [PSI+] and nine representing red [psi-].  
*-previously characterized mutant 
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3.2 Phenotypic analysis of Ssa1 PBD mutants 
Four novel PBD mutants that were identified as impairing [PSI+] prion propagation. 
We further characterized mutants with respect to prion propagation and other cellular 
processes. Phenotypic analysis for the four novel PBD mutants; V439I, F475S, M515I 
and S545F was carried out, mutant phenotypes were reconfirmed by growing mutants 
on YPD along with controls Ssa1 [PSI+] and [psi-] (Figure 3.3).  
 
 
 
 
 
 
 
       
                 
 
 
 
 
 
 
 
 
 
 
 
 
Ssa1 [psi-]  
 
Ssa1 [PSI+] Ssa1S545F 
Figure 3.3 Phenotypes of yeast cells expressing Ssa1 mutants in G402. Cells 
were streaked onto YPD and incubated at 30oC for 48 hours. WT Ssa1 [PSI+] 
(white) and [psi-] (red) were used as controls. 
Ssa1F475S Ssa1V439I 
 
Ssa1M515I 
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3.2.1 Comparison of growth rates of wildtype and PBD mutants 
To further compare the phenotypic differences between wildtype Ssa1 and PBD 
mutants, growth rates were assessed. A substantial difference in growth rates may be 
indicative that PBD mutants are not just impairing prion propagation but  are also 
affecting other cellular functions The mean generation time (MGT), is the time 
(minutes) in which the yeast cells double. From Table 3.2 it can be deduced that the 
PBD mutations do not have a major effect on the growth rate of S. cerevisiae. The 
mutant with the biggest difference in growth rate is Ssa1F475S which is approximately 
12% slower in comparison to wildtype. This highlights that mutants in the PBD do not 
have a significant effect on cell growth when expressed in yeast. 
 
                                     
 
 
 
 
 
 
 
 
Table 3.2 Comparison of PBD growth rates. Growth rates were obtained by 
diluting overnight 30oC cultures which expressed Ssa1 or PBD mutants, to an OD600 
0.1, the OD600 of cultures was, measured every two hours for approximately ten hours 
(section 2.7.1) 
 
 
 
 
 
 
Mutations in 
SSA1 
MGT 
(Mins) 
MGT % of WT 
SSA1 111.5 100%  
V439I 119.5 93% ±0.7% 
F475S 126.5 88% ±0.7% 
M515I 115.5 96% ±2.12% 
S545F 109 102% ±2.82% 
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3.2.2 Investigation of PBD mutant’s temperature sensitivity. 
 
 Hsp70 functions as a heat shock protein, refolding misfolded or aggregated proteins 
at higher temperatures. Therefore measuring the ability of cells expressing mutated 
Hsp70 growing at higher temperatures such as 37oC or 39oC is indicative of altered 
Hsp70 function. The ability of the PBD mutants to grow at higher temperatures; 37oC 
and 39oC was tested. Previously isolated PBD mutants L483W (Jung. et al., 2000) and 
G481D (Loovers. et al., 2007) had no effect on growth at higher temperatures.  
Testing mutant temperature sensitivity reveals Ssa1F475S is temperature sensitive (t.s) 
at 37oC whereas other PBD mutants grow similarly to wildtype (Figure 3.4). This may 
be due to the F475S mutation causing Ssa1 to become unstable. All mutants, with the 
exception of S545F appear t.s at 39oC (Figure 3.4). This indicates that the ability of 
Hsp70 to rescue aggregated proteins at elevated temperatures is effected by mutations 
in the PBD.  
 
                30oC                                              37oC                                                  39oC                 
 
  
 
 
 
 
 
Figure 3.4 Temperature sensitivity of PBD mutants. Cells incubated at specific 
temperatures for 48 hours on YPD. Cells were diluted by a 1/5 serial dilution. Spots 
labeled accordingly. Wildtype [PSI+] and mutants expressed in G402 as sole source of Ssa 
in strain. 
 
Ssa1 
 
V439I 
 
F475S 
 
M515I 
 
S545F 
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3.2.3 Analysis of cell growth and cell morphology of Ssa1F475S 
The phenotypical analysis carried out so far on the PBD mutants has highlighted that 
Ssa1F475S is the only PBD mutant to date that exhibits impairment of prion propagation 
and a 37oC t.s phenotype. Due to Ssa1F475S possessing both phenotypes we decided to 
further analyze the growth and morphology of this mutant. S.cerevisiae is a budding 
yeast, i.e. reproduces asexually by a small outgrowth forming from parental cell. The 
nucleus of the parental bud divides and the daughter nucleus migrates to the bud, 
which increases in size and eventually breaks off. Due to the growth of yeast cells 
being concentrated in the bud, the bud gives us an indication of the cells position in 
the cell cycle. For example, when yeast cells are exponentially growing one third of 
cells will have small buds, one third will have large buds and one third will contain no 
buds. This allows comparative analysis between wildtype and mutant strains in 
relation to their stage in the yeast cell cycle. 
To compare cell growth of wildtype Ssa1 and Ssa1F475S,  overnight yeast cultures 
expressing either Ssa1 or Ssa1F475S were diluted to an OD600 0.2 and then grown to an 
OD600 1.0. Cells from both strains were examined by light microscopy at both stages. 
Images (A) and (B) indicate that both strains are exponentially growing with roughly 
one third of cells with small buds, one third of cells with large buds and one third of 
cells with no buds. Images (C) and (D) indicative that cells have stopped dividing and  
may both be in stationary phase.  There appears to be no difference between wildtype 
Ssa1 and Ssa1F475S with respect to their growth rates or cellular morphology (Figure 
3.5). 
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 (A)                                                                                           (B) 
(C)                                                                                  (D) 
Figure 3.5 Comparison of growth and morphology between Ssa1 and Ssa1F475S.  Cells that 
expressed Ssa1 or Ssa1F475S were cultured in 5ml of YPD at 30oC overnight. They were then 
diluted to an OD600 of 0.2 and grown at 30oC until an OD600 of 1.0 was reached. Cells were 
observed by microscopy (x40) at both stages. Images (A) and (B) represent Ssa1 and Ssa1 F475S 
respectively at an OD600 of 0.2, images (C) and (D) represent Ssa1 and Ssa1 F475S respectively at 
an OD600 of 1.0.   
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3.3 Analysis of Hsp70 and Hsp104 expression of PBD mutants 
It is clear that protein chaperones play an essential role in prion propagation. 
Therefore analysis of Hsp70 and Hsp104 levels is an essential step whilst 
investigating impairment of [PSI+] propagation; as their levels can influence 
propagation of the prion. Protein levels for wildtype and mutant alleles were observed 
by Western blotting. Total protein was extracted from cells and probed with Hsp70 
(SPA-822) and Hsp104 antibodies. The majority of the mutant alleles have a similar 
abundance of Hsp70 in comparison to wildtype with the exception of Ssa1F475S 
appearing to have lower levels (Figure 3.6). Reduced amount of Hsp70 in the 
presence of the F475S mutation may be due to protein stability or an altered gene 
expression.  Hsp104 does not seem to be increased in cells expressing Ssa1F475S 
suggesting that cells are not stressed.          
 
                                     
      
 
 
 
 
 
 
 
(A) 
(B) 
70kDa 
 
 
  104kDa 
Figure 3.6 Basal levels of Hsp70 and Hsp104. Lysates prepared from overnight 30oC cultures. 
Aliquots of proteins (10µg) were separated on two polyacrylamide gels and each gel was 
immunoblotted with antibodies either specific for (A) Hsp70 (SPA-822, 1/2000 dilution) or (B) 
Hsp104 (HSP104, 1/150,000 dilution). PVDF membrane stained with amido black representative 
of sample loading. Mutant alleles are as indicated. 
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3.4 Protein refolding activity of Ssa1F475S 
A major function of Hsp70 is refolding proteins that have become misfolded due to 
heat stress. The ability of chaperones to refold misfolded proteins can be measured by 
performing a luciferase assay. The luciferase enzyme is unstable at high temperatures 
and emits light in the presence of its substrate decanal, which can be measured on a 
luminometer. Cells expressing wildtype Ssa1 or Ssa1F475S were transformed with a 
plasmid (pDCM90), expressing the luciferase protein. Exposing cells to elevated 
temperatures causes unfolding of proteins to occur. Hsp104 is critical for survival at 
elevated temperatures and its function is dependent on Hsp70 and Hsp40. To monitor 
luciferase activity, exponentially growing cells were shifted from 30oC to 37oC, 
inducing the expression of heat shock proteins. Cells were then shifted to 42oC for one 
hour to induce unfolding of the luciferase protein, after fifty minutes of the 42oC 
incubation cycloheximide was added to prevent synthesis of new luciferase during 
recovery period. Cultures were shifted to 25oC to allow recovery of unfolded 
luciferase by the heat shock proteins. Luciferase levels were measured using a 
luminometer. In wildtype cells 81% of luciferase activity was restored compared to 
72% restoration in cells expressing Ssa1F475S (Figure 3.7), therefore we can conclude 
that luciferase refolding activity of Ssa1 is not significantly affected by the F475S 
mutation. 
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Figure 3.7 Refolding activity of Ssa1F475S. Cultures of strains expressing luciferase and Ssa1 
or Ssa1F475S were shifted from 30oC to 37oC for 30 minutes and then shifted to 42oC for one 
hour. Cycloheximide was added 50 minutes after shifting to 42oC to prevent synthesis of 
luciferase during the recovery period. Luciferase activity, expressed as a percentage of pre-
heat shock activity, was measured after allowing cells to recover for 30 minutes at 25oC. 
Experiment was repeated twice in triplicate. There appears to be no significant difference 
between WT and F475S.  
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3.5 Location of PBD mutants on Hsp70 crystal structure 
Previously, structural analysis of mutations in Ssa1 that affected prion propagation 
was carried out using the E.coli Hsp70 homologue, DnaK, model (Loovers et al., 
2007; Jones and Masison., 2003). The DnaK model has 62.6% similarity to yeast 
Hsp70. More recently, the bovine homologue of Hsp70, Hsc70, PBD has been 
modeled. The Hsc70 model has 87.3% homology to yeast Hsp70. Therefore, it was 
decided, the locations of the PBD mutations are revealed by mapping mutant residues 
onto a 3-D crystal structure modeled from the 3C7N template  (chain B) 
(Schuermann. et al., 2008).This model revels that a majority of the mutants, with the 
exception of M515I and S545F, are located closely to one another (Table 3.3). 
Although the F475 residue appears to be closely located to the other mutated residues, 
none of the other mutants exhibit a 37oC t.s phenotype.  Both V439I and F475S are 
located in a ß-strand, G481D is in a turn region, L483W is located at the top of the 
strand and M515I is located in the helix (Figure 3.8). 
 
 
 
 
 
 
  
 
 
 
 
 V439I G481D L483W F475S 
V439I   - 22.17 16.69 12.97 
G481D   -   - 5.9 17.62 
L483W   -   -   - 13.36 
 
Table 3.3 Cα-Cα distances (Å) for residues at the 
base of the PBD. Modeled from the 3C7N template 
(chain B) (Schuermann. et al. 2008). 
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Figure 3.8 Substrate binding domain (380-570) of yeast: Hsp70 modeled 
from the 3C7N template (chain B) (Schuermann et al., 2008). Images were 
generated using Pymol (DeLano. 2002).  
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3.6 Comparative analysis of PBD mutants Ssa1L483W and Ssa1 F475S 
Mapping the PBD mutants onto the 3D crystal structure reveals that Ssa1 F475S is 
located closely to the previously isolated mutant Ssa1L483W (SSA1-21) (Jung et al., 
2000). Further studies on the SSA1-21 revealed that the [psi-] phenotype could be 
suppressesed by the introduction of second site suppressors of the L483W mutation 
(Jones and Masison., 2002). In order to determine whether Ssa1F475S impairs prion 
propagation in a similar manner to SSA1-21, three second site suppressors (A519T, 
E540K and P636S) were introduced to the pJ120 F475S plasmid by site-directed 
mutagenesis. F475S in combination with P636S was the only combination that 
restored the [PSI+] phenotype, A519T and E540K in combination with F475S proved 
detrimental (Figure 3.9). This result shows that F475S is slightly similar to L483W, 
but also behaves differently. 
 
  
 
 
 
 
 
 
 
 
 
 
3.6.1 Ssa1F+P636S  restores the [PSI+] phenotype but not the 37oC t.s phenotype  
  
 
 
(D) 
Figure 3.9 Phenotypes of PBD mutants with second site suppressors. Cells replicated to 5-FOA from 
SD minus leucine plates and incubated at 30oC for 48 hours. (A) SSA1 L483W and second site suppressors 
that restore [PSI+] phenotype when in combinatio  with L483W. (B-D) Ssa1F475S and second site 
suppressors labeled accordingly. [PSI+] is restored when the F475S mutation is combined with P636S. 
 
L483W 
L483W+P636S 
  F475S F+A519 F+E540K F475S F+P636S F475S 
(A) 
  (B) (C) 
L483W+A519T 
L483W+E540K 
 103 
The comparative analysis between SSA1-21 and Ssa1F475S lead us to conclude that   
Ssa1F+P636S restore the [PSI+] phenotype. However, Ssa1F475S differs from SSA1-21 as 
phenotypical analysis revealed Ssa1 F475S is t.s at 37oC. We therefore tested whether 
Ssa1F+P636S could also restore the t.s phenotype or was it just unique to [PSI+] 
restoration. From Figure 3.10 it can be concluded that Ssa1F+P636S cannot restore the 
37oC t.s phenotype of Ssa1F475S, in fact it appears to worsen the phenotype. The P636 
residue is in a highly conserved motif of Ssa1’s C-terminal (GPTVEEVD), which 
mediates interactions with tetratricopeptide repeat (TPR) Cochaperones such as Sti1 
(Scheufler et al., 2000). This suggests that interactions with TPRs may be more 
significant for prion propagation than other cellular functions. 
 
 
 
 
                         
 
  
 
 
 
 
 
300C 370C 
Figure 3.10 Temperature sensitivity assay of Ssa1F+P636S  
Cells incubated at 30oC and 37oC on YPD for 48 hours.  Spots labeled accordingly. Cells 
diluted by a 1/5 serial dilution. Wildtype [PSI+] and mutants expressed in G402 therefore 
are sole source of Ssa in strain. 
 
WT 
 
 
F475S 
 
F+P636S 
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3.7 Second- site suppressors of Ssa1F475S that restore 37oC t.s phenotype  
Comparative studies between SSA1-21 and Ssa1F475S lead us to conclude that there are 
a number of similarities and differences between these PBD mutants. The major 
difference is Ssa1F475S is t.s at 37oC. To provide further insight on how Ssa1F475S is 
affecting [PSI+] propagation and the Ssa1 heat shock function, a random mutagenesis 
screen was carried out to isolate second-site suppressors of the F475S mutation. The 
mutagenesis screen was employed to isolate mutants that were [PSI+] or were viable 
at 37oC (Figure 3.11). This screen identified three second-site suppressors of F475S 
that restored growth the t.s 37oC phenotype; A394V, P432S and V477I, all of which 
are located in the PBD (Table 3.4). The screen yielded no second-site suppressors that 
restored [PSI+] propagation, highlighting another difference with SSA1-21 which 
yielded many second-site suppressors from a random mutagenesis screen (Jones and 
Masison, 2003). Interestingly cells expressing Ssa1F475S in combination with second-
site suppressors P432S and V477I appear to remain [psi-] (Figure 3.12), whereas cells 
expressing A394V appear [PSI+] leading us to conclude that certain regions of Ssa1 
may be involved with suppressing particular cellular functions whereas other regions 
e.g. the conserved motif of Ssa1’s C-terminal (GPTVEEVD) may be exclusively 
involved with [PSI+] propagation mediated through co-chaperones. 
 
3.7.1 Phenotypical analysis of all second-site suppressors of F475S 
To further our knowledge of how these second-site suppressors are affecting Ssa1 
function, phenotypical analysis was carried out on all Ssa1F475S suppressors; A394V, 
P432S, V477I and P636S, [PSI] status was analyzed by streaking mutants onto YPD 
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F474S* 
LEU 
*=Hydroxylamine mutagenized library 
SSA
1 
URA 
∆ssa1,2,3,4  
ade2-1  
[PSI+] 
5-FOA 
selection at 
37oC 
F475S* 
LEU 
∆ssa1,2,3,4  
ade2-1  
[PSI+] 
 
 
 Screen for colonies that can now grow at 
37oC  
Screen for colonies that are now [PSI+] 
 
 Mutations suppress t.s phenotype of 
Ssa1F475S 
 
 Mutations confirmed by sequencing 
analysis 
Figure 3.11 Strategy for isolating second site suppressor mutations of SSA1F475S T.S 
phenotype. To create a mutant library of second site suppressors of Ssa1 F475S mutation, pJ120F475S 
was randomly mutagenized by hydroxylamine at 70oC for one hour. The mutant library was 
transformed into G402 and mutants were selected for by the plasmid shuffle technique by selecting 
for growth on 5-FOA at 37oC after 48 hours. Potential mutant plasmids were isolated and 
retransformed into G402 and a secondary screen was preformed, mutations were confirmed by 
sequencing. 
 
 
G402 
  G402 
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Plasmid 
name 
SSA1 nucleotide 
change 
Amino Acid 
change  
Screen results Color in G402 
2-20 Position 1182 C-T 
Position 1424- T-C 
A394V 
F475S 
1 5 
2-16 Position 1294 C-A 
Position 1424- T-C 
P432S 
F475S 
3 9 
2-8 Position  1438 G-A 
Position 1424- T-C 
V477I 
F475S 
1 9 
Table 3.4 Second-site suppressors of Ssa1F475S that restore t.s phenotype. The 
screen identified three mutations; A394V, P432S and V477I that in combination with 
F475S suppress the t.s phenotype i.e. enable strains to grow at 37oC. All three 
mutations are located in the peptide-binding domain of Ssa1. Each mutant was isolated 
once with the exception of P432S, which was isolated, three times. Color of strains 
expressing Ssa1 mutants were subjectively scored; zero representing [PSI+] (white) 
and nine representing [psi-]. 
 
 
 
Ssa1 
 
F475S 
 
F+A394V 
 
F+P432S 
 
F+V477I 
 
 
30oC                                                                     37oC 
Figure 3.12 Confirmation of restored T.S phenotype by second-site suppressors. Mutants 
expressed in G402 were incubated at 30oC and 37oC on YPD for 72 hours. Cells diluted by a 1/5 
serial dilution. Mutants as indicated. Second-site suppressors exhibit recovery of t.s phenotype at 
37oC. 
 
 107 
and incubating at 30oC for 48 hours. Ssa1 F+P432S and Ssa1 F+V477I (t.s suppressing 
mutants) remained [psi-] whereas Ssa1 F+P636S and Ssa1F+ A394V have [PSI+] restored 
(Figure.3.13). Ssa1F+P432S and Ssa1F+V477I have the strongest [psi-] phenotypes whereas 
Ssa1F+A394V appears to be [PSI+] phenotype (Figure 3.13). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.7.2 Relative effects of second-site suppressors on cell growth 
 
To provide further insight of how second-site suppressors are restoring phenotypes 
relating to the Ssa1F475S mutation, growth rates of second-site-suppressors were 
measured. In section 3.2.3, it is observed that the growth rate of Ssa1F475S is 88% of 
the MGT of wildtype Ssa1. Ssa1F+A394V appears to restore growth rate similar to that 
of wildtype, Ssa1 F+P432S and Ssa1 F+V477I  appear to have no effect on growth rates 
 
Ssa1F475S 
Ssa1F+A394V 
Ssa1F+P432S 
Ssa1F+V477I 
Ssa1F+P636S 
Figure3.13 [PSI] status of second-site suppressors. Phenotypes of 
second-site suppressors being expressed in yeast as only source of the 
Ssa. Cells streaked onto YPD plate and incubated at 30oC for 48 
hours. Mutants are as indicated. White color indicated the presence of 
[PSI+] prion and pink and red indicates presence of [psi-] prion. 
Ssa1 
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remaining similar to that of Ssa1F475S. Ssa1F+P636S appears to have the greatest effect, 
with the growth rate being reduced to almost half of Ssa1 (Table 3.5). This is 
indicative that alteration of the conserved motif of Ssa1’s C-terminal (GPTVEEVD) 
in combination with the F475S mutation does have a severe effect on cell growth. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Second-site suppressor 
mutations 
MGT 
(Mins) 
MGT % of WT 
SSA1 105.66 100% 
SSA1F475S 119.33 112.9%  ±6.02% 
SSA1F+A394V 103.33 98.7% ±1.53% 
SSA1F+P432S 112.67 107%  ±3.51% 
SSA1F+V477I 120 113.5%    ± 1.73% 
SSA1F+P636S 202.67 191% ± 13.5% 
Table 3.5 MGT of second-site suppressors. This table represents the 
mean generation time of second-site suppressors of the Ssa1F475S 
mutation. Overnight 30oC cultures diluted to an OD600 0.1. Cultures 
grown at 30oC, OD600 measured every two hours for approximately ten 
hours (section 2.7.1) 
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3.8 Basal levels of Hsp70 and Hsp104 in yeast expressing Ssa1F475S second-site 
suppressors 
 
 Abundance of Hsp70 in yeast strains expressing Ssa1F475S appeared lower in 
comparison to those expressing wildtype Ssa1 when immunoblotted with an Hsp70 
antibody (Figure 3.14). Lower levels of Hsp70 in Ssa1F475S could lead to the t.s 
phenotype observed at 37oC and the impairment of [PSI+] propagation.  To test this 
hypothesis, abundance of Hsp70 in yeast cells expressing second-site suppressors of  
Ssa1F475S was observed by western blotting. As previously observed the abundance of 
Hsp70 in yeast cells expressing Ssa1F475S is reduced in comparison to wildtype. Hsp70 
levels in yeast cells expressing Ssa1F+A394V and Ssa1F+P433S are restored to levels 
similar to wildtype. Whereas the abundance of Hsp70 in yeast cells expressing 
Ssa1F+V477I and Ssa1F+P636S appears slightly reduced in comparison to Ssa1F475S. This 
result indicates that abundance of Hsp70 in Ssa1F475S is not the cause of the t.s or prion 
phenotype and A394V and P432S may be suppressing the F475S mutation in a 
different manor to V477I. 
 
 
70kDa 
 
(B) 
 
(C) 
 
 
 
Figure 3.14. Abundance of Hsp70 in Ssa1F475S second-site suppressors. Lysates prepared from 
overnight 30oC cultures. Aliquots of proteins (10µg) were separated on three polyacrylamide gels, 
gels were either immunoblotted with antibodies either specific for (A) Hsp70 (SPA-822, 1/2000 
dilution) and (B) Hsp104 (Hsp104, 1/1000 dilution) or stained (C) coomassie brilliant blue 
stained overnight and destained the following day. Mutant alleles are as indicated. 
 
   1           2          3          4           5          6 
1: Ssa1 
2:Ssa1F475S 
3:Ssa1F+A394V 
4:Ssa1F+P432S 
5:Ssa1F+V477I 
6:Ssa1F+P636S 
 
(A) 
104kDa 
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3.9 Structural analysis of second-site suppressors  
Carrying out structural analysis on F475S and the second-site suppressors, will give 
us an indication of how closely located suppressors are to the F475 residue and this 
maybe indicative as to how they restore phenotypes caused by F475S. From Table 3.6 
we can infer that V477I is located in the ß-strand and is the closest suppressor located 
to F475S. A394V is located in the flexible linker region between domains and P432S 
is located at top of the ß-strand (Figure 3.15). As A394V and P432S appear to have 
similar affects, with respect to abundance of Hsp70 and effects on growth rates, it 
seems these mutants are affecting Hsp70 in the same manor. As A394V is located 
within the linker region between the ATPase domain and PBD, this may infer that 
F475S is affecting inter-domain communication, which could affect the heat shock 
function of Hsp70, and the A394V and P432S mutations are restoring the function. 
 
 
 A394 P433 V439 F475 V477 G481 L483 
A394 - 39.46 21.88 17.69 12.97 10.02 11.91 
P433  - 20.52 23.24 29.16 39.48 33.98 
V439   - 12.73 12.56 22.17 16.69 
F475    - 6.40 17.62 13.36 
V477     - 11.29 7.73 
G481      - 5.9 
L483       - 
 
 
Table 3.6 Cα-Cα distances (Å) for residues at the base of the PBD. Those closest 
(< 15 Å) are indicated in red. Modeled from the 3C7N template (chain B) 
(Wiederstein et al., 2007). 
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Figure 3.15 Substrate binding domain (380-570) of yeast Hsp70 modeled 
from the 3C7N template (chain B). Locations of PBD mutants and F475S 
second-site suppressors mapped. Images were generated using Pymol 
(DeLano. 2002).  
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3.10 Biochemical analysis of Ssa1 and PBD mutant  
To further our understanding of the role of Hsp70 and PBD mutants in prion 
propagation it was essential to gather biochemical data in addition to in vivo genetic 
data. Originally our goal was to purify Ssa1 using the Pichia pastoris expression 
system (Invitrogen, San Diego). The P. pastoris expression system is frequently used 
as Pichia does not require complex growth media, genetic manipulation is relatively 
simple and it has a eukaryotic protein synthesis pathway.   To achieve expression, 
SSA1 was cloned into a P. pastoris expression vector under the alcohol oxidase 
(AOX1) promoter, which is a methanol inducible promoter. This was digested by a 
Sac1 restriction digest and the linear plasmid was integrated into P. pastoris by 
homologous recombination. Expression of recombinant Pichia proteins was induced 
by methanol and proteins were purified by ion exchange chromatography, 
hydrophobic interaction chromatography and size exclusion chromatography (Wegele 
et al., 2003). This method of Hsp70 purification has been used to determine the 
function of yeast Hsp70 and its isoforms and the involvement of Sti1 as an activator 
of Ssa1 (Wegele et al., 2003; Tutar et al., 2006). However, Western blot analysis of 
purified Hsp70 revealed no signal when probed with the Hsp70 specific antibody 
SPA-822, yet the purified protein exhibited ATPase activity. Investigative analysis of 
this purified protein by the Perrett group in Beijing revealed that the purified protein 
was actually Aox1. Interestingly Aox1 had not previously been identified as an 
ATPase and expression of Aox1 in S. cerevisiae appears to impair the propagation of 
the yeast prion [URE3] (Zhang. et al., 2009). 
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Due to evidence that P. pastoris expression system was not suitable for Hsp70 
purification, we decided to purify Ssa1in E.coli. The Ssa1 expression plasmid was 
provided by Prof. Susan Lindquist (Adegene plasmid 1231). 
 
3.10.1 Viability of His(6X) tagged Ssa1F475S in vivo 
Fusing a His (6X) tag to the N- terminal of a protein of interest may lead to functional 
changes, for example, fusing a His (6X) tag to L483W caused the mutant to become 
non-functional in vivo (G. Jones personal communication). The ATPase assays and 
CD spectroscopy were carried out in vitro, therefore it was necessary to examine the 
viability of the His (6X) tagged versions of Ssa1 and Ssa1F475S. Similarly, to L483W, 
fusing a His tag to the N-terminus of Ssa1F475S causes the mutant to become non-
functional in vivo (Figure 3.16) 
 
 
 (A)                                         (B)                                               (C) 
  
Figure 3.16 Viability of His tagged Ssa1F475S. (A)Ssa1 (His6X) (B) Ssa1F475S and (C) 
Ssa1F475S with N-terminus fused His (6X) tag, were transformed into G402. Cells 
replicated from SD media lacking Leucine onto 5-FOA. Cells incubated at 30oC for 48 
hours. The His (6X) tags appears not to affect wildtype Ssa1 but causes Ssa1F475S to 
become non-functional in vivo. 
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3.10.2 Protein Purification Hsp70 and PBD mutant 
We chose to purify Ssa1F475S as it is a unique PBD; it is the first PBD mutant to 
exhibit (both impairment of [PSI] propagation and temperature sensitivity at 37oC. 
The F475S mutation was introduced by site-directed mutagenesis into a bacterial 
expression vector that expresses Ssa1 which has an N-terminus fused Histidine (6X) 
tag (Figure 3.17). Ssa1 and Ssa1F475S were purified under native conditions by Ni2+ 
affinity chromatography, dialysis and size exclusion chromatography (chapter 2.6). 
To condense large volumes of protein supernatant collected from dialysis and size 
exclusion chromatography, protein samples were condensed using Millipore 
condensing tubes. Previous results in the Perrett lab have identified two protein 
fractions of interest following Ssa1 purification by size exclusion chromatography. 
Peak one has been shown to be aggregated Hsp70 whereas peak two is native Hsp70. 
Therefore two protein fractions were collected from size exclusion chromatography; 
peak one and peak two which is native Hsp70 (Figure 3.18).   
 
3.10.3 Confirmation of Ssa1 purification 
Following purification, protein purity was assessed by SDS-page and coomassie 
staining (Figure 3.19). Fractions pre-purification and post Ni2+ affinity 
chromatography, dialysis and size exclusion chromatography were collected and 
boiled in protein sample buffer and run on a 12.5% polyacrylamide gel. A majority of 
Hsp70 is lost during size exclusion chromatography but this is an essential step as 
protein samples are not pure after Ni2+ affinity chromatography and dialysis (Figure 
3.19). To further confirm the protein purified was Hsp70, P1 protein samples 
collected from size-exclusion chromatography were analyzed by western blot. 
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Samples were probed with antibodies specific for Hsp70 and His6X tag (Figure 3.20). 
Western blot confirms presence of both Hsp70 and His (6X) tag. 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.17 Methodology for protein purification in E.coli. The F475S mutation was introduced to the 
pPROEX-Htb-SSA1 plasmid (A) by SDM. Introduction of the TTT-TCT mutation was confirmed by 
sequencing (B). The PRO-SSA1F475S plasmid was expressed in E.coli (BL21-DE3). Proteins were extracted 
and purified by Ni2+ affinity chromatography, dialysis and size exclusion chromatography. 
Expression in E.coli 
Protein purification: 
• Ni2+ affininity chromatography 
• Dialysis 
• Size-exclusion chromatography 
(A) 
(B) 
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Figure 3.18 Size- exclusion chromatography chromatogram. Gel filtration column (HiLoad superDex 
200pg, GE Health care) loaded with (A) Ssa1  and (B) Ssa1F475S supernatant. Peak one represents 
aggregated Ssa1 and peak two represents native Ssa1. Both fractions were collected and stores at -70oC. 
 
(A) 
(B) 
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Figure 3.19 Determination of purity of Ssa1 and Ssa1F475S by SDS-page 
Protein fractions run on 12.5% polyacrylamide gel at 200V for one hour. Gels stained in coomassie brilliant 
blue for one hour and destained overnight. Gel (A) represents purification of Ssa1; Lanes 1 represents 
supernatant pre purification, lanes 2-4 represents  fractions collected from Ni column eluted with MCAC-10, 
MCAC-100 and MCAC-350 respectively, lanes 5 represent post condensing of proteins post dialysis, lanes 6 
and 7 represent peak one (P1) and  peak two (P2) post size exclusion chromatography and lane 8 represents 
P1 post condensing. Gel (B) represents purification of Ssa1F475S, lane 1 is loaded with supernatant pre 
purification, lanes 2-4 loaded as gel (A), lane 5 is protein post dialysis and lanes 6 and 7 peak one and peak 
two post size exclusion chromatography post condensing. 
 
Figure 3.20 Detection of Hsp70 and His6X tag by western blotting.  Peak one purified 
Ssa1 and Ssa1F475S separated by SDS-page. Gels were immunoblotted with antibodies 
specific for Hsp70 (SPA-822, 1/2000 dilution) and His6x tag (anti His-Santa Cruz 1/200 
dilution). Gel (A) shows Ssa1 (1) and Ssa1F475S (2) probed with SPA-822 and gel (B) 
exhibits Ssa1 (1) and Ssa1F475S (2) probed with an anti-His tag antibody. 
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3.11 Measuring ATPase activity of Hsp70 
The binding of Hsp70 to its substrates is dependent on the binding and hydrolysis of 
ATP. In an ATP bound state there is rapid substrate exchange. When ATP is 
hydrolyzed to ADP, the substrate is trapped by Hsp70, this cycle is influenced by co-
chaperones such as Hsp40 (Ydj1). One hypothesis of how Ssa1 mutants impair [PSI+] 
is alteration of ATPase cycle to favor ADP bound form appears to impair prion 
propagation. Previous ATPase analysis on the PBD mutant SSA1-21 showed nearly a 
ten fold increase of ATPase activity in comparison to wildtype. The 483 residue is 
closely located to two important regions related to inter-domain regulation. A change 
to the 483 residue could result in an inappropriate stimulatory signal to the NBD 
(Needham and Masison.,  2008). Therefore testing ATPase activity of mutants may 
aid in gaining insight into how mutants such as Ssa1F475S are impairing [PSI+] 
propagation. The method employed for measuring ATPase activity depends on a 
coupled enzyme assay which is based on the conversion of phosphoenol pyruvate 
(PEP) to pyruvate by pyruvate kinase (PK) which is dependent on ATP hydrolysis 
(Figure 3.21). This reaction is coupled to the conversion of pyruvate to lactate by 
lactate dehydrogenase (LDH), which requires NADH being oxidized to NAD+. 
NADH is strongly absorbed at OD340 but NAD+ is not (Figure 3.21). This enables 
reduction of NADH over time to be monitored by decrease in absorbance value 
(Ferard et al., 1975). This assay can be used to indirectly measure the ATPase activity 
of Hsp70 through measuring absorbance of NADH. 
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Figure 3.21 Measuring ATPase activity of Hsp70. Measuring the ATPase activity of Hsp70 
using coupled enzymes assay which involves the conversion of PEP to pyruvate by the enzyme 
PK that is dependent on the hydrolysis of ATP to ADP. This reaction is coupled to the 
conversion of Pyruvate to lactate by LDH, which is dependent on the conversion of NADH to 
NAD+. NADH is strongly absorbed at 340nm whereas NAD+ is not. As the function of Hsp70 is 
dependent on hydrolysis of ATP, the ATPase activity of Hsp70 can be measured indirectly by 
this assay. 
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3.11.1 Investigation of ATPase activity of Ssa1F475S 
 Alterations to ATPase activity of Ssa1F475S were measured as described in section 
3.10. Previous studies on the ATPase cycle of the PBD mutant SSA1-21 revealed a ten 
fold increase of intrinsic ATPase activity in comparison to wildtype (Needham and 
Masison., 2008). Similarly, Ssa1F475S appears to have increased ATPase activity, 
which is nearly three fold higher in comparison to that of wildtype (Figure 3.22).  
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Figure 3.22 Investigation of ATPase activity Ssa1F475S. Comparison of ATPase activity 
between wildtype and Ssa1F475S was measured.  ATPase assay carried out using 2µM 
purified wildtype Ssa1 and Ssa1F475S. The x-axis represents proteins being assayed and y-
axis represents rate of ATP turnover per minute. Assays repeated three times in triplicate. 
Ssa1F475S appears to have increased ATPase activity almost three fold higher in comparison 
to wildtype. 
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3.11.2 Stimulation of ATPase activity by Hsp40 (Ydj1) 
The hydrolysis of ATP is essential for the functioning of Hsp70; hydrolysis is 
stimulated by the Hsp40 family of co-chaperones. In yeast Ydj1 is a major Hsp40 
involved in this process, increasing wildtype ATPase activity by seven fold (Needham 
and Masison., 2008). A recent study predicted that Hsp70 with increased ATPase 
activity would be less dependent on co-chaperones such as Ydj1 (Hu et al., 2006). 
This hypothesis was observed with the SSA1-21, the mutant’s ATPase activity was 
stimulated two fold by Ydj1, suggesting the mutant might not be regulated by Hsp40 
as efficiently as wildtype (Needham and Masison., 2008). Ydj1 was purified as 
described in chapter 2.7, by Ni2+ affinity chromatography and dialysis (Figure 3.23).  
The stimulation of ATP hydrolysis of Ssa1F475S was increased by less than two fold by 
Ydj1, suggesting that the function of Ssa1F475S may not be as efficiently regulated by 
Hsp40 as wildtype Ssa1 (Figure 3.24). 
                           
 
 
 
 
 
 
 
 
 
 
Figure 3.23 Purified Ydj1. Ydj1 was expressed and extracted from E.coli. The 
expressed protein with an N-terminal His6 tag was purified using Ni2+ affinity 
chromatography and dialysis. Purified protein was run on a 12.5% polyacrylamide 
gel and stained with coomassie overnight and destained the following day. 
40kDa 
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Figure 3.24 Stimulation of Ssa1 ATPase by Hsp40. This graph represents the 
stimulation of ATPase activity of Ssa1 and Ssa1 F475S by Hsp40. ATPase assay 
carried out using 2µM of purified proteins. The x-axis represents proteins being 
assayed and y-axis represents rate of ATP turnover per minute. Assay carried out 
once in triplicate. Wildtype ATPase activity increases by four fold in presence of 
Hsp40 whereas there is only a modest increase with Ssa1 F475S. 
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3.12 Analysis of protein structure of Ssa1F475S  
 
The increase in the rate of ATP turnover in Ssa1F475S   may be due to the F475S 
mutation causing a conformational change in the structure of the Ssa1p. Comparing 
the secondary structure of wildtype Ssa1 and Ssa1F475S by Circular Dichroism (CD) 
spectroscopy may elicit changes to secondary structure to Ssa1F475S. CD spectroscopy 
measures differences in the absorption of left-handed polarized light versus right-
handed polarized light which arise due to structural asymmetry. Alpha-helix and beta 
sheet each give rise to a characteristic shape and magnitude on CD spectrum; alpha-
helix structures absorb at and OD222 whereas beta sheet structures absorb at OD216 
(Figure 3.25) 
 
 
 
Figure 3.25 Example of CD spectroscopy. Alpha- Helices absorb at OD208 and OD222 as represented by 
black line. Beta-sheets absorb at 216nm, the absence of B-sheet is represented by a bell shape between 
OD208 and OD222, the presence of B-sheet is represented by a dip in line between OD208 and OD222 this is 
represented by blue line (http://besley.chem.nottingham.ac.uk/research/cdcurves.gif). 
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CD spectroscopy analysis of Ssa1F475S revealed no major structural changes to the 
secondary structure of Ssa1 (Figure 3.26), indicating that the increased rate of ATP 
turnover is probably not correlated with a change in protein structure caused by the 
F475S mutation. 
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Figure 3.26 CD spectroscopy analysis of Ssa1F475S. CD spectroscopy was preformed 
measuring the absorbance of 4µM of purified Ssa1p and Ssa1F475S in a total volume of 
350µl of dialysis buffer on a Pistar CD stopped flow spectrophotometer (Applied 
biophysics limited). 
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3.13 Functional conservation of F475S across the Ssa family 
Ssa1 and Ssa2 are constitutively expressed and have 97% homology, Ssa3 and Ssa4 
have 87% homology and are induced when the cell encounters stress, stationary phase 
or during sporulation. To assess functional conservation, the F475S mutation was 
introduced into SSA2, SSA3 and SSA4 genes by site-directed mutagenesis. Mutated 
plasmids were transformed into G402 and by the plasmid shuffle technique; each 
mutant was expressed in yeast as the sole source of the Ssa family. To compare each 
mutant to Ssa1F475S the prion impairing and t.s phenotype for each mutant was 
assessed. Ssa2F475S and Ssa4 F475S behaved in the same manner as Ssa1F475S; exhibiting 
a [psi-] phenotype and temperature sensitivity at 37oC (Figure 3.27- A). Interestingly 
when the F475S mutation was introduced into Ssa3, the protein became non-
functional (Figure 3.27- B). Therefore, in Ssa2 and Ssa4 the F475 residue also appears 
to be important for prion propagation and heat shock functions. For an unknown 
reason, the mutation has a different effect in Ssa3. 
 
 
3.14 Affect of Hsp70 in cell wall integrity signaling  
Damage to the cell wall occurs when yeast encounter heat and chemicals such as 
caffeine or congo red. When such encounters occur a MAP kinase pathway, which is 
a signal transduction pathway is activated; cell wall damage is transmitted by protein 
kinase C to the MAP kinase pathway, this is a linear pathway comprised of many 
components that 
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Figure 3.27 (B) 
Figure 3.27 Analysis of F475S mutation in Ssa1-4. (A) Ssa1, 2 and 4 mutants, as indicated, expressed in G402 
as sole source of Ssa. Cells diluted by a 1/5 serial dilution and incubated for 48 hours.Ssa2F475S and Ssa4 F475S 
exhibited the same phenotypes as Ssa1 F475S (B) Ssa1 F475S expressed in G402, pre and post 5-FOA.  
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terminates with the phosphorylation of the transcription factors Rlm1 and SBF, which 
then activate the expression of genes involved in cell wall repair and synthesis (Figure 
3.28). Introducing mutations to components of the cell wall integrity (CWI) signaling 
pathway results in common phenotypes such as temperature sensitivity at 37oC and 
sensitivity to drugs that damage the cell wall. Both phenotypes can be rescued by 
osmotic support (e.g. sorbitol) in growth media. Hsp90 and the Hsp70 nucleotide 
exchange factor Sse1 have been implicated in the cell wall integrity signaling 
pathway. Hsp90 was identified as a Slt2 binding partner (Millson. et al., 2005) and 
Sse1 genetically interacts with the SBF and MBF cell cycle-regulated transcription 
factors to support growth. (Shaner et al., 2008). The Ssa1F475S mutant may implicate 
Ssa1 as playing a role in the cell wall integrity signaling pathway as Ssa1F475S exhibits 
the temperature sensitivity phenotype at 37oC. To test this hypothesis the 37oC t.s 
mutants Ssa1F475S, Ssa2F475S and Ssa4F475S were incubated at 37oC on YPD containing 
1M sorbitol. Recovery of the 37oC t.s mutants on 1M sorbitol is indicative that Ssa1 is 
a component of the cell wall integrity signaling pathway (Figure 3.29). 
 
3.14.1 Effect of 1M sorbitol on expression of Ssa1F475S 
 To further our inverstigation of Ssa1’s involvment in the cell wall integrity signalling 
pathway we examined the abundance of Ssa1F475S at 30oC and 37 oC  in the presence 
of 1M sorbitol. This was achieved by making lysates from yeast cultures expressing 
Ssa1F475S  that were grown at 30oC and 37oC  in YPD supplemented with 1M sorbitol 
(YPDS). Abundance of Hsp70 and Hsp104 was observed by western blot analysis. 
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Figure 3.28 Cell wall integrity signaling pathway. A linear MAP Kinase signaling 
cascade is responsible for the amplification of damage to the cell wall. It has been 
established that Pkc1 activates Bck1 which then activates Mkk1/2, which then 
phosphorylates Slt2. Slt2 phosphorylates and activates the transcription factors Rlm1 
and SBF which activate genes involved in cell wall synthesis and repair. Hsp90 and the 
Hsp70 nucleotide exchange factor Sse1 have been implicated as part of this pathway via 
a partnership with Slt2. 
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Figure 3.29 Recovery of 37oC t.s phenotype by 1M sorbitol. Cells incubated at  
37oC on YPD and YPD supplemented with 1M sorbitol for 48 hours. Cells diluted by 
a 1/5 serial dilution. Mutants as indicated. The 37oC t.s phenotype of SSA1F475S,  
Ssa2 F475S and Ssa4F475S were recovered by growing cells at 37oC on YPD 
supplemented with 1M sorbitol.  
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Ssa1F475S  was unable to grow in YPD 37 oC  but  was recovered when grown in 
YPDS. Growing wild type in YPDS seems to have no effect on the abundance of Ssa1 
at  37oC , whereas growing Ssa1F475S  in YPDS the protein level appears to increase at 
30oC and recovers at 37oC (Figure 3.30).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                   1                  2                3               4             5                            
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Figure 3.30 Effect of 1M sorbitol on abundance of Hsp70 and Hsp104. Lysates prepared 
from overnight 30oC and 37oC cultures grown in YPD and YPD supplemented with 1M 
sorbitol (YPDS). Aliquots of proteins (10µg) were separated on three polyacrylamide gels, 
gels were either immunoblotted with antibodies either specific for (A) Hsp70 (SPA-822, 
1/2000 dilution) and (B) Hsp104 (HSP104, 1/150,000 dilution) or stained (C) coomassie 
brilliant blue stained overnight and destained the following day. Lanes 1-2 contain wildtype 
Ssa1 grown at 37oC in YPD and YPDS, lanes 3-4 contain Ssa1F475S grown at 30oC in YPD 
and YPDS, lanes 5 contains Ssa1F475S grown at 37oC in YPDS. 
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3.14.2 Expression of constitutively active components of CWI pathway 
It has been well established that chaperones and cochaperones such as Hsp90 and 
Sse1 play a role in CWI signaling pathway. Or results may implicate Hsp70 as also 
playing a role. To further test this hypothesis, we assessed the effects of expressing 
constiuitevly active components of the CWI signaling pathway, Bck1 and Pkc1. Loss 
of function of any of the componets below Pkc1 results in a 37oC t.s phenotype. Cells 
harboring the Ssa1F475S mutation were transformed with plasmids expressing either 
constitutively active Bck1 or Pkc1 and phenotypes were observed at 37oC. Recovery 
of Ssa1F475S  by the expression of Bck1 and Pkc1 is indicative that the 37oC t.s 
phenotype is due to a disruption in the CWI signaling pathway (Figure 3.31). 
 
 
 
 
Wildtype 
Ssa1F475S 
Ssa1F475S + Bck1 
Ssa1F475S + Pkc1 
Figure 3.31 Recovery of Ssa1F475S 37oC t.s phenotype by components of CWI 
signaling pathway. Plasmids expressing components of the CWI signaling pathway, 
Bck1 and Pkc1 were expressed in cells harboring Ssa1F475S.  Cells incubated at 37oC for 
48 hours on YPD. Cells diluted by a 1/5 serial dilution. Mutants as indicated. The 37oC 
t.s phenotype of Ssa1F475S was recovered in the presence of Bck1 and Pkc1.  
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3.15 Effects of PBD mutations on other cellular functions.  
 
We have observed the Hsp70 PBD mutant Ssa1F475S  as impairing [PSI+] propagation 
and have implicated Hsp70 as playing a role in CWI signalling pathway through 
investigation of the Ssa1F475S 37oC t.s phenotype. To gain further insight of the role of 
Hsp70 we decided  to investigate the effect of Ssa1F475S on other cellular functions. 
The three cellular functions we assessed  in S.cerevisiae were; pleiotropic drug 
resistance (Pdr), Hsp70 self- regulation and the unfolded protein response. 
 
3.15.1- Investigation of the effect of Ssa1F475S  on PDR 
Pleiotropic drug resistance (Pdr) is a major problem in the treatment utilizing 
antifungal drugs. Isolation of S. cerevisiae containing single nuclear mutations have 
exhibited resistance to a wide range of toxic compounds, these cells are refered to as 
having a Pdr phenotype. In S. cerevisiae a complex network of genes mediates the Pdr 
response. Pdr1 and Pdr3 are two major transcription factors which control the Pdr 
response by activating genes such as Pdr5, Pdr10 and Pdr15  which encode ATP- 
binding cassette (ABC) transporters which operate as drug efflux pump. Ssa1 was 
found to co-purify with the transcription factor Pdr3 and further studies revealed that 
binding of Ssa1 to Pdr3 keeps this protein in a low activity state (Shahi. et al. 2007).  
To analyze the effect of Ssa1F475S, we received a ß-galactosidase reporter plasmid 
which expresses the PDR5 promoter fused to the lacZ reporter gene. The bacterial 
lacZ gene encodes the ß-galactosidase enyme which cleaves the compond o-
nitrophenol- ß-D-galactoside (ONPG) to produce a coloured compound o-nitrophenol, 
which can be quantified by measuring its absorbance at OD420 (Figure 3.32). In order 
for us to assess the effect of Ssa1F475S on Pdr5 expression, the Pdr5 ß-galactosidase 
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reporter plasmid was transformed into G402 yeast cells expressing wildtype Ssa1 or 
Ssa1F475S. The ß-galactosidase activity was measured as decribed in chapter 2.8. The 
F475S mutation appears to increase the activity of the Pdr5 promoter by more than six 
fold (Figure 3.33).  This may be indicitave that the F475S mutation affects binding of 
Ssa1 to Pdr3 and this may impair the negative regulation of Pdr3 by Ssa1. 
. 
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X*= PDR5 promoter/ SSA1 promoter/ UPR promoter 
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ade2-1  
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Figure 3.32 Strategy for performing ß-galactosidase assays in yeast. The lacZ reporter plasmid 
was transformed into the yeast strain G402 which was expressing Ssa1F475S as the sole source of 
Ssa. The transcription of Ssa1F475S may affect levels of expression of lacZ depending on promoter 
fused to the reporter gene. When o-nitrophenol- ß-D-galactoside (ONPG) is added the reaction will 
turn yellow over a period of time, depending on how strong/weak the reaction is. Reaction is 
measured at OD420. 
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Figure 3.33 Effect of Ssa1F475S on PDR5 expression. Yeast cells expressing wildtype Ssa1 
or Ssa1F475S were transformed with the Pdr5 ß-galactosidase reporter palsmid. Transformed 
strains were grown overnight in 5ml of YPD at 30oC to a concentration of 5x106 (cells/ml). 
Cells were then grown to a concentration of 1x107-2x107 (cells/ml).  Cells were chilled on 
ice and then harvested at 4oC. Protein was extracted and reaction was initiated by adding 
ONPG, once a pale yellow color was observed the reaction was terminated by adding 1M 
Na2CO3.  o-nitrophenol was quantified by measuring absorbance at OD420. Units of ß-
galactosidase activity (Y axis) were defined as (OD420) X (1.7)/ (.0045) X (volume) X 
(time) X (protein concentration). Ssa1F475S appears to have more than a six fold increase in 
PDR5 promoter activity in comparison to the effect of wildtype Ssa1 on PDR5 promoter 
activity.  
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3.15.2 Effect of Ssa1F475S  on Ssa1 expression 
In yeast the Ssa family consists of four highly conserved proteins, Ssa1-Ssa4. Ssa1 
and Ssa2 are constitutively expressed but only expression of Ssa1, Ssa3 and Ssa4 are 
induced by shock. The induction of heat shock proteins by stress depends on heat 
shock factors (HSF), which bind to heat shock elements (HSE) in the promoters of 
heat shock genes. The SSA1 promoter contains  HSE’s, HSE2 has proven to be 
necessary for basal and heat inducible expression (Slater and Craig, 1987). Ssa1 is 
autoregulatory, i.e. it negatively regulates its own expression (Stone and Craig, 1990).  
 
To test the effect of Ssa1F475S on SSA1 expression, the SSA1 promoter was fused to the 
lacZ gene and the plasmid was transformed into cells expressing wildtype Ssa1 or  
Ssa1 F475S and activity was measure by ß-galactosidase assay (section 3.12.1). 
Expression of Ssa1 is increased by more than two fold when the F475S mutation is 
present (Figure 3.34). This indicates the the F475S mutataion may have an effect on 
the transcriptional levels of the SSA1 gene.  
 
 
3.15.3 Effect of Ssa1F475S on the unfolded protein response 
As Hsp70 is a chaperone that is involved in folding of nascent proteins and the 
refolding of misfolded proteins, we decided to analyze the effect of Ssa1F475S on the 
unfolded protein response in yeast. Biosynthesis and maturation of secretory proteins 
occurs in the endoplasmic reticulum (ER). Stress in the ER inhibit these events and 
trigger the unfolded protein response (UPR). The type I transmembrane protein Ire1 is 
a key component of the UPR, it detects elevated unfolded protein levels in the ER.  
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Figure 3.34 Effect of SSA1F475S on SSA1 expression. Yeast cells expressing wildtype 
Ssa1 or Ssa1F475S were transformed with the SSA1 promoter ß-galactosidase reporter 
plasmid (pZFO) . ß-galactosidase assays were carried out as described in Figure 3.33. The 
F475S mutation appears to increase transcription of the SSA1 promoter by more than two 
fold in comparison to wildtype. 
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The C-terminus of Ire1 possesses RNase activity, which acts to splice HAC1 precursor 
mRNA. The spliced HAC1 mRNA is translated into the transcription factor Hac1, 
which targets promoters of various genes containing the unfolded protein response 
element (UPRE), which encode protein chaperones and protein folding catalysts 
(Figure 3.35). The gene KAR2 that encodes the ER Hsp70, Bip, contains UPRE and is 
thought to be involved in the UPR (Kohno. et al., 1993). An additional function of the 
Hsp70 protein, Bip, is the repression of the UPR by interacting with Ire1 (Okamura. et 
al., 2000).  
 
To assess whether the Ssa1F475S mutation affects the UPR, we measured the activity of 
an unfolded protein response element. This was achieved by utilizing a ß-
galactosidase reporter plasmid which expressed the UPRE promotor fused to the lacZ 
gene. The reporter plasmid was transformed into yeast cells expressing wildtype Ssa1 
or Ssa1F475S. To ensure measurments of the UPR were accurate, the assay was 
preformed with and without 5mM of the reducing agent dithiothreitol (DTT). 
Therefore DTT should increase protein unfolding and there should be a higher rate of 
the UPR in assays containing DTT. 
 
We observed that in yeast cells expressing Ssa1F475S, the expression of the UPRE had 
increased nine fold in comparison to cells expressing wildtype Ssa1 in the presence of 
5mM DTT (Figure 3.36). The addition of DTT had a modest affect on the UPRE 
promoter activity; this may be due to strain background. This may implicate cytosolic 
Hsp70 as playing a part in the UPR. One predication may be that Bip utilizes 
cytosolic  
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Figure 3.35 The unfolded protein response in yeast. Stress in the ER causes unfolding 
of proteins. This stress is sensed by the type I transmembrane protein Ire1. The C-
terminal of Ire1 exhibits RNase activity which splices to splice HAC1 precursor mRNA 
in the cytoplasm. The mature mRNA is translated into a transcription factor (Hac1), 
which moves to the nucleus. Hac1 binds to promoters of genes that contain UPRE, 
which encode protein chaperones and protein folding catalysts.  
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Hsp70 or its activity for the inhibition of Ire1 and the F475S mutation somehow 
inhibits this process causing the rise in expression of the UPRE. 
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3.16 Microarray analysis of Ssa1F475S  
To gain further insight into the affects of expressing Ssa1F475S as the sole source of 
Ssa1, we decided to analyze the affects of the mutant on gene expression in 
comparison to cells expressing wildtype Ssa1. Detailed microarray analysis data is 
Figure 3.36 The effect of Ssa1F475S on the unfolded protein response. Yeast cells 
expressing wildtype Ssa1 or Ssa1F475S were transformed with the UPRE promoter ß-
galactosidase reporter palsmid (pUPRE). ß-galactosidase assays were carried out described 
in Figure 3.33, with the exception of adding 5mM DTT into cultures for thirty minutes at 
30oC. The X-axis indicates the strains used in the assay; wildtype Ssa1 and Ssa1F475S with 
and without DTT. The Y axis indicates the ß-gal units.  
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supplemented as a hard copy (CD). As previously mentioned, the PBD mutant 
Ssa1F475S impairs prion propagation and has a t.s 37oC phenotype that can be 
remediated by growth in the presence of 1M sorbitol, which may implicate Ssa1 as 
playing a role in the CWI signaling pathway. The presence of the F475S mutation also 
appears to have an affect on the expression of genes involved in diverse cellular 
functions such as; the pleiotropic drug response, unfolded protein response and 
expression of Ssa1.Table 3.7 lists genes that are exclusively up-regulated in Ssa1F475S 
(up-regulation of genes compared to expression of genes in Ssa1, 2, 3 and 4). Twelve 
genes are up-regulated by more than three-fold in the Ssa1F475S strain. Genes that are 
up-regulated appear to be involved in glucose transportation (GAL2 and SNF3), Iron 
homeostasis (FET4 and FIT3) and cell wall integrity (SSD1). 
As Ssa1 F475S may implicate Ssa1 as playing a role in the CWI signaling pathway, up-
regulation of the SSD1 gene may provide further insight into this. Ssd1 plays a role in 
the maintenance of cellular integrity. It has been reported that Ssd1 may regulate a 
pathway parallel to the Pkc1 pathway to maintain cell wall structure and cell wall 
integrity (Kaeberlein and Guarente, 2002). Interestingly it has also been reported that 
Ssd1 is required for Hsp104 mediated protein dissaggregation (Mir et al., 2009). Ssd1 
influences the ability of Hsp104 to hexamerize, which then permits interaction with 
the co-chaperone Sti1 and consequently binding of protein aggregates (Mir et al.,, 
2009). 
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ORF/Gene Gene function Ssa1F475S 
YLR081W/GAL2 Galactose permease, required for utilization of 
galactose; also able to transport glucose. 
6.241 
YOR383C/FIT3 Mannoprotein that is incorporated into the cell wall via 
a glycosylphosphatidylinositol (GPI) anchor, involved 
in the retention of siderophore-iron in the cell wall. 
3.922 
YMR319C/FET4 Low-affinity Fe(II) transporter of the plasma 
membrane 
3.756 
YPR101W/SNT309 Member of the NineTeen Complex (NTC) that 
contains Prp19 and stabilizes U6 snRNA in catalytic 
forms of the spliceosome containing U2, U5, and U6 
snRNAs 
3.556 
YAL055W/PEX22 Putative peroxisomal membrane protein required for 
import of peroxisomal proteins. 
3.397 
YDR293C/SSD1 Protein with a role in maintenance of cellular integrity, 
interacts with components of the TOR pathway 
3.187 
YDR019C/GCV1 T subunit of the mitochondrial glycine decarboxylase 
complex, required for the catabolism of glycine to 5, 
10-methylene-THF. 
3.156 
YNR067C/DSE4 Daughter cell-specific secreted protein with similarity 
to glucanases, degrades cell wall from the daughter 
side causing daughter to separate from mother 
3.129 
YLD194W/SNF3 Plasma membrane low glucose sensor that regulates 
glucose transport 
3.125 
YDL078C/ATG8 Component of autophagosomes and Cvt vesicles 3.085 
YDR406W/PDR15 Plasma membrane ATP binding cassette (ABC) 
transporter, multidrug transporter and general stress 
response factor implicated in cellular detoxification; 
regulated by Pdr1, Pdr3 and Pdr8. 
3.043 
YOR378W/Unknown Unknown 3.040 
 
Table 3.7 Up-regulation of genes in Strains expressing Ssa1F475S.  Analysis of microarray 
data revealed twelve genes that are up-regulated in the Ssa1F475S strain. Expression of genes was 
compared to expression in Ssa1. Functions of genes were obtained from the Saccharomyces 
genome database (SGD). 
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The Ssa1F475S strain was the only strain that exhibited up-regulation of the SSD1 gene. 
Up-regulation of this gene may be linked to some of the phenotypes caused by the 
F475S mutation. For example, if the Ssa1F475S mutation somehow affects the Pkc1 
CWI signaling pathway, alternative pathway may be up-regulated in order to deal 
with stress.  
 
Another up-regulated gene in strains expressing Ssa1F475S is PDR15. Pdr15 is 
regulated by the transcription factors Pdr1 and Pdr3, and along with Pdr10 and Pdr5, 
it encodes ATP- binding cassette (ABC) transporters that operate as drug efflux pump. 
We have observed that the Ssa1F475S had an affect on the transcription level of the 
PDR5 promoter (Figure 3.33). As previously stated, Ssa1 was found to co-purify with 
the transcription factor Pdr3 and further studies revealed that binding of Ssa1to Pdr3 
keeps this protein in a low activity state (Shahi et al., 2007). The Ssa1F475S may have 
an affect on the binding of Ssa1 to Pdr3, thereby inhibiting this interaction. To study 
this further, we observed the expression of PDR3, PDR5 and PDR10 in the Ssa1 F475S 
strain (Table 3.8). Expression of PDR3, PDR5 and PDR10 were not up-regulated to 
the same extent as PDR15 (Table 3.8). In order to confirm this result we chose to 
carry out RT-PCR to detect expression levels of PDR5, PDR10 and PDR15, ACT1 
was used as a control (Figure 3.37). From RT-PCR analysis, no detecTable change is 
observed in any of the PDR gene’s expression in the Ssa1F475S strain. 
We also analyzed genes that appeared to be down-regulated in strains expressing 
Ssa1F475S in comparison to wildtype. Thirteen genes were found to be down-regulated 
by five-fold or more in cells expressing Ssa1F475S (Table 3.9). Down- regulated genes 
are involved in a variety of cellular processess and components including protein 
export 
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ORF/Gene Gene Function Ssa1 F475S 
YBL005W/ PDR3 Transcriptional activator of the pleiotropic drug resistance 
network regulates expression of ATP-binding cassette (ABC) 
transporters through binding to cis-acting sites known as PDREs 
(PDR responsive elements). 
1.331 
YOR152W/ PDR5 Plasma membrane ATP-binding cassette (ABC) transporter, 
multidrug transporter.  
1.284 
YOR328W/ PDR10 ATP-binding cassette (ABC) transporter, multidrug transporter 
involved in the pleiotropic drug resistance network. 
1.012 
YDR406W/ PDR15 Plasma membrane ATP binding cassette (ABC) transporter, 
multidrug transporter and general stress response factor implicated 
in cellular detoxification 
3.043 
 
Table 3.8 Up-regulation of PDR genes in Ssa1F475S. Analysis of microarray data revealed three 
PDR genes that were very slightly up-regulated in the Ssa1F475S strain. The PDR15is the most up-
regulated as it is expressed three times higher in Ssa1F475S strain. Expression of PDR genes were 
compared to expression in Ssa1. Functions of genes were obtained from the Saccharomyces 
genome database (SGD). 
 
200bp 
Figure 3.37 RT-PCR analysis of PDR genes. RNA was extracted from cells 
expressing wildtype Ssa1 or Ssa1F475S and cDNA was prepared.  Primers were 
designed to amplify approximately 200bp fragments of PDR5, PDR10 and PDR15 
and the housekeeping gene ACT1 that was used as a control. Lanes 1-4 contain 
amplified genes PDR5, PDR10, PDR15 and ACT1 respectively from wildtype 
strain and lanes 5-8 amplified genes PDR5, PDR10, PDR15 and ACT1 
respectively from Ssa1F475S strain. 
 1        2          3      4         5        6          7       8 
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Table 3.9 Down-regulation of genes in strains expressing Ssa1F475S. Analysis of 
microarray data revealed sixteen genes that were down-regulated strains expressing 
Ssa1F475S by approximately five-fold or more. Expression of genes were compared to 
expression in Ssa1. Functions of genes were obtained from the Saccharomyces 
genome database (SGD). 
 
ORF/Gene Gene Function Ssa1F475S 
YNL036W/NCE103 Carbonic anhydrase; involved in non-classical 
protein export pathway 
0.006 
YER153C/PET122 Mitochondrial translational activator specific for 
the COX3 mRNA 
0.146 
YHR174W/ENO2 Enolase II, a phosphopyruvate hydratase that 
catalyzes the conversion of 2-phosphoglycerate to 
phosphoenolpyruvate during glycolysis and the 
reverse reaction during gluconeogenesis; 
expression is induced in response to glucose 
0.146 
YIL076W/SEC28 Epsilon-COP subunit of the coatomer; regulates 
retrograde Golgi-to-ER protein traffic 
0.150 
YLR061W/ RPL22A Protein component of the large (60S) ribosomal 
subunit 
0.152 
YGR159C/ NSR1 Nucleolar protein that binds nuclear localization 
sequences, required for pre-rRNA processing and 
ribosome biogenesis 
0.155 
YIL053W/ RHR2 Constitutively expressed isoform of DL-glycerol-3-
phosphatase; involved in glycerol biosynthesis 
0.167 
YPL113C/ 
Unknown 
Glyoxylate reductase; acts on glyoxylate and 
hydroxypyruvate substrates 
0.187 
YOL124C/ TRM11 Catalytic subunit of an adoMet-dependent tRNA 
methyltransferase complex. 
0.195 
YJL177W/RPL17B Protein component of the large (60S) ribosomal 
subunit 
0.204 
YER052C/HOM3 Aspartate kinase (L-aspartate 4-P-transferase); 
cytoplasmic enzyme that catalyzes the first step in 
the common pathway for methionine and threonine 
biosynthesis 
0.207 
YBL043W/ ECM13 Unknown 0.208 
YOR302W CPA1 uORF, Arginine attenuator peptide, 
regulates translation of the CPA1 mRNA 
0.209 
YDR341C Arginyl-tRNA synthetase 0.209 
YGR060W/ERG25 C-4 methyl sterol oxidase, catalyzes the first of 
three steps required to remove two C-4 methyl 
groups from an intermediate in ergosterol 
biosynthesis 
0.212 
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glycolysis, ribosomal biogenesis, methionine, threonine and ergosterol biosynthesis. 
The presence of the F475S mutation in Ssa1 appears effect the expression levels of 
numerous genes in comparison to wild-type Ssa1, which may contribute to 
phenotypes observed in strains expressing this mutant.  
 
  
3.17 Discussion  
We have identified five novel mutations, within the peptide-binding domain of the 
major cytosolic chaperone Hsp70-Ssa1 of S. cerevisiae, that impair [PSI+] 
propagation. Previous Hsp70 genetic screens have mainly isolated mutated residues 
that affect [PSI+] propagation located in the ATPase domain, highlighting the 
importance of this domain for prion propagation (Jung et al., 2000; Jones and 
Masison, 2003; Loovers et al., 2007). The majority of PBD mutants did not have a 
major effect on cell growth. 
 
Aggregated Sup35 in [PSI+] cells are composed of individual SDS-insoluble polymers 
and large aggregates. The large aggregates are composed of complexes formed by 
SDS-insoluble polymers and other associated proteins (Kryndushkin et al. 2003). It 
has been proposed that Hsp104 generates prion seeds by breaking down polymers and 
separating polymers from aggregates, increasing the amount of free polymers 
(Kryndushkin et al., 2003). Studies on the PBD mutant, SSA1-21, show that there is a 
ten-fold decrease in the number of transmissible seeds per cell but only a two to three 
fold reduction in the amount of aggregated Sup35 (Jung et al., 2000). By utilizing a 
Sup35-GFP fusion protein, it was observed that aggregates present in strains 
expressing SSA1-21 are larger as there are more polymers per aggregate (Song et 
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al.,2005). Therefore, if there are a large proportion of polymers associated with large 
aggregates, there will be fewer free polymers. Efficiency of Sup35 recruitment into 
prion aggregates depends on the number of seeds present. This may explain in SSA1-
21, how the reduced number of seeds affects Sup35 solubility (Song et al., 2005). 
Similarly, to SSA1-21, F475S is a dominant mutant with regard to prion propagation. 
The PBD mutant residues isolated in this study are closely located to SSA1-21. Both 
F475S and SSA1-21 share many phenotypic similarities. Therefore, it may be possible 
that F475S and the other PBD mutants are having a similar affect on number of prion 
seeds and size of Sup35 aggregates, causing loss of the prion. 
 
Another explanation as to why mutations of Ssa1, such as SSA1-21 and F475S may 
impair prion propagation, is they affect the Ssa1 function of dismantling polymers 
from Sup35 aggregates. It has recently been shown that Ssa1/2 interacts with SDS 
resistant polymers (Bagriantsev et al., 2008). Work carried out has shown, the 
interaction of Ssa1/2 was weaker in non-prion Sup35 than in Sup35 prion form and 
this process is independent of levels of Ssa1 (Bagriantsev et al., 2008). Binding of 
Ssa1/2 to the prion form of Sup35 may be due to the refolding of the N-terminal 
domain of Sup35 during prionization (Bagriantsev. et al., 2008). Previous work 
suggests the PBD mutant SSA1-21 has increased substrate binding in comparison to 
wildtype Ssa1 (Jones and Masison, 2003; Jones et al., 2004). Interestingly, SSA1-21 
second site suppressor E540K is homologous to the bovine Hsp70 residue E543K, 
which has been shown to cause a decrease in affinity for substrate (Ha et al., 1997). 
Although we have not tested the rate of substrate binding of F475S, this mutation 
shows many similarities to SSA1-21; they are closely located, both suppressed by the 
P636S mutation, both do not affect luciferase recovery and both exhibit an increase in 
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ATPase activity. Therefore, it is possible that F475S will also show an increase in 
substrate binding. Ssa1/2 binding more avidly to Sup35 aggregates, may affect the 
Hsp70 function of dismantling aggregates into polymers directly or by an association 
with Hsp104 (Song. et al., 2005).  
 
The isolation of second-site suppressors of both SSA1-21 and F475S, allows us to gain 
further insight on how these PBD mutations may be effecting prion propagation. The 
P636S mutation counteracts the [PSI+] impairment phenotypes of both SSA1-21 and 
F475S.  The ATPase domain of Hsp70 regulates the function of the PBD. In an ATP 
bound state, the PBD is in an open confirmation and this allows for rapid substrate 
exchange. Hydrolysis of ATP to ADP converts the PBD into a closed confirmation, 
establishing a tight association with its substrate. Hsp70 ATPase activity is stimulated 
by the PBD, which suggests inter-domain communication, which is influenced by co-
chaperones, and TPR co-chaperones motifs (Shomura et al.,, 2005). The P636 residue 
is located within a conserved octapeptide GPTVEEVD. This motif in humans 
interacts with the Hop1, suggesting that this mutation may suppress SSA1-21 and 
F475S by interfering with their ability to interact with Sti1 (yeast homologue of 
Hop1). It appears a weak interaction of Hsp70 with Sti1 is favorable for [PSI+] 
propagation, overexpression of Sti1 (promotes substrate binding) impairs [PSI+] 
propagation whereas deletion of Sti1 restores prion propagation (Jones et al., 2004). 
Conversely, the NEF Fes1 facilitates the release of substrates. Overproduction of 
Fes1inhibits the impairment of [PSI+] propagation by SSA1-21 and depletion of Fes1 
(which prolongs substrate binding) impairs [PSI+] propagation in both wildtype and 
SSA1-21 (Jones et al. 2004). This shows that in order for [PSI+] propagate, a weak 
interaction with Fes1 is required.  
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Previously isolated mutants of Ssa1 that impair [PSI+] propagation have not had a 
significant effect on cell growth, leading to the conclusion that Ssa function in 
essential cellular pathways can be separated from Ssa function in prion propagation 
(Jung et al., 2000; Jones and Masison, 2003; Loovers et al., 2007). However, the 
F475S mutation appears to be unique as it demonstrates temperature sensitivity at 
elevated temperatures, suggesting that essential cellular pathways are not separate to 
the Ssa function in prion propagation. Remediation of the t.s phenotype by osmotic 
support and recovery by constitutively expressed components of the signaling 
cascade, leads us to believe that the F475S mutation may implicate Ssa1 as having a 
role in the CWI signaling pathway. Chaperones and co-chaperones that function in 
concert with Hsp70 are involved in the CWI signaling pathway. Hsp90 binds Slt2 and 
is essential for activating the downstream target Rlm1 (Millson et al., 2005).  Sse1 
functionally partners with Hsp90 as a Hsp70 NEF, and it has been shown that Sse1 
binds to Slt2 in vivo, yet Slt2 stability and phosphorylation is not affected in cells that 
are ∆Sse1yet activation of Rlm1 does not occur (Shaner et al., 2008). Cells containing 
an Ydj1 deletion also exhibit phenotypes consistent with cell wall defects and 
overexpression of Pkc1 improves cell growth (Wright et al., 2007). Hsp70 maybe 
indirectly affects CWI through any of the above components or alternatively it maybe 
directly affecting the pathway its components such as Pkc1 or Bck1. Functional 
conservation of the F475S mutation in Ssa2 and Ssa4 suggests that it may be a more 
of a general involvement of Hsp70 family members in the CWI signaling pathway. 
 
Analysis of the effects of  Ssa1F475S on the promoter activity of PDR5, UPRE and 
SSA1 expression may indicate that this mutant is having an effect on these genes. 
Alternatively, western blot analysis indicated that there was a lower abundance of 
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Ssa1 when the F475S mutation was present (Figure 3.6). Lower levels of Ssa1 may 
explain the effects of the Ssa1F475S mutation on the expression of the various 
promoters. If Ssa1 is required for binding to Pdr3, causing it to go into a low activity 
state, reduced amounts of Ssa1 may not be sufficient for this process and an increase 
in Pdr5 is observed in comparison to the effects of wildtype Ssa1.Similarly reduced 
amounts of Ssa1 may not be sufficient for negative regulation of its expression. Ssa1 
levels may also be a reason for the increase of UPRE promoter activity. 
 
Isolation of novel mutations in the PBD of Hsp70, that effect prion propagation and 
other cellular functions, has provided us with new insight into the role of Hsp70 in   
S. cerevisiae. These mutations have implicated the PBD as playing a role in prion 
propagation, which may be caused by alterations to inter-domain communication, 
binding of Ssa1 to Sup35 or interactions of co-chaperones with Ssa1. The F475S 
mutation suggests that Ssa function in essential cellular pathways cannot be separated 
from Ssa function in prion propagation as the mutation appears to implicates Ssa1 in 
the CWI signaling pathway and has an effect on other diverse cellular functions. 
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4.0 Introduction 
 
The aim of this chapter is to further characterize and perform biochemical analysis on 
previously isolated Hsp70 ATPase mutants that affect prion propagation and to assess 
the effects of C-terminally truncated Hsp70 on prion propagation. Hsp70 is composed 
of a 44kDa ATPase domain (NBD), an 18kDa peptide-binding domain (PBD) and a 
10kDa C-terminal variable domain. The function of Hsp70 requires coordinated 
action between these three domains. As the effects of mutations of Ssa1 in the PBD 
has already been assessed, this chapter will assess the role of the ATPase domain and 
C-terminal (CTD) in [PSI+] propagation.  
 
The importance of the Hsp70 ATPase domain for [PSI+] propagation  is highlighted 
by the isolation of numerous mutants located within the domain that impair prion 
propagation (Jones and Masison, 2003; Jones et al., 2004 and Loovers. et al., 2007).  
A majority of these mutants appear to be located in regions of the NBD that are 
important for inter-domain communication between the ATPase domain and PBD 
domain (Loovers. et al., 2007).  A number of isolated ATPase mutants are located in 
the IIB region of the NBD (Loovers. et al., 2007). This region has been identified in 
mammals for the binding of the nucleotide exchange factor (NEF), HspBP1, which is 
the mammalian homologue of the yeast Ssa1 NEF, Fes1. The isolation of these 
ATPase mutants and ATPase mutants that can suppress the PBD mutant SSA1-21 has 
implicated inter-domain communication and the function of Hsp70 NEF’s and co-
chaperones as playing an essential role in prion propagation ( Jones and Masison, 
2003; Jones et al., 2004 and Loovers. et al., 2007). 
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The CTD forms a lid like structure over the SBD that enables the trapping of 
substrates in the PBD. Substrate trapping by this lid like structure is dependent on 
communication between the SBD and the PBD. The Hsp70 co-chaperone Ydj1, which 
stimulates the activity of Hsp70, interacts with the NBD and the CTD to facilitate the 
transfer of substrates to the PBD. Deletion of the C-terminal in the Hsp70 E.coli 
homologue DnaK, exhibits a five- fold reduction in peptide binding affinity in 
comparison to wildtype (Pellecchia. et al., 2000). Furthermore, the addition of ATP to 
truncated DnaK lowers peptide binding by a magnitude similar to wildtype 
(Pellecchia. et al., 2000). This evidence suggests that the CTD is not necessary for 
inter-domain communication. However, it was observed that deletion of the CTD, 
increased peptide release induced by ATP by almost one hundred fold in comparison 
to wildtype (Pellecchia. et al., 2000). 
 
To understand the precise role of Hsp70–Ssa in amyloid prevention, formation, and 
propagation, biochemical analysis is required in addition to genetic analysis. 
Furthermore, it is necessary to investigate the effects of ATPase mutants on other 
cellular functions within the yeast cell. It is also necessary to investigate whether there 
is a role for the CTD in prion propagation by analyzing the affects of various CTD 
truncations on [PSI] propagation.  
The main objective of this chapter was to: 
• Genetically and biochemically characterize isolated ATPase mutants. 
• Analyze the effects of ATPase mutants on other cellular functions. 
• Investigate if CTD has a role in [PSI+] propagation independent of co-
chaperones. 
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4.1 Isolation of Hsp70 ATPase mutants that impair [PSI+] propagation 
Previous genetic screens have identified the ATPase domain of Hsp70 as playing an 
essential role in prion propagation (Jones et al., 2003). To further investigate the 
effects of mutated Hsp70 on prion propagation an extensive genetic screen to identify 
mutants in both the major cytosolic Ssa proteins was carried out (Loovers et al., 
2007). All but one of mutations that effected [PSI+] propagation are located in the 
ATPase domain (Table 4.1) (Loovers et al., 2007). When ATPase mutants are 
expressed as the sole source of Ssa1 in yeast cells, only Ssa2A176T exhibited an affect 
on the growth rate (MGT).  A subset of the mutant residues (A53, G73, R74, A146 
and T223) are located in a region, which has recently been shown to be important for 
inter-domain communication in the E.coli Hsp70, DnaK (Revington et al., 2005). 
Another subset of the mutant residues (R259, G287, T295 and A297) are located 
within the IIB region of the ATPase domain. The IIB region of the ATPase domain 
has been implicated as interacting with the Fes1 homologue, HspBP1, in mammals 
(Shomura et al., 2005).  Therefore, mutants may be altering the IIB region in a way 
that Hsp70 cannot interact with the NEF Fes1 in yeast, which then alters [PSI+] 
propagation. To further assess the role of Hsp70 ATPase mutants on [PSI+] 
propagation, we chose three mutants (G73D, G287D and T295I), which are 
representative of both subsets. Isolation of G287D and T295I in Ssa2, suggests that 
Ssa2 is carrying out a similar function as Ssa1 with regard to prion propagation.  
Furthermore, G73D is suppressed by three previously established second-site 
suppressors (A519T, E540K and P636S), which suppress other previously isolated 
ATPase mutants (Jones and Masison, 2003); whereas G287D is unaltered by 
mutations suggesting G73D and G287D function in different manners. 
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Ssa1 mutants Ssa2 mutants Times isolated MGT % of WT 
WT WT  100 
 A4T 1 81   ± 8 
 D30N 1 95   ± 1 
 G41D 5 118 ± 2 
 G50D 1 90   ± 9 
A53V  1 95   ± 4 
 A53V 2 100 ± 5 
 A53T 4 105 ± 3 
T64I  3 101 ± 2 
 T64I 4 101 ± 4 
G73D  3 101 ± 5 
R74K  1 94   ± 4 
 R74K 1 77   ± 30 
S119F  2 96   ± 4 
 A146T 2 101 ± 3 
A155V  2 113 ± 10 
A155T  1 94   ± 4 
 A176T 1 131 ± 7 
T223I  8 94   ± 2 
R259K  2 100 ± 6 
G287D  4 102 ± 5 
 G287D 5 101 ± 5 
T295I  1 95   ± 3 
 T295I 1 105 ± 5 
A297T  1 107 ± 3 
G481D  1 98  ±  5 
Table 4.1 Relative effects of Ssa1 and Ssa2 mutants on prion propagation and cell growth. 
Hsp70 mutants isolated as in chapter 3.1. All but one of mutants are located in the ATPase 
domain of Ssa1/Ssa2. Mean generation time expressed as a percentage of wildtype. Highlighted 
mutants (G73D, G287D and T295I), were further characterized in this chapter. This table is an 
adapted version from Loovers et al.,2007. 
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4.2 Analysis of [PSI] propagation and Hsp70 function of ATPase mutants 
 
As the main function of Hsp70 is refolding misfolded or aggregated proteins at  
elevated temperatures it is necessary to test this function of Hsp70 mutants at elevated 
temperatures. Previous analysis of ATPase mutants revealed that mutation in the 
ATPase domain of Hsp70 did not effect Hsp70’s heat shock function, suggesting that  
different regions of Ssa1 caused the same impairment of [PSI+] without affecting 
normal Hsp70 function (Jones and Masison, 2003). The isolated mutants G287D and 
T295I appear not to affect the function of Hsp70, as cells expressing each mutant as 
the sole source of Ssa1 are viable at 37oC and 39oC.  However, the G73D mutation 
causes a 39oC t.s phenotype, which is recovered on 1M sorbitol. This suggests that the 
G73D mutation may affect the function of Ssa1 at elevated temperatures and could 
further implicate Ssa1 as playing a role in the CWI signaling pathway. 
 
 
 
                  
 
 
 
 
 Ssa1 
G73D 
 G287D 
  T295I 
30oC 37oC                                        39oC    
Figure 4.1 Effect of elevated temperatures on ATPase 
mutants. Cells harboring WT Ssa1 and ATPase mutants were 
incubated at specific temperatures for 48 hours. Cells were 
diluted by a 1/5 serial dilution. Spots are labeled accordingly. 
Wildtype and mutants expressed as the sole source of Ssa in 
yeast. As G73D appeared 39oC t.s we preformed growth assay 
on 1M Sorbitol at 39 oC (B).     
 
 
 Ssa1 
G73D 
(B) 
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4.3 Hsp70 structural analysis 
As stated previously, G73D is located in a region that has recently been shown to be 
important for inter-domain communication in the E.coli Hsp70, DnaK (Revington et 
al., 2005) and G287D and T295I are located in the IIB region of the ATPase domain 
which has been implicated as interacting with the Fes1 homologue, HspBP1 in 
mammals (Shomura et al., 2005). Previous structural analysis of the ATPase mutants 
was carried out utilizing the bacterial Hsp70 homologue DnaK has 62.6% similarity to 
yeast Hsp70. More recently, the bovine Hsp70 (Hsc70) homologue has been 
crystallized which has 87.3% similarity to yeast Hsp70; therefore mutants were 
mapped onto the bovine model (Figure 4.2). The crystal structures were downloaded 
from the protein databank (PDB) and prepared for later homology modeling using the 
Accelrys Discovery Studio 2.5.  Based on the Hsc model. Models were generated by 
MODELER (Sali and Overington, 1994). From this analysis we can tell, Gly73 
residue is located in a turn region of the ATPase domain. A hydrogen bond (HB) 
interaction is formed with Leu71, while neighboring residues include Ile72, Arg74, 
Asn75, Glu115, Asn149, Ser151, Gln152, Ala155. The G73D mutation changes a 
polar uncharged residue to a polar acidic residue. As an Asp the HB to Leu71 is lost 
and additional neighboring residues include Asp73, Arg153 and Gln154. Gly287 is 
located in a turn between beta strands. No HBs are present with G287 and neighbors 
include Leu257, Phe285, Glu286, Ile288, Asp289 and Leu284. With the change from 
a polar uncharged residues to a polar acidic residue HBs are predicted involving 
Ile288 and Asp289, additional neighbors include Asp249 and Ile288. The Thr295 is 
located in beta strand. The polar uncharged Thr295 Hbs to Ile194, Lys268 and 
Ser278. T295 Neighbors: Gln276 (ADP binding site), Thr277, Ser278, Val279 
(neighbors ADP binding site), Ser293, Ile294, Lys268, Arg296, Glu300, Glu280, 
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Phe299, Ala297 (involved in HSP110 interaction).  Although the mutation changes 
from a polar uncharged to a nonpolar hydrophobic residue both are favored in the 
middle of Beta strands. When the mutation I295 is present there is a change in the 
predicted Hydrogen bonding pattern with only the HB with Ser278 being maintained. 
New neighbors include Ser272.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.2- Yeast HSP70 ATPase domain model developed 
from the 37CN crystal structure (chain B).  Position of ATPase 
mutations on Hsp70 crystal structure. 
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4.3.1 Structural analysis of the binding of the Ssa1 NEF, Sse1 to Hsp70 
Binding and release of substrates by Hsp70 is driven by the ATPase cycle. ATP 
binding to the NBD of Hsp70 induces conformational changes in the C-terminal PBD, 
which results in rapid substrate exchange. When Hsp70 is in an ADP bound state, the 
substrate becomes tightly bound. Many factors influence this process, such as Hsp40 
and the nucleotide exchange factor (NEF) Hsp110.  Two highly homologous 
members, Sse1 and Sse2, in S. cerevisiae, represent Hsp110. Peptide release can be 
triggered by NEF’s, by helping liberate bound ADP and their facilitating ATP 
rebinding.  Recent studies have found Sse1 is required for de novo [URE3] and [PSI+] 
formation and efficient prion propagation (Kryndushkin. et al., 2007; Fan. et al., 
2007; Sadlish et al., 2008). From structural analysis of the interaction between Hsc70 
and Sse1 (Figure 4.3) we have defined residues in Hsc70 that are important for Sse1 
binding (Table 4.2). The highly conserved Hsp70 residue Ala300H mediates a Van 
der Walls (vdw) contact to the Sse1 backbone between the Sse1 residues Glu575 and 
Glu576, which in turn are engaged in hydrogen bond (HB) contacts to Hsp70 residues 
Thr298 and Lys348. The Sse1 residue Tyr579 makes additional vdw contacts to 
Ala300 and Glu304. Interestingly, the yeast homologue of the Hsc70 residue Thr298 
is Thr 295. A mutation to this residue may affect the ability of Hsp70 to bind to Sse1, 
this may explain why Ssa1 harboring the mutation T295I cannot maintain [PSI+]. This 
further suggests efficient NEF activity is required for [PSI+] propagation. 
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G34 G32 
A54 A52 
N57 N55 
L133 L131 
Y134 G132 
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K348 K345 
Figure 4.3 Binding of Sse1 to Hsp70. Image is the 37CN crystal structure (Schuermann. et 
al. 2008). In blue is the ATPase domain, in red the peptide-binding domain of Hsp70 and in 
green is Hsp110. Images were generated using Pymol.  
Table 4.2 Bovine HSP70 residues that contact Hsp110 in the 3C7N crystal 
structure with the corresponding aligned residues in yeast Hsp70.  Bovine 
Hsp70 residues revealed that the T295 Bovine homologue is involved in the 
binding of Sse1. 
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4.4 Basal levels of Hsp70 and Hsp104 in yeast expressing ATPase mutants 
 
Analysis of the abundance of Hsp70 and Hsp104 proteins in cells expressing mutants 
that affect [PSI+] propagation is critical as their levels may effect prion propagation. 
Previous studies indicated that the abundance of Hsp70 or Hsp104 was not affected by 
mutations in the ATPase domain (Jones and Masison, 2003; Loovers et al., 2007). As 
previously observed (Loovers et al., 2007), levels  of Hsp70 or Hsp104 in yeast cells 
expressing the ATPase mutants were not considerably different in mutant strains in 
comparison to wildtype (Figure 4.4).  This indicates that impairment of [PSI+] 
propagation is not a result of altered amounts of Hsp70. 
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Figure 4.4 Basal levels of Hsp70 and Hsp104 in cells expressing ATPase mutants. 
Lysates prepared from overnight 30oC cultures. Aliquots of proteins (10µg) were 
separated on three polyacrylamide gels, gels were either immunoblotted with antibodies 
either specific for (A) Hsp70 (SPA-822, 1/2000 dilution) and (B) Hsp104 (HSP104, 
1/150,000 dilution) or stained (C) Coomassie brilliant blue stained overnight and 
destained the following day.  Mutant alleles as indicated. 
     WT           G73D           G287D     T295I 
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4.5 Protein refolding activity of Hsp70 ATPase mutants 
As a heat shock protein, one of its major functions of Hsp70 is refolding proteins that 
have become misfolded due to heat stress. The ability of chaperones to refold 
misfolded proteins can be measured by performing a luciferase assay. The luciferase 
enzyme is unstable at high temperatures. In the presence of its substrate decanal, 
luciferase emits light, which can be measured on a luminometer. Luciferase assays 
were preformed as in chapter 3.4. As Hsp104 is critical for survival at elevated 
temperatures and its function is dependent on Hsp70 and Hsp40, a yeast strain with 
ablated Hsp104 should exhibit a low reading for luciferase refolding whereas a 
wildtype strain such as G600 should exhibit a high percentage of luciferase refolding 
as all chaperones are present.  Both strains were used as controls to measure the 
accuracy of assay (Figure 4.5). Yeast strains expressing wildtype Ssa1 and the 
ATPase mutants G73D, G287D and T295I were transformed with the plasmid 
(pDCM90), expressing the luciferase protein. Luciferase assays were preformed as in 
chapter 3.4. As expected, the yeast strain with the Hsp104 deletion exhibited low 
luciferase re-folding (29%) and the wildtype strain G600 exhibited the highest rate of 
luciferase refolding (99%) (Figure 4.5).  There was no significant difference in the 
rate of luciferase folding between wildtype Ssa1 and ATPase mutants. This result 
suggests that these specific mutations in the ATPase domain do not effect refolding of 
aggregated proteins post heat shock. 
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Figure 4.5- Refolding activity of ATPase mutants. Overnight cultures of G600, ∆104 and 
ATPase assays expressing luciferase were shifted from 30oC to 37oC for 30 minutes and then 
shifted to 42oC for one hour. Cycloheximide was added 50 minutes after shifting to 42oC to 
prevent synthesis of luciferase during the recovery period. Luciferase activity, expressed as a 
percentage of pre-heat shock activity, was measured after allowing cells to recover for 30 
minutes at 25oC. Experiment was repeated twice in triplicate. There was no significant 
difference in the rate of luciferase folding between wildtype Ssa1 and ATPase mutants. The  
∆ Hsp104 strain exhibited low luciferase folding and the wildtype strain G600 exhibited the 
highest rate of luciferase refolding. 
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4.6 Conservation of ATPase mutations across the Ssa family 
There is a high degree of conservation among the Hsp70 family. It is conserved in 
archaea, eubacteria, eukaryotes and organelles (mitochondria, chloroplasts) (Karlin 
and Brocchieri, 1998).  Ssa1 and Ssa2 are constitutively expressed and have 97% 
homology; Ssa3 and Ssa4 have 87% homology and are induced when the cell 
encounters stress. Therefore, conservation of mutations of Hsp70, that impair prion 
propagation, may be useful targets for therapeutics or designing treatments for prion 
diseases. To test whether the ATPase mutations were conserved in Ssa2, Ssa3 and 
Ssa4, mutations were inserted by SDM into plasmids expressing each protein. We 
were unable to obtain the G73D mutation in SSA2 and SSA3. As previously described 
the G287D and T295I also impair prion propagation in Ssa2 (Figure 4.6) (Loovers et 
al., 2007). We can now conclude that the G287D and T295I mutations are 
functionally conserved in Ssa3 and Ssa4. Cells expressing the Ssa3 and Ssa4 mutants 
appear to be growing at a much slower rate in comparison to Ssa1 and Ssa2 cells 
harboring the G287D and T295I mutations. The G73D mutation appears to make the 
Ssa4 protein non-functional as the presence of the mutation appears to be detrimental. 
Functional conservation of these ATPase mutations and the PBD mutation (F475S) is 
indicative of a general role of the Hsp70 Ssa family in [PSI+] propagation. 
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Figure 4.6- Conservation of ATPase mutants across Ssa family. Plasmids expressing Ssa1-4 with ATPase 
mutations, were transformed into the yeast strain G402 onto SD agar lacking leucine. Cells were grown at 
30oC for 48 hours.  Colonies from Leucine plates were then restreaked onto SD agar lacking leucine and 
grown at 30oC for 48 hours. Strains were  replicated onto 5-FOA and incubated 30oC for 48 hours.  
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4.7 Biochemical analysis of ATPase mutants 
Mutations in the ATPase domain of Ssa1 (G73D, G287D and T295I) appear to have 
little effect on the essential cellular functions carried out by this protein chaperone, 
yet they are able to impair [PSI+] propagation. To further our knowledge on the 
ATPase domain mutants, we carried out initial biochemical analysis in addition to 
genetic studies. As mutants are located in regions important for inter-domain 
communication (G73D) and binding of NEF’s such as Fes1 (G287D and T295I), we 
decided to carry out ATPase assays to deduce whether mutants affect the rate of ATP 
turnover. We purified ATPase mutants from E.coli, using a well established E.coli 
system. From previous experience it is known that an N-terminally fused His (6X) tag 
may be lethal to Ssa1 (G. Jones personal correspondence). To test this we expressed 
Ssa1-(His6X) ATPase mutants in yeast. We were unable to obtain the G287D 
mutation in the Ssa1-(His6X) construct.  The N-terminal His (6X) tag did not affect 
the viability of ATPase mutants; G73D and T295I  in vivo (Figure 4.7) 
 
 
 
 
 
 
 
 
 
               G73D                                        T295I 
Figure 4.7 -Viability of His(6X) tagged ATPase mutants. ATPase mutations were inserted into 
pC210 expressing Ssa1 with a N-terminal His(6X) tag by site-directed mutagenesis. Mutant 
plasmids were then transformed into G402 on SD agar that lacked leucine at 30oC for 48 hours.  
Colonies from Leucine plates were then restreaked onto SD agar lacking leucine and grown at 30oC 
for 48 hours. Strains were then replicated onto 5-FOA and incubated 30oC for 48 hours. Strains 
were then streaked onto YPD and grown at 30oC for 48 hours. Mutants as indicated. 
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4.7.1 Protein purification of ATPase mutants 
We decided to purify ATPase mutants from E.coli. This was achieved by inserting the 
ATPase mutations G73D, G287D and T295I into an expression vector which 
expressed Ssa1 with an N-terminally fused His (6X) tag. ATPase mutants were 
purified under native conditions by Ni2+ affinity chromatography, dialysis and size 
exclusion chromatography. To condense large volumes of protein supernatant 
collected from dialysis and size exclusion chromatography, protein samples were 
condensed using Millipore condensing tubes. Two protein fractions were collected 
from size exclusion chromatography; peak one which is aggregated Hsp70 and Peak 
two which is native Hsp70 (Findings of Perrett group)(Figure 4.8).   
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Figure 4.8 Size- exclusion chromatography chromatogram Gel filtration column (HiLoad 
superDex 200pg, GE Health care) loaded with ATPase mutants supernatant. Peak one represents 
aggregated Ssa1 and peak two represents native Ssa1. Mutants as indicated. All fractions were 
collected and stores at -70oC. 
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4.7.2 Confirmation of purified ATPase mutants 
Purity of purified Ssa1 and ATPase mutants was judged by SDS-page and coomaisse 
staining (Figure 4.9). Pre purified and post purified proteins were run on 12.5% 
polyacrylamide gels. To further confirm the protein purified was Hsp70, P1 protein 
samples collected from size-exclusion chromatography were analyzed by western 
blot. Samples were probed with antibodies specific for Hsp70 and His6X tag (Figure 
4.10). Western blot confirms presence of both Hsp70 and His (6X) tag. SDS-page and 
coomaisse staining confirmed purity of proteins. Immunoblotting of proteins with 
antibodies specific for Hsp70 and His (6X) tag further clarified that correct protein 
was purified (Figure 4.10). 
 
 
 
 
 
 
 1      2      3    4      5     6       7       8                                  1       2     3        4        5       
6 
           
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(A)                                                                            (B) 
70kDa 
 168 
           1       2       3       4        5      6                                   1              2          3           4 
 
                   
                     1                 2                  3                4 
 
 
 
 
 
                 
 
 
 
Figure 4.9 Determination of purity of Ssa1p and ATPase mutants by SDS-page. 
Protein fractions run on 12.5% polyacrylamide gel at 200V for one hour. Gels stained in coomassie 
brilliant blue for one hour and destained overnight. Gel (A) represents purification of  Ssa1; Lanes 1 
represents supernatant pre purification, lanes 2-4 represents  fractions collected from Ni column 
eluted with MCAC-10, MCAC-100 and MCAC-350 respectively, lanes 5 represent post condensing 
of proteins post dialysis, lanes 6 and 7 represent Peak one (P1) and  peak two (P2) post size exclusion 
chromatography and lane 8 represents P1 post condensing. Gel (B) represents purification of 
Ssa1G73D, lane 1 loaded with supernatant pre purification, lane 2 loaded with run-through, Lane 3 
loaded with fraction post MCAC-350, lane 4 loaded with condensed 350 fraction and lanes 5 and six 
are peak one and peak two post size exclusion chromatography post condensing. Gel (C) represents  
Ssa1G287D and is loaded as gel (B). Gel (D) represents purification of Ssa1T295I, lane 1 represents 
supernatant pre purification, lane 2 loaded with run-through, lane 3 loaded with fraction post MCAC-
350 and lane 4 loaded with condensed 350 fractions.  
(C)                                                                              (D) 
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Figure 4.10 Detection of Hsp70 and His6X tag by western blotting.  Peak 1 purified Ssa1 and ATPase 
mutants separated by SDS-page. Gels were immunoblotted with antibodies specific for Hsp70 (SPA-822, 
1/2000 dilution) and His6x tag (anti His-Santa Cruz 1/200 dilution). Gel (A) shows (1) Ssa1, (2) Ssa1G73D, 
(3) Ssa1G287Dand (4) Ssa1T295I probed with SPA-822 and gel (B) samples loaded in the same order as gel 
(A) probed with an anti-His tag antibody. 
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4.7.3 Investigating intrinsic ATPase activity of ATPase mutants 
Hsp70 plays many roles in protein quality control such as; synthesis, protection during 
aggregation caused by stress and recovery of aggregates. Hsp70 functions by binding 
hydrophobic stretches of incompletely folded proteins, this process depend on 
conformational changes of Hsp70, which is regulated by ATP hydrolysis and 
ADP/ATP exchange. When Hsp70 is in an ATP bound state rapid substrate exchange 
occurs, hydrolysis of ATP to ADP results in an ADP bound state in which the 
substrate becomes tightly bound. Co-chaperones are also involved in this process, 
Hsp40 (Ydj1) presents substrates to Hsp70 and stimulates Hsp70 ATP hydrolysis. 
Nucleotide exchange factors such as Fes1 and Sse1 are also required to accelerate the 
release of ADP and the rebinding of ATP causing Hsp70 to release its substrate. As 
the ATPase mutants are located in regions of the ATPase domain involved with inter-
domain communication (G73D) and binging of NEF’s (G287D and T295I), 
investigating alterations to the ATPase cycle is critical. ATPase assays were carried 
out as in chapter 3.10. The ATPase activity of G73D is similar to that of wildtype 
suggesting that this mutation may not be affecting communication between the 
ATPase domain and PBD (Figure 4.11). The ATPase activity of G287D and T295I 
was increased by approximately two fold in comparison to wildtype (Figure 4.11). 
These results indicate that the ATPase mutants are not having a major effect on the 
ATPase cycle of Hsp70. 
 
 
 
 
 
 170 
 
 
Invetigation of ATPase activity
0
0.01
0.02
0.03
0.04
0.05
0.06
0.07
0.08
0.09
0.1
WT G73D G287D T295I
Mutants
Ra
te
 
(m
in
-
1)
 
 
 
 
 
 
 
 
 
 
 
 
  
Figure 4.11 Investigation of ATPase activity. Comparison of ATPase activity between 
wildtype and ATPase mutants was  measured .  ATPase assay carried out using 2µM 
purified wildtype and ATPase mutants. The x axis represents proteins being assayed and y 
axis represents rate of ATP turnover per minute. Assays repeated three times in triplicate.  
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4.7.4 Stimulation of ATPase activity by Hsp40 (Ydj1) 
The hydrolysis of ATP to ADP in the Hsp70 ATP cycle is a critical event in the ATP 
cycle of Hsp70. A variety of co-chaperones are involved in this event, with Hsp40 
being the most prevalent. Hsp40 presents substrate to Hsp70 and coordinates Hsp70 
ATPase hydrolysis with substrate binding. In yeast the major Hsp40 is Ydj1, 
increasing wildtype ATPase activity by seven fold (Needham and Masison. 2008).To 
test whether Ydj1 stimulates ATPase activity of wildtype Ssa1 and ATPase mutants, 
we tested the rate of ATPase activity with and without Ydj1. Ydj1 was purified as in 
chapter 3.10.2. Wildtype ATPase activity increases by four fold in presence of Hsp40. 
ATPase mutants do not appear to be stimulated by the presence of Ydj1 to the same 
degree as wildtype. 
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Figure 4.12. Stimulation of Ssa1 ATPase by Hsp40. This graph represents the 
stimulation of ATPase activity of ATPase mutants by Hsp40. ATPase assay carried out 
using 2µM of purified proteins. The x axis represents proteins being assayed and y axis 
represents rate of ATP turnover per minute. Assay carried out once in triplicate.  
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4.7.5 Analysis of protein structure of ATPase mutants  
The ATPase mutants do not appear to significantly alter the ATPase activity of 
Hsp70; however, a decrease in the rate of ATPase activity by Ydj1 stimulation is 
observed. This decrease may be due to a structural change in Hsp70 caused by 
ATPase mutations. To investigate this we analyzed the secondary structures of the 
ATPase mutants in comparison to wildtype using Circular Dichroism spectroscopy. 
CD spectra carried out as in chapter 3.11. CD spectra reveals there is no major 
difference in the secondary structure of ATPase mutants in comparison to wildtype 
(Figure 4.13). 
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CD spectroscopy of G287D
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CD spectra of T295I
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Figure 4.13- CD spectroscopy analysis of ATPase mutants. CD spectroscopy was 
preformed measuring the absorbance of 4µM of purified ATPase mutants in a total volume of 
350µl of dialysis buffer on the Pistar CD stopped flow (Applied biophysics limited) 
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4.8 Affect of ATPase mutants on cellular functions 
Hsp70 is involved in many cellular processes. Therapies based on affecting Hsp70 
machinery may have side effects if Hsp70 is involved in a variety of cellular 
functions. The ATPase mutants have so far only exhibited an effect on prion 
propagation, no significant differences with respect to cellular functions were 
observed. This may be advantageous, as if these sites only affect prion propagation 
they may be used for potential targets for future treatments. To test this hypothesis we 
decided to investigate the affects of ATPase mutants on other cellular functions in 
S.cerevisiae such as; pleiotropic drug resistance (Pdr), Hsp70 self- regulation and the 
unfolded protein response.  
 
 
4.8.1 Affect of ATPase mutants on expression of PDR5  
Pleiotropic drug resistance (Pdr) enables S. cerevisiae to become resistant to 
numerous toxic compounds. In yeast Pdr1 and Pdr3 are two major transcription 
factors which control the Pdr response by activating genes such as PDR5, PDR10 and 
PDR15  which encode ATP- binding cassette (ABC) transporters which operate as 
drug efflux pump.  ß-galactosidase assays were employed to measure the ATPase 
mutants effects on the expression of the transcription factor Pdr5. Methodology of 
PDR5 ß-galactosidase assays described in section 3.14.1. The ATPase mutants appear 
to have no significant effect on expression of PDR5 (Figure 4.14) 
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Figure 4.14- Effect of ATPase mutants on PDR5 expression. Yeast cells expressing 
wildtype Ssa1 or ATPase mutants were transformed with the Pdr5  ß-galactosidase reporter 
palsmid. Transformed strains were grown overnight in 5ml of YPD at 30oC to a 
concentration of 5x106 (cells/ml). Cells were then grown to a concentration of 1x107-2x107 
(cells/ml).  Cells were chilled on ice and then harvested at 4oC. Protein was extracted and 
reaction was initiated by adding ONPG, once a pale yellow color was observed the reaction 
was terminated by adding 1M Na2CO3.  o-nitrophenol was quantified by measuring 
absorbance at OD420nm. Units of ß-galactosidase activity (Y axis) were defined as (OD420) 
X (1.7)/ (.0045) X (volume) X (time) X (protein concentration) (section 2.9) 
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4.8.2 Effect of ATPase mutants on Ssa1 expression 
The induction of heat shock proteins by stress depends on heat shock factors (HSF), 
which bind to heat shock elements (HSE) in the promoters of heat shock genes. The 
Ssa1 promoter is known to contain HSE’s and Ssa1 is also thought to negatively 
regulate its own expression (Stone and Craig., 1990). Although protein levels of 
ATPase mutants are similar to wildtype it was still necessary  to investigate whether 
the ATPase mutants could cause changes at the transcriptional level for the Ssa1 
promoter. To analyze the effect of ATPase mutants on transcriptional levels of the 
Ssa1 promoter we preformed a ß-galactosidase assay as described in section 3.12.2. 
The mutant G73D was the only ATPase mutant to show increased Ssa1 expression 
with it being expressed almost one and a half times higher than wildtype (Figure 
4.15). A decrease of more than one and a half fold, in Ssa1 expression was observed 
with the mutants G287D and T295I in comparison to wildtype. Although abundance 
of Hsp70 appears similar for ATPase mutants, transcriptional levels appear to vary, 
indicating mutants may some how be affecting this. 
 
4.8.3 Effect of ATPase mutants on unfolded protein response 
As one of the primary functions of Hsp70 is the refolding of proteins that have 
become unfolded due to cellular stress, we decided to investigate the effect of the 
Hsp70 ATPase mutants on the unfolded protein response (UPR) in yeast. The 
unfolded protein response is described in chapter 3.14.3.  To assess whether the 
ATPase mutants have an affect on the UPR, we measured the activity of an unfolded 
protein response element. 
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This was achieved by utilizing a ß-galactosidase reporter plasmid which expressed the 
promotor conyaing UPRE elements fused to the lacZ gene (chapter 3.14.3). None of 
the ATPase mutants appear to have a significant effect on the unfolded protein 
response. 
Figure 4.15 Effect of ATPase mutants on Ssa1 expression. Yeast cells expressing 
wildtype Ssa1 or ATPase mutants were transformed with the SSA1 promoter ß-
galactosidase reporter palsmid (pZFO) . ß-galactosidase assays were carried out as 
described in Figure 4.14.  
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Figure 4.16 -The effect of ATPase on the unfolded protein response. Yeast cells 
expressing wildtype ATPase mutants were transformed with the UPRE promoter ß-
galactosidase reporter palsmid (pUPRE). ß-galactosidase assays were carried out described 
in section 4.14, with the exception of adding 5mM DTT into cultures for thirty minutes at 
30oC. The X-axis indicates the strains used in the assay. The Y axis indicates the ß-gal units. 
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4.9 Effects of CTD truncations on prion propagation and Hsp70 function 
 
Hsp70 is composed of three domains; PBD, the ATPase domain and the C-Terminal 
domain (CTD). We have identified mutants located in the PBD and ATPase domain 
of Hsp70 that affect prion propagation. The construct used to identify PBD mutants 
contained part of the CTD, yet no mutations were isolated in this region that affected 
prion propagation. To determine whether the CTD plays a role in prion propagation 
and other Hsp70 functions, we decided to investigate the affect of various CTD 
truncations in S. cerevisiae. To assess the possible influence of CTD in prion 
propagation we created three different amino acid truncations of the CTD; ∆20 (1-
622), ∆40 (1-602) and ∆60 (1-582) (Figure 4.17).  Primers designed to amplify 
truncated versions of Ssa1 were utilized and truncated Ssa1 PCR products were 
ligated into the pJ120 vector (Figure 4.18), resulting plasmids were named pJ120- 
∆20, ∆40 and ∆60. 
       1  MSKAVGIDLG TTYSCVAHFA NDRVDIIAND QGNRTTPSFV AFTDTERLIG 
      51  DAAKNQAAMN PSNTVFDAKR LIGRNFNDPE VQADMKHFPF KLIDVDGKPQ 
     101  IQVEFKGETK NFTPEQISSM VLGKMKETAE SYLGAKVNDA VVTVPAYFND 
     151  SQRQATKDAG TIAGLNVLRI INEPTAAAIA YGLDKKGKEE HVLIFDLGGG 
     201  TFDVSLLSIE DGIFEVKATA GDTHLGGEDF DNRLVNHFIQ EFKRKNKKDL 
     251  STNQRALRRL RTACERAKRT LSSSAQTSVE IDSLFEGIDF YTSITRARFE 
     301  ELCADLFRST LDPVEKVLRD AKLDKSQVDE IVLVGGSTRI PKVQKLVTDY 
     351  FNGKEPNRSI NPDEAVAYGA AVQAAILTGD ESSKTQDLLL LDVAPLSLGI 
     401  ETAGGVMTKL IPRNSTIPTK KSEIFSTYAD NQPGVLIQVF EGERAKTKDN 
     451  NLLGKFELSG IPPAPRGVPQ IEVTFDVDSN GILNVSAVEK GTGKSNKITI 
     501  TNDKGRLSKE DIEKMVAEAE KFKEEDEKES QRIASKNQLE SIAYSLKNTI 
     551  SEAGDKLEQA DKDTVTKKAE ETISWLDSNT TASKEEFDDK LKELQDIANP      
             601       IMSKLYQAGG APGGAAGGAP GGFPGGAPPA PEAEGPTVEE VD*        
 
 
Figure 4.17- Ssa1 protein sequence exhibiting CTD truncations. Ssa1 protein 
sequence was retrieved from Saccharomyces genome datatbase (SGD). ∆20, ∆40 and 
∆60 truncations represented by color code; ∆20 truncation highlighted in blue, ∆40 
truncation highlighted in blue and pink and ∆60 truncation highlighted in blue, pink and 
red. 
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ATG 
pJ120    ATPase PBD CTD 
TAA 
1 380 570 622 
ATG 
 
20 R Primer Ssa1 F 
 
 
20 truncated 
SSA1 cloned 
into pJ120 
Figure 4.18 Strategy employed for creating CTD truncations of Ssa1- This schematic diagram 
exhibits the method employed for creating the ∆20 CTD Ssa1 truncation, the ∆40 and ∆60 
truncations were made utilizing the same strategy. The ∆20 reverse primer was designed to 
exclude the last twenty amino acids of Ssa1. Ssa1 was amplified by a PCR reaction utilizing a 
Ssa1 forward primer and the ∆20 reverse primer. The resulting truncated Ssa1 product was cloned 
into the pJ120 plasmid by a Sph1 and Nde1 ligation.   
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4.9.1 Assessment of viability of Ssa1 CTD truncations  
To analyze the effects of CTD truncations on prion propagation and other essential 
Hsp70 functions, it was necessary to test the viability of these truncations in vivo. In 
order for this to be achieved we transformed [PSI+] and [psi-] versions of G402 with 
CTD truncated plasmids, pJ120 (positive control) and pRS315 (negative control). 
Growth of cells was observed for roughly one week on 5-FOA agar at room 
temperature. Initially, no cells appeared to grow for the G402 [PSI+] cells transformed 
with truncated CTD plasmid, colonies then began to appear on day four, with most 
growth appearing on the ∆40 patches, all cells remained [PSI+] (Figure 4.19). The 
[psi-] cells expressing the ∆20 and ∆40 CTD truncations exhibited growth after three 
days. Both strains remained [psi-] and growth appeared to be slower than wildtype 
(Figure 4.20). The ∆60 CTD truncation appears to be unable to support cells growth 
in both [PSI+] and [psi-] strains. In both cases controls acted correctly; cells 
transformed with pRS315 were unable to grow once placed on 5-FOA as cells had no 
members of the Ssa family being expressed and this is a lethal deletion and cells 
transformed with pJ120, which expresses Ssa1 grew as normal on 5-FOA. These 
results suggest that ∆20 and ∆40 CTD truncations can maintain cell viability and ∆60 
CTD truncation cannot. This is indicative that a region between the ∆40 and ∆60 is 
important for Hsp70 function. 
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Figure 4.19 Viability of truncated CTD mutants in [PSI+] G402. Truncated CTD mutants, 
pRS315 and pJ120 were transformed into [PSI+] G402 and were grown at 30o for 48 hours on SD 
agar lacking Leucine. Transformants were patched onto SD agar lacking Leucine (Pre 5-FOA) and 
grown at 30o for 48 hours. Patches were replicated onto 5-FOA and growth was observed over six 
days. 
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4.20 Viability of truncated CTD mutants in [psi-] G402. Truncated CTD mutants, 
pRS315 and pJ120 were transformed into [psi-] G402 and were grown at 30o for 48 hours 
on SD agar lacking Leucine. Transformants were patched onto SD agar lacking Leucine 
(Pre 5-FOA) and grown at 30o for 48 hours. Patches were replicated onto 5-FOA and 
growth was observed over five days. 
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4.9.2 Confirmation of CTD truncations  
To confirm the strains are expressing truncated versions of Ssa1, we hypothesized that 
a slight shift in protein size should be visible by Western blot analysis. To test this we 
extracted total protein from [psi-] strains pre 5-FOA and post 5-FOA and 
immunoblotted with an antibody specific for Hsp70. From Figure 4.20, it is clear that 
there is a shift in protein size for ∆20 and ∆40 post 5-FOA treatment confirming that 
truncated proteins are being expressed in the yeast cells and can sustain growth as sole 
source of Ssa family in strain. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
    1          2           3        4        5         6         7 
Figure 4.21- Confirmation of expression of CTD truncated proteins. Lysates 
prepared from overnight 30oC cultures. Aliquots of proteins (10µg) were separated on a 
polyacrylamide gel. Gels was then immunoblotted with an antibody specific Hsp70 
(SPA-822, 1/2000 dilution). Lanes 1-4 represent the samples pJ120, ∆20, ∆40 and ∆60 
pre 5-FOA and lanes 5-7 represent samples pJ120, ∆20 and ∆40 post 5-FOA treatment. 
A shift in protein size is observed ∆20 and ∆40 post 5-FOA treatment, which confirms 
truncated proteins are being expressed. 
 
 187 
4.9.3 Analysis of growth rates of CTD truncation in Yeast 
Previous analysis of the effects Ssa1 ATPase and PBD mutation on growth rates of 
yeast cells has shown that there are no significant alterations to growth rates. As we 
observed slower growth rates of ∆20 and ∆40 on 5-FOA and no growth for ∆60 
(Figure 4.19 and 4.20), we decided to measure the mean generation time of both 
[PSI+] and [psi-] strains. As we observed on the plates, ∆40 [PSI+] grows slightly 
quicker than ∆20 [PSI+] (Figure 4.19). The [psi-] strains also appear to correspond to 
growth rates on plates with ∆20 growing faster than ∆40 (4.2). These results indicate that 
truncations of the CTD of Hsp70 have an effect on the growth rate of S. cerevisiae. This 
indicates that the CTD of Ssa1 is essential for normal cellular growth. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CTD 
Truncations 
MGT 
(Mins) 
MGT % of WT 
SSA1 110.33 100%  
∆20 [PSI+]  142 129% ± 13% 
∆40 [PSI+] 135 122% ± 24% 
∆20 [psi-] 164 149% ±25% 
∆40 [psi-] 201 182% ±18% 
Table 4.3 Effects of Hsp70 CTD truncations on the growth rate of 
yeast cells. Mean generation time of CTD truncations  was measured  by 
diluting overnight 30oC cultures  to an OD600 0.1. Cultures grown 
exponentially at 30oC, OD600 measured every two hours for approximately 
ten hours. 
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4.9.4 Analysis of Hsp70 function in strains expressing CTD truncations 
Analysis of the ability of Hsp70 containing mutations in the ATPase and the PBD to 
recover misfolded protein during heat shock, lead us to believe that mutations in 
ATPase domain did not affect this function but the PBD mutation Ssa1F475S caused a 
t.s phenotype at 37oC. As the CTD works in concert with the PBD (CTD forms a lid 
over PBD trapping substrate), we therefore decided to evaluate the affect of the ∆20 
and ∆40 CTD truncations on protein recovery by Hsp70 during heat shock. We 
analyzed growth of ∆20 and ∆40 at 30oC and 37oC.  At 30oC, ∆20 and ∆40 appear to 
be growing at a slower rate in comparison to wildtype (Figure 4.21), which was 
previously observed (Table 4.2). Interestingly, ∆20 and ∆40 appear t.s at 37oC (Figure 
4.21). This suggests that truncations of the Hsp70 CTD may be inhibiting recovery of 
misfolded proteins during heat shock or it may further implicate Ssa1 as playing a role 
in the CWI signaling pathway.  
 
 
 
 
30oC                                                              37 oC 
WT 
 
 
∆20 
 
 
∆40 
Figure 4.22- Hsp70 function in cells expressing CTD truncations. Cells incubated at 
specific temperatures for 72 hours on YPD. Cells were diluted by a 1/5 serial dilution. Spots 
labeled accordingly. Wildtype [psi-] and mutants expressed in G402 therefore are sole 
source of Ssa in strain. 
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4.9.5 Implicating Ssa1 as playing a role in the CWI signaling pathway 
The cell wall integrity signaling pathway is a MAP kinase pathway, which contains 
many components, and results in the phosphorylation of the transcription factor Slt2 
that induces the expression of genes involved in cell wall repair and synthesis (Figure 
3.28). A variety of chaperones such as Hsp90 and the NEF Sse1 have been implicated 
in this pathway. Introducing mutations to components of the cell wall integrity (CWI) 
signaling pathway results in common phenotypes such as temperature sensitivity at 
37oC and sensitivity to drugs that damage the cell wall. We have observed that the 
Ssa1F475S was 37oC t.s and its recovery on 1M sorbitol indicated that Ssa1 might be 
involved in this pathway. Therefore, we decided to test for recovery of the ∆20 and 
∆40 37oC t.s phenotype on 1M sorbitol. Both ∆20 and ∆40 exhibited recovery of the 
t.s phenotype when gown at 37oC on YPD supplemented with 1M sorbitol (Figure 
4.22). This result further indicates that Ssa1 may play a role in the CWI signaling 
pathway. 
 
              
 
 
YPD                                                               YPD + 1M Sorbitol 
Figure 4.23- Recovery of CTD truncations at 37oC. Cells incubated at 37oC for 72 hours 
on YPD and YPD+ 1M sorbitol. Cells were diluted by a 1/5 serial dilution. Spots labeled 
accordingly. Wildtype [psi-] and mutants expressed in G402 therefore are sole source of Ssa 
in strain. 
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∆20 
 
 
 
∆40 
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4.9.6 Further evaluation of [PSI+] strain expressing CTD truncations 
Assessment of the viability of CTD truncations in the G402 strain, lead us to observe 
single white colonies appearing on the ∆20 and ∆40 patches after four days. To 
further test these colonies we decided to assess their curing ability. Millimolar 
concentrations of the chaotropic salt guanidine hydrochloride (GdnHCL) eliminates 
[PSI+] from cells, resulting in a change from [PSI+] (white) to [psi-] (red) (Tuite et al., 
1981). To test the ∆20 and ∆40 ability to cure, colonies were picked from patches and 
restreaked onto YPD plate’s containing 3mM GdnHCL. We observed that ∆20 and 
∆40 cured when placed on 3mM GdnHCL.  
 
 
                          YPD                                                       YPD + 3mM GdnHCL 
 
 
 
 
 
Figure 4.24 Curing of [PSI+] ∆20 and ∆40 strains by 3mM GdnHCL.  The [PSI+] strains 
harboring the CTD truncation were streaked onto YPD and YPD + 3mM GdnHCL and 
incubated at 30oC for 48 hours. 
  ∆20              ∆40                                           ∆20              ∆40 
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4.9.7 Growth rates of cured ∆20 and ∆40 strains 
Initially when we assessed the growth rates of the [PSI+] and [psi-] strains expressing 
CTD truncations, ∆40 appeared to grow faster in [PSI+] strain and slower than ∆20 in 
[psi-] strain. To assess whether curing of ∆20 and ∆40 [PSI+] strains made cells act 
similarly to [psi-] strains expressing ∆20 and ∆40 we analyzed the growth rates of 
[PSI+], cured [PSI+] and [psi-] cells expressing the CTD truncations. Cured versions 
of [PSI+] appeared to grow more similarly to [psi-] strains with ∆40 growing slower in 
both cases (Table 4.4) This suggest the presence of the [PSI+] prion has an affect on 
the functioning of truncated Hsp70. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
CTD truncations MGT (mins) MGT % of WT 
Ssa1 105 100% 
∆20 [PSI+] 142 135% ±14% 
∆40 [PSI+] 135 129% ±25% 
∆20 Cured 137 130% ±18% 
∆40 Cured 151 144% ±31% 
∆20 [psi-] 138  131%±14% 
∆40 [psi-] 172  163% ±38% 
Table 4.4 Growth rate of cured [PSI+] cells expressing CTD truncations. Mean 
generation time of CTD truncations  was measured  by diluting overnight 30oC cultures  
to an OD600 0.1. Cultures grown exponentially at 30oC, OD600 measured every two hours 
for approximately ten hours (chapter 2.7.1). 
 
 192 
4.10 Microarray analysis of ∆20 
To further analyze the affects of Ssa1 CTD truncations, we investigated the effects of 
expressing ∆20 as the sole source of Ssa1 on gene expression in G402. We found a 
considerable amount of genes that were regulated differently in strains expressing ∆20 
in comparison to wild-type. We found eight genes in the ∆20 strain that were up-
regulated by three-fold or more in comparison to the wild-type strain. The DAN1 and 
TIR1 genes are both up-regulated in cells expressing ∆20 (Table 4.5). Both these 
genes are part of the DAN/TIR family, which is comprised of eight genes and are up-
regulated during adaptation to anaerobic growth conditions (Sertil et al., 2003, Tai et 
al., 2005). Other genes up-regulated include genes involved in methionine 
biosynthesis (MET2) (Forlani et al., 1991) and de novo lipid  synthesis (PAH1) (Han 
et al.,2006).  
From the microarray analysis we also observed that a number of genes were down-
regulated in cells expressing ∆20 in comparison to wild-type (Table 4.6). Nine genes  
were down-regulated by five-fold or more in ∆20 cells, including genes involved in a 
diverse range of cellular structures and functions, including ribosomal structure 
(RPS8A), cytokenesis (EGT2) and transcriptional activation (MSN1) (Table 4.6). The 
down-regulation of the EGT2, which encodes a GPI cell wall protein required for 
correct cytokenesis after cell separation, may result in the reduced growth rate 
observed in cells harboring the ∆20 mutation. By analyzing gene expression in strains 
harboring ∆20 mutant, it was observed that the presence of an Ssa1 CTD truncation 
has an affect on the regulation of a number of genes. Detailed microarray analysis 
data is supplemented as a hard copy (CD). 
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ORF/Gene Gene function Ssa1-
∆20 
YNR034W/SOL1 Protein with a possible role in tRNA export. 5.506 
YHL021C/AIM17 Unknown 4.752 
YGR204C-
A/Unknown 
Unknown 3.586 
YHR179W/CYE Conserved NADPH oxidoreductase containing 
flavin mononucleotide may be involved in 
sterol metabolism, oxidative stress response, 
and programmed cell death 
3.509 
YNL277W/MET2 L-homoserine-O-acetyltransferase, catalyzes 
the conversion of homoserine to O-acetyl 
homoserine which is the first step of the 
methionine biosynthetic pathway 
3.328 
YMR165C/PAH1 Mg2+-dependent phosphatidate (PA) 
phosphatase, catalyzes the dephosphorylation 
of PA to yield diacylglycerol and Pi, 
responsible for de novo lipid synthesis 
3.301 
YJR150C/DAN1 Cell wall mannoprotein with similarity to Tir1, 
Tir2, Tir3, and Tir4. 
3.062 
YER011W/TIR1 Cell wall mannoprotein of the Srp1/Tip1 family 
of serine-alanine-rich proteins 
3.014 
 
Table 4.5 Up-regulation of genes in cells expressing ∆20. Analysis of microarray 
data revealed eight genes that were up-regulated in strains expressing the Ssa1 CTD 
truncation ∆20 by approximately three-fold or greater. Expression of genes was 
compared to expression in Ssa1. Functions of genes were obtained from the 
Saccharomyces genome database (SGD). 
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ORF/Gene Gene function Ssa1-∆20 
YLR431C/ATG23 Peripheral membrane protein required for the cytoplasm-to-
vacuole targeting (Cvt) pathway and efficient 
macroautophagy 
0.087 
YKR022C/NTR2 Essential protein that forms a dimer with Ntr1; also forms a 
trimer, with Ntr2 and the DExD/H-box RNA helicase 
Prp43, that is involved in spliceosome disassembly 
0.089 
YNL186W/ 
UBP10 
Ubiquitin-specific protease that deubiquitinates ubiquitin-
protein moieties; may regulate silencing by acting on Sir4; 
involved in posttranscriptionally regulating Gap1 and 
possibly other transporters; primarily located in the nucleus 
0.102 
YoL116W/MSN1 Transcriptional activator involved in regulation of invertase 
and glucoamylase expression, invasive growth and 
pseudohyphal differentiation, iron uptake, chromium 
accumulation, and response to osmotic stress; localizes to 
the nucleus 
0.109 
YNL004W/HRB1 Poly (A+) RNA-binding protein, involved in the export of 
mRNAs from the nucleus to the cytoplasm. 
0.166 
YJR155W/AAD10 Putative aryl-alcohol dehydrogenase with similarity to P. 
chrysosporium aryl-alcohol dehydrogenase 
0.180 
YFR008W/FAR7 Protein involved in recovery from cell cycle arrest in 
response to pheromone 
0.186 
YNL327W/EGT2 Glycosylphosphatidylinositol (GPI)-anchored cell wall 
endoglucanase required for proper cell separation after 
cytokinesis 
0.196 
YBL072C/RPS8A Protein component of the small (40S) ribosomal subunit 
 
0.205 
 
 
Table 4.6 Down-regulation of genes expressing ∆20. Analysis of microarray data 
revealed nine genes that were down-regulated strains expressing the Ssa1 CTD 
truncation ∆20 by approximately five-fold or more. Expression of genes was 
compared to expression in Ssa1. Functions of genes were obtained from the 
Saccharomyces genome database (SGD). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 195 
 
 
4.11 Discussion 
 
We have identified twenty-five mutants within the Ssa family that impair [PSI+]  
propagation in S. cerevisiae (Loovers. et al., 2007). Five of theses mutants were 
identified in both Ssa1 and Ssa2, further highlighting the importance of the Ssa family 
in prion propagation. Similarly to previous studies (Jones and Masison, 2003), a 
majority of the mutations (with the exception of G481D) were located in the ATPase 
domain. This demonstrates the importance of ATPase regulation of Hsp70 as being an 
important function for [PSI+] propagation.  
 
Hsp70 chaperones are two domain proteins that assist in protein folding. The 
functioning of Hsp70 is highly dependent on inter-domain communication between 
the ATPase domain and the PBD. The protein folding activity of the PBD is regulated 
by the ATPase domain, studies have indicated that inter-domain communication is 
mediated by a twelve amino acid PBD helix that rests in a grove between lobes IA 
and IIA of the ATPase domain (Jiang et al., 2005). Also when Hsp70 is in a peptide 
bound state, conformational changes are observed in the ATPase domain (Revington 
et al., 2005). A subset of the Ssa1 ATPase mutants (A53, G73, R74, A146 and T223) 
are located in a region that has recently been shown to be important for inter-domain 
communication in the E.coli Hsp70, DnaK (Revington et al., 2005). Structural 
analysis of the G73D mutation reveals that presence of the mutation changes this 
amino acid from a  polar uncharged residue to a polar acidic residue and also there are 
additional neighbors when mutation is present, suggesting that the mutation may 
cause a slight conformational change which in turn may affect the inter-domain 
communication of Hsp70.  
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Structural analysis of another subset of mutant residues (R259, G287, T295 and 
A297) revealed that these mutants are located within the IIB region of the ATPase 
domain. The IIB region of the ATPase domain has been implicated as interacting with 
the Fes1 homologue, HspBP1, in mammals (Shomura et al., 2005). The NEF Fes1 
facilitates the release of Ssa1 substrates. Previous studies on the Ssa1 PBD mutant 
SSA1-21 showed that overproduction of Fes1inhibits the impairment of [PSI+] 
propagation by SSA1-21 and depletion of Fes1 (which prolongs substrate binding) 
impairs [PSI+] propagation in both wildtype and SSA1-21 (Jones et al., 2004). This 
indicates that in order for [PSI+] to propagate, a weak interaction with Fes1 is 
required. Mutations to this region may have an affect on Fes1 interaction with Ssa1, 
which then may affect [PSI+] propagation. Structural analysis of the Hsp70 bovine 
homologue, Hsc70, revealed that the residue T298 (homologue of T295) forms a 
hydrogen bond with residues in the Nucleotide exchange factor Sse1.  Recent studies 
have found Sse1 is required for de novo [PSI+] formation and efficient prion 
propagation (Kryndushkin et al., 2007; Fan et al., 2007). A mutation at the T295 
residue may effect binding of Sse1 to Hsp70, as both Sse1 and Hsp70 are crucial for 
prion propagation, altering this interaction may lead to impaired prion propagation. 
These results indicate that alterations to the ATPase cycle of Hsp70 in favor towards 
an ADP bound state appear to impair [PSI+] propagation. 
Enhanced substrate binding may impair [PSI+] propagation in numerous ways. Firstly, 
prolonged substrate binding may affect the Hsp104 disaggregase function. Generation 
of yeast prion seeds requires the disaggregating function of Hsp104. It is believed that 
Hsp104 breaks down Sup35 polymers into prion seed which are then passed on to 
daughter cells during cell division (Shorter and Lindquist, 2004). If mutations are 
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making Ssa1 bind more avidly to Sup35 aggregates, this may restrict access of 
Hsp104 to disaggregate Sup35 polymers. If this was the case, this indicates that 
Hsp104s disaggregase function for prions differs from its disaggregase function for 
thermally denatured substrates as ATPase as the mutations did not affect the ability of 
Hsp104 to refold  luciferase post heat shock. Another way that enhanced substrate 
binding by Hsp70 might impair [PSI+] propagation is that it may affect the role of 
Ssa1 in dismantling polymers from Sup35 aggregates. Ssa1/2 have a stronger 
interaction with the prion form of Sup35 in comparison to the non-prion form 
(Bagriantsev et al., 2008). If Ssa1 has prolonged substrate binding, this may affect the 
Hsp70 function of dismantling aggregates into polymers directly or by an association 
through Hsp104. 
 
Unlike the PBD mutant Ssa1F475S the ATPase mutants do not appear to have a 
significant affect on the expression of factors involved in a variety of cellular 
functions, with the exception of Ssa1 self-regulation. Although abundance of Hsp70 
appears similar for ATPase mutants, transcriptional levels of the Ssa1 promoter 
appear to vary; indicating mutants may increase or decrease the transcription of Ssa1. 
The G73D mutation was the only ATPase mutation to show a 39oC t.s phenotype, 
indicating that this mutation may alter Hsp70 function. Overall, mutations in the 
ATPase domain of Hsp70, that impair [PSI+] propagation, do not appear to have a 
significant affect on a majority of the functions of Hsp70. Although Ssa1T295I may 
effect the interaction between Ssa1 and the NEF Sse1, there appears to be no 
significant difference in ATPase activity of Ssa1T295I in comparison to wildtype.  The 
fact that these mutations do not appear to have an effect on Hsp70 function but impair 
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prion propagation and Hsp70 is a highly conserved protein, may suggest that these 
residues are potential targets for future treatments. 
 
As we had analyzed the effects of alterations to the ATPase domain and PBD of 
Hsp70 with respect to prion propagation and Hsp70 function, we decided to 
investigate the effects of alterations to the CTD. A sixty amino acid truncation of the 
CTD proved to be detrimental when expressed in both [PSI+] and [psi-] versions of 
G402. Expression of twenty and forty amino acid truncations of the Hsp70 CTD 
exhibited viability in both [PSI+] and [psi-] strains, indicating that that a region 
between the 582 and 602 residues is important for Hsp70 function.  Expression of ∆20 
and ∆40 CTD truncations did not appear to have an effect on [PSI+] propagation. 
Growth rates were severely affected especially in [psi-] strain at normal and elevated 
temperatures. The 37oC t.s phenotype of ∆20 and ∆40 were remediated by growth on 
1M sorbitol, further indicating that Ssa1 could potentially be involved in the CWI 
signaling pathway. 
 
The CTD truncations further highlight the importance of co-chaperones in [PSI+] 
propagation. The regulatory motif EEVD is a highly conserved sequence at the 
extreme end of the C-terminus (Freeman et al., 1995). This motif is involved in the 
recognition of co-chaperones that contain tetratricopeptide repeats (TPR). In humans 
this motif interacts with the Hsp90 co-chaperone Hop1 (Scheufler et al., 2000) which 
is the homologue of Hsp90 co-chaperone Sti1 in yeast. Sti1 interacts with Ssa and 
activates ATPase activity. Cells harboring ∆20 and ∆40 CTD truncations can 
maintain [PSI+] propagation indicating that Sti and Hsp90 are not required for prion 
maintenance. This is in agreement with previous results that depletion of Fes1 
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improved [PSI+] propagation whereas overexpression  weakened it (Jones et al., 
2004). Although prion propagation and maintenance does not appear to be affected by 
the CTD truncations, cell growth and Hsp70 function appears to be severely affected. 
Deletion or mutation of the EEVD motif has an affect on ATPase activity and ability 
of Hsp70 to interact with substrates (Freeman et al., 1995). This may explain why 
∆20 and ∆40 CTD truncations are non-functional at 37oC. 
The isolation of Ssa1 ATPase mutations and CTD truncations has provided  a new 
insight into the role of Hsp70 and co-chaperones in prion propagation. The ATPase 
mutations may have implicated alterations to inter-domain communication; Ssa1 
NEF’s and increased Ssa1 substrate binding as affecting [PSI+] propagation. With the 
exception of G73D, the mutations do not appear to affect other cellular functions, 
which may make theses regions potential therapeutic targets. The ∆20 and ∆40 CTD 
truncations confirm that Hsp90 and its co-chaperone, Sti1 are not necessary for [PSI+] 
propagation and the truncations have severe affects on Ssa1 function. 
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5.0 Introduction  
The aim of this chapter is to gain insight into the influence of individually expressing 
members of the Ssa family, and analyzing their effects on prion propagation and 
Hsp70 functions. In addition we also propose to analyze the effects of N-terminally 
fused His (6X) tag on Ssa1 viability, growth rates and affect on prion propagation. We 
also propose to analyze trends in gene expression in cells solely expressing Ssa1-4, 
the PBD mutation Ssa1F475S and the CTD truncation ∆20. 
 
Hsp70 constitutes as one of the most conserved protein families, members of this 
family may be heat inducible or constitutively expressed (Daugaard et al., 2007). 
Hsp70 from different species share functional redundancy for e.g. Drosophila Hsp70 
can protect mammalian cells from heat stress (Pelham 1984). Yeast contain nine 
cytosolic Hsp70’s, which include the Ssa family, Sse family and three ribosome 
associated Hsp70’s (Ssb1-2 and Ssz). The Ssa sub-family, of cytosolic Hsp70, 
consists of four members Ssa1-4, which are functionally redundant and abundance of 
at least one is necessary for growth (Werner-Washburne et al., 1987).  The 
constitutively expressed Ssa1/2 are 98% identical, the heat-inducible Ssa3/Ssa4 are 
88% identical to one another and are 80% identical to Ssa1/2 (Sharma and Masison, 
2008).   
Due to the high degree of conservation among Hsp70 family and the fact that the 
presence of one family member is essential for growth, it was hypothesized that some 
of these family members may be functionally redundant (Kabani and Martineau, 
2008). However, recent evidence concerning prion propagation and biofilm 
formation, suggests that this is not the case and there is functional difference among 
Hsp70 orthologs. Altered abundance of Hsp70 appears to affect prion propagation in 
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different ways. Overexpression of Ssa1 appears not to weaken the [PSI+] prion but 
cures the [URE3] prion, conversely depleting Ssa1 weakens [PSI+] but not [URE3] 
(Schwimmer and Masison, 2002; Roberts et al., 2004). Interestingly, the Ssa2 appears 
to have the opposite effect, depletion weakens [URE3] but not [PSI+] (Sharma and 
Masison, 2008). Hsp70 has been reported to play a role in biofilm formation in yeast 
(Martineau et al., 2007). Deletion of Ssa1 had a more severe affect on biofilm 
formation than an Ssa2 deletion. The additional deletions of Ssa3 and Ssa4 appeared 
to enhance the defects caused by the Ssa1/Ssa2 deletions, suggesting that there is 
cooperation between constitutive and inducible Hsp70’s (Martineau et al., 2007). 
As mentioned previously Ssa1 is involved in prion maintenance, propagation, and 
many cellular functions such as translation, translocation and protecting cells from 
stress by preventing aggregation. In order to extensively study the affects of mutations 
of Ssa1 on these functions, it is necessary to purify the Ssa1 protein to carry out 
biochemical assays. Fusing a His(6X) to the N-terminal of Ssa1 allows purification of 
Ssa1 by Metal-Chelate Affinity Chromatography (MCAC), in which metal ions 
(Nickel) are bound to solid matrices that bind to Histidine residues therefore capturing 
the protein of interest. As previously observed, fusing a His (6X) tag to Ssa1F475S 
caused Ssa1 to become non-functional (Figure 3.16). Therefore, we decided to 
analyze the affects of a N-terminally fused His (6X) tag on wildtype Ssa1. 
The main objective of this chapter was to: 
• To gain insight into the differences and similarities between yeast strains   
       expressing individual members of the Ssa family 
• To decipher the affects of a N-terminally fused His(6x) tag on Ssa1 functions 
and prion propagation 
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• To analyze common trends in gene expression in yeast cells expressing Ssa1-
4. 
 
5.1 Strategy for Ssa1-4 comparison 
In order for us to carry out comparative analysis on the Ssa1-4 proteins, we first had 
to obtain plasmids expressing each gene under a constitutively active promoter. To 
achieve this each member of the Ssa family was cloned into a plasmid under the 
control of the Ssa2 promoter. After failed attempts of cloning Ssa2 and Ssa4, we 
received plasmids expressing Ssa2 (pDCM64) and Ssa4 (PA4) from the Masison 
group. Ssa1 was previously cloned into the pRS315 plasmid under the control of the 
Ssa2 promoter (pC210) by a former member of our lab. The SSA3 gene (2KB)  was 
amplified from the genomic DNA of the wildtype yeast strain G600, utilizing primers 
which added thirty base pair overhangs at the 5’ and 3’ ends of SSA3 (Figure 5.1(A)) .  
The overhangs were homologous to sequence at gene incision site of pC210. The 
pC210 (6KB) plasmid was digested by an Nde1 and Sph1 restriction digest to remove 
the SSA1 (2KB) insert (Figure 5.1(B)) and digested plasmid was isolated by gel 
extraction (Figure 5.1(c)). The SSA3 PCR construct and digested pC210 were 
simultaneously transformed into G600 to allow homologous recombination to occur, 
potential colonies harboring SSA3 clones were selected for on SD media lacking 
Leucine. To confirm homologous recombination was successful, diagnostic Nde1 and 
Sph1 restriction digests were preformed on plasmids isolated from colonies that 
exhibited growth on SD media lacking Leucine. Diagnostic digest (Figure 5.1 (D)) 
and DNA sequencing confirmed SSA3 was cloned into pC210. 
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Figure 5.1 Cloning Ssa3 into pC210. All agarose gels made from 0.8% agarose and 1µl of Ethidium 
Bromide, dissolved in 50ml of 1X TAE buffer. Agarose gels were run at 90V for approximately thirty 
minutes (A) A faint band is observed at 2KB which represents SSA3 with pC210 overhangs, amplified 
from G600 genomic DNA. (B) Sph1 and Nde1 restriction digest of pC210, the top band is located 
around 6KB and represents the digested pC210 vector and the lower band represents SSA1 which was 
liberated by restriction digest and is located at 2KB. (C) Digested pC210 vector post gel extraction. 
(D) Potential SSA3 clones were isolated and a Sph1 and Nde1 restriction digest was carried out. As a 
control undigested pC210 was run alongside digestion. Diagnostic digest reveals that SSA3 is present. 
(A)                                                        (B)                                             
2KB 
6KB 
 
2KB 
6KB 
(C)                                                       (D) 
SSA3 
pC210 
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5.1.1 Expression of Ssa family in G402 
In order to compare the functions of individual Ssa members, each member must be 
expressed as the sole source of Ssa in a strain. To achieve this, each plasmid was 
transformed into a [PSI+] version of G402 and potential transformants were selected 
on SD agar lacking Leucine.  Colonies from SD lacking Leucine were replicated onto 
5-FOA to eliminate the pRDW10 plasmid and were restreaked onto YPD (Figure 5.2 
A-D). All members of the Ssa family individually support growth of G402. In cells 
expressing Ssa3 the prion was maintained (Figure 5.2C), [PSI+] was also maintained 
in cells expressing Ssa1 and Ssa2 but not to the same degree as Ssa3 (Figure 5.2A-B). 
All strains were curable by 3mM GdnHCL (Figure 5.2E-F). Cells expressing Ssa4 
were unable to propagate the prion (Figure 5.2 D). These results are indicative that 
prions are affected differently by different Hsp70’s, which indicates members of the 
Ssa family are distinct from one another with respect to prion propagation.  
 
5.1.2 Growth rates of cells expressing Ssa1-4 
The Ssa subfamily of Hsp70 is essential for growth in S.cerevisiae; we have shown 
that each member of the Ssa family individually supports growth of S.cerevisiae that 
lacks all four chromosomal SSA genes (Figure 5.2 A-D). To assess whether individual 
Ssa members affected the growth rate of S.cerevisiae differently, we analyzed the 
growth rates of cells expressing Ssa members. Cells expressing the constitutively 
expressed Ssa1 and Ssa2 grow quicker than the heat inducible Ssa3 and Ssa4 (Table 
5.1). Ssa3 appears to have the greatest affect, with the growth rate being reduced by 
approximately 50% in  
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(A)                                                             (B) 
(C)                                                           (D) 
 
 
(E)                                                                    (F) 
5.2 Expression of Ssa1-4 in G402. Ssa1-4 were transformed into G402 and each 
was expressed as the sole source of the Ssa family by the plasmid shuffle 
technique. Cells were streaked from 5-FOA onto YPD and incubated at 30oC for 
forty-eight hours. Figures A-D show Ssa1-4 respectively.  Figures E and F 
represent cured versions of Ssa1 and Ssa3 respectively. Strains cured by 
incubating cells on 3mM GdnHCL at 30oC for forty-eight hours. 
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comparison to Ssa1 (Table 5.1). Previous studies indicate that Ssa4 had the greatest 
affect on cell growth (Sharma et al., 2009). Although our results vary  from the 
previous study, it is clear that the heat inducible members of the Ssa family do not 
support growth rates of S.cerevisiae as efficiently as the constitutively expressed Ssa1 
and Ssa2.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Strain MGT 
(Mins) 
MGT  
%WT 
Ssa1 103  100% 
Ssa2 113 109% ±5.6% 
Ssa3 156 151% ±9% 
Ssa4 128 124% ±4.2% 
Table 5.1 MGT of cells expressing individual members of Hsp70 
subfamily Ssa. Overnight cultures of cells expressing individual Ssa’s were 
diluted from overnight 30oC cultures to an OD600 0.1. The OD600 of cultures 
was measured every two hours for approximately ten hours (chapter 2.7.1) 
 
 207 
 
5.1.3 Investigation of Ssa1-4 temperature sensitivity 
Members of the Hsp70 subfamily Ssa function to protect cells from stress injuries by 
preventing aggregation of partially unfolded proteins. In order to gain insight on 
whether individual Ssa’s can protect cells at elevated temperatures, we tested cells 
expressing individual Ssa’s at various temperatures. There was no affect on growth of 
cells expressing individual Ssa members up to 37 oC. Cells individually expressing 
Ssa3 and Ssa4 were t.s at 39oC (Figure 5.3). This shows that Ssa3 and Ssa4 are not 
efficient for protection against stress injuries, when solely expressed in yeast. 
 
               25oC                                                        30oC 
 
 
 
 
 
 
 
 
 
 
 
Ssa1 
 
Ssa2 
 
Ssa3 
 
Ssa4 
 
 
 
 
 
 
 
Ssa1 
 
Ssa2 
 
Ssa3 
 
Ssa4 
      37oC                                                         39oC 
Figure 5.3 Temperature sensitivity of cells expressing Ssa1-4.  Cells incubated at specific 
temperatures for 48 hours on YPD. Cells were diluted by a 1/5 serial dilution. Spots labeled 
accordingly. Ssa1-4 expressed in G402 as sole source of Ssa in strain. 
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5.1.4 Recovery of t.s 39oC phenotype by 1M sorbitol 
As previously described, the F475S mutation in the PBD of Ssa1, 2 and 4 causes a t.s 
37oC phenotype, which is recovered by growth on 1M sorbitol (Figure 3.29). This 
may implicate the Hsp70 Ssa subfamily in the CWI signaling pathway. As Ssa3 and 
Ssa4 are both t.s at 39oC we decided to analyze the effects of 1M sorbitol on their 
growth at 39oC.  Growth of both Ssa3 and Ssa4 is rescued by growth on 1M Sorbitol. 
This is a common phenotype we have observed with Ssa1 t.s mutants (Ssa1F475S, 
Ssa1G73D, ∆20 and ∆40). This could quite possibly suggest that Ssa1 is playing either 
a direct or indirect role in the CWI signaling pathway.  It may also be the case that 
these mutations are causing the Ssa1 protein to become unstable and the sorbitol is 
somehow making the Ssa1 protein unstable.   
 
 
 
 
            
 
 
 
 
 
 
 
 
 
 
 
Ssa1 
 
 
Ssa2 
 
 
Ssa3 
 
 
Ssa4 
Figure 5.4 Recovery of Ssa3 and Ssa4 by 1M Sorbitol at 39oC. Cells were 
incubated at 39oC for 48 hours on YPD supplemented with 1M sorbitol . Cells 
were diluted by a 1/5 serial dilution. Spots labeled accordingly. Ssa1-4 
expressed in G402 as sole source of Ssa in strain. 
 
 209 
5.1.5 Effect of Ssa1-4 on thermotolerance 
In order for Hsp70 to prevent aggregation of partially unfolded proteins, it must 
cooperate with the molecular chaperones Hsp40 and Hsp104. As Ssa3 and Ssa4 are t.s 
at 39oC, we decided to analyze the effects of a short lethal heat shock (52oC), on cells 
individually expressing Ssa1-4. Survival rates of yeast post lethal shocks are 
improved by pre-treating cells with a non-lethal shock, which stimulates elevated heat 
shock proteins. To assess the affects of a lethal heat shock on cells individually 
expressing Ssa1-4, cells were grown at 30oC until a final concentration of 5x106 
cells/ml was reached. Cells were then shifted to 37oC for one hour to induce elevated 
expression of heat shock proteins; 1ml of the culture was then removed and stored on 
ice. Culture was then shifted to 52oC for thirty minutes, with samples being removed 
at fifteen and thirty minutes. Cells were then replicated onto YPD and grown at 30oC 
for forty-eight hours. Apart from Ssa3 colonies appearing slightly smaller, there 
appears to be no significant difference between members of the Ssa family with 
regards to thermotolerance, indicating that individual members of Ssa family can cope 
with lethal heat shock in the presence of elevated levels of chaperones such as Hsp40 
and Hsp104. 
 
5.1.6 Protein refolding activity of Ssa family 
A major function of Hsp70 is refolding proteins that have become misfolded due to 
heat stress. The ability of chaperones to refold misfolded proteins can be measured by 
performing a luciferase assay. The luciferase enzyme is unstable at high temperatures 
and omits light in presence of its substrate decanal, which can be measured on a 
luminometer. Cells individually expressing Ssa1-4 were transformed with the 
pDCM90 plasmid  
 210 
 
 
                      Ssa1                                                                Ssa2 
 
 
 
 
 
 
 
                        Ssa3                                                               Ssa4 
                        
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
T0 
 
T1 
 
 
T2 
 
 
 
 
TO 
 
 
T1 
 
 
T2 
Figure 5.5 Effects of solely expressing Ssa1-4 on thermotolerance in yeast. Cells individually  
expressing Ssa1-4 were grown overnight at 30oC in YPD. Cells were diluted to an OD600 of 0.15 and 
were grown at 30oC in YPD, until a final concentration of 5x106 cells/ml was reached. Cells were then 
shifted to 37oC for one hour. Following this one hour incubation, 1ml of cells from each culture was 
transferred into a sterile 1.5ml tube and stored on ice (T0). The remainder of the culture was shifted to 
52oC for thirty minutes, 1ml samples were removed at fifteen minutes (T1) and another 1ml was 
removed at thirty minutes (T2). Cells were diluted by a 1/5 serial dilution and replicated onto YPD and 
incubated at 30oC for forty-eight hours. Spots labeled accordingly. 
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and luciferase assays were carried out as in chapter 3.4. In Ssa1 86% of luciferase 
activity was restored which agrees with our previous results (Figure 3.7 and 4.5). Ssa2 
and Ssa4 have similar luciferase recovery rates at 76% and 70% respectively. Ssa3 
has the lowest recovery rate with only 60% of luciferase being recovered; this may 
explain why colonies appeared smaller for Ssa3 thermotolerance as recovery of 
unfolded proteins is slower. 
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Figure 5.6 Refolding activity of Ssa1-4. Cultures of strains expressing luciferase and Ssa1-
Ssa4 were shifted from 30oC to 37oC for 30 minutes and then shifted to 42oC for one hour. 
Cycloheximide was added 50 minutes after shifting to 42oC to prevent synthesis of luciferase 
during the recovery period. Luciferase activity, expressed as a percentage of pre-heat shock 
activity, was measured after allowing cells to recover for 30 minutes at 25oC. Experiment was 
repeated twice in triplicate.  
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5.1.7 Basal levels of Hsp70 and Hsp104 in cells expressing individual Ssa’s 
 
Abundance of Hsp70 and Hsp104 in a yeast cell may be a contributing factor for 
impairment of [PSI+] propagation. Protein levels for Ssa1-4 were observed by 
Western blotting. Total protein was extracted from cells and probed with a general 
Hsp70 (SPA-822), Ssa1/2 (Santa Cruz), Ssa3/4 (60591) and Hsp104 specific 
antibodies. In addition to analyzing abundance of Hsp70 and Hsp104 in cell, western 
blot should also confirm each strain is expressing individual members of Ssa family. 
Abundance of Ssa3 and Ssa4 appears slightly lower in comparison to Ssa1 and Ssa2 
when probed with the general Hsp70 antibody. This difference in abundance may be 
due to Ssa3/4 being only 80% identical to Ssa1/2, therefore the affinity of a general 
Hsp70 antibody may be weaker in Ssa3/4 if binding epitope is slightly different than 
Ssa1/2. The Ssa1/2 and Ssa3/4 antibodies show that strains are expressing individual 
members of the Ssa family and the there appears to be no variation in the amount of 
Hsp104 being expressed between strains. Strains expressing Ssa3 and Ssa4 appear to 
have a similar level of Hsp70 yet exhibit opposite phenotypes with respect to [PSI+] 
propagation; cells solely expressing Ssa3 are [PSI+] whereas cells solely expressing 
Ssa4 cannot maintain the prion and are [psi-]. This may indicate that Ssa3 and Ssa4 
are functionally different with respect to [PSI+] propagation. 
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Figure 5.7 Basal levels of Hsp70 and Hsp104. Lysates prepared from overnight 
30oC cultures. Aliquots of proteins (10µg) were separated on five 
polyacrylamide gels, gels were either immunoblotted with antibodies either 
specific for (A) Hsp70 (SPA-822, 1/2000 dilution) and (B) Ssa1/2 (1/200, Santa 
Cruz)(C) Ssa3/4 (1/5000, 60591) (D) Hsp104 and (E) Coomassie brilliant blue 
stained overnight and destained the following day. 
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5.2 Affect of fusing an N-terminal HIS (6X) tag on Ssa1 in vivo 
Fusing a His (6X) tag to the N-terminal of a protein of interest proves as a useful tool 
for protein purification. Our chosen system for purifying Ssa1 was E.coli. Assays 
preformed on purified Ssa1, such as ATPase assays and CD spectra, were preformed 
in vitro. Therefore it was necessary to analyze the affects of fusing a His (6X) tag to 
the N terminal of Ssa1 in vivo, as a His (6X) tag may alter the structure or function of 
a protein. In order to achieve this we first had to clone the His (6X) Ssa1 construct 
into a yeast expression vector (pC210). We chose to clone the SSA1-His (6X) 
construct into the pC210 vector by homologous recombination. The  SSA1- His(6X)  
gene (2KB)  was amplified from the  pROEX-HTb plasmid, utilizing primers that 
added thirty base pair overhangs at the 5’ and 3’ ends of the gene (Figure 5.8 (A)). 
The overhangs were homologous to sequence at gene incision site of pC210. The 2kB 
band which represents the SSA1-His(X6) construct was isolated by gel extraction 
(Figure 5.8 (B)). The pC210 (6KB) plasmid was digested by an Nde1 and Sph1 
restriction digest (Figure 5.8 (C)) to remove the SSA1 (2KB) insert and digested 
plasmid was isolated by gel extraction. The SSA1-His(X6) PCR construct and 
digested pC210 were simultaneously transformed into G600 to allow homologous 
recombination to occur, potential colonies harboring SSA1-His(X6) clones were 
selected for on SD media lacking leucine. To confirm homologous recombination was 
successful, diagnostic Nde1 and Sph1 restriction digests were preformed on plasmids 
isolated from colonies that exhibited growth on SD media lacking leucine (Figure 5.8 
(D)). Diagnostic digest and DNA sequencing confirmed SSA1-His(X6) was cloned 
into pC210. 
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Figure 5.8 Cloning SSA1-His(6X) into pC210.All agarose gels made from 0.8% agarose and 1µl of 
Ethidium Bromide, dissolved in 50ml of 1X TAE buffer. Agarose gels were run at 90V for 
approximately thirty minutes (A) Band at 2KB represents SSA1-His(6X) with pC210 overhangs, 
amplified from the pPROEX-HTb plasmid. (B) SSA1-His(6X) with pC210 overhangs post gel 
extraction (C) Sph1 and Nde1 restriction digest of pC210, the top band is located around 6KB and 
represents the digested  empty pC210 vector and the lower band represents SSA1 which was liberated 
by restriction digest and is located at 2KB. (D) Potential SSA1-His(6X) clones were isolated and a Sph1 
and Nde1 restriction digests were carried out. Out of a potential four clones, one was successful. 
Plasmid was verified by sequencing. 
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5.2.1 Expression of Ssa1-His (6X) in vivo 
To assess the affects of a His (6X) tag on the function of Ssa1, the Ssa1-His (6X) 
plasmid must be expressed as the sole source of the Ssa family in yeast. To achieve 
this we transformed the plasmid into [PSI+] and [psi-] versions of G402 and selected 
for colonies on SD media lacking Leucine. Potential transformants were restreaked 
onto SD media lacking Leucine and replicated onto 5-FOA to eliminate the pRDW10 
plasmid.  Ssa1-His (6X) is functional in both [PSI+] and [psi-] strains (Figure 5.9-A). 
When Ssa1-His(6X) is expressed as the sole source of Ssa, the [PSI+] prion appears  
to be maintained more efficiently than when wildtype Ssa is expressed. 
 
We previously observed that His (6X) tags in combination with mutations in the PBD 
of Ssa1 such as F475S (Figure 5.9-B) and L483W (G. Jones personal 
communication), result in a non-functional Ssa1. Furthermore fusing a His (6X) tag to 
the N-terminal of Ssa1 containing ∆20, ∆40 and ∆60 deletions also results in non-
functional Ssa1 (Figure 5.9-C). Interestingly, mutations in the ATPase domain such as 
G73D and T295I in combination with a His (6X) tag appear not to affect the function 
of Ssa1 (Figure 5.9-B). This may indicate that the N-terminal region of Ssa1 is 
important for the functioning of the PBD and CTD of Ssa1, whereas alterations to the 
N-terminus may not affect the functioning of the ATPase domain. 
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Figure 5.9 Effects of Ssa1-His(6X) tag on yeast viability. (A) [PSI+] and [psi-] versions 
of G402 were transformed with Ssa1and Ssa1-His(6X). Potential transformants were 
selected on SD lacking Leucine and the replicated onto 5-FOA and grown at 30oC for 48 
hours. (B) PBD and ATPase mutations inserted into Ssa1-His(6X) by SDM (C) His(6X) 
fused ∆20, 40 and 60 CTD truncations expressed as sole source of Ssa in G402. 
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5.2.2 Confirmation of Ssa1-His (6X) expression 
 
To further confirm the Ssa1 being expressed has a fused His (6X) tag, we analyzed 
total protein from cells expressing Ssa1 and Ssa1-His (6X) by Western blot analysis. 
Total protein was extracted from cells and probed with antibodies specific for either 
Hsp70 or His (6X). Western blot analysis shows a signal for cells expressing the Ssa1-
His (6X) construct but no signal was detected for wildtype when probed with anti-His 
(6X) antibody. This confirms that the His (6X) is fused to the N-terminal of Ssa1. 
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5.10 Confirmation of His(6X) tag. Total protein from Ssa1 and Ssa1-His(6X)  
[PSI+] and [psi-] strains was separated by SDS-page. Gels were immunoblotted 
with antibodies specific for (A) Hsp70 (SPA-822, 1/2000 dilution) and (B) 
His6x tag (anti His-santa cruz 1/200 dilution). Lanes 1-4 represent Ssa1 [PSI+], 
Ssa1 [psi-], Ssa1-His(6X) [PSI+] and Ssa1-His(6X) [psi-] respectively. 
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5.2.3 Investigation of Ssa1-His (6X) growth rates 
 
The Hsp70 Ssa subfamily is essential for cell growth; we have already observed that 
expressing individual Ssa proteins under the control of the SSA2 promoter in the yeast 
strain G402 can support cell growth (Figure 5.2). We have observed that Ssa1-His 
(6x) can also support cell growth when being expressed as the sole source of Ssa. To 
gain insight on whether the His (6X) tag is affecting the growth of yeast cells we 
analyzed the growth rates of cells expressing Ssa1-his (6X) in [PSI+] and [psi-] cells. 
In [PSI+] and [psi-] cells expressing Ssa1-His (6X) the growth rate appears to be 
reduced by 22% and 39% respectively. This indicates that the addition of a His-(6X) 
tag to the N-terminus of Ssa1 has an affect on the growth rate of G402. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Strain MGT (mins) MGT %WT 
Ssa1 Ψ+ 104 100% 
Ssa1 Ψ- 117 112% ±2.12% 
Ssa1-His(6X) Ψ+ 133 128% ±11.31% 
Ssa1-His(6X) Ψ- 145 139% ± 12% 
Table 5.2 Growth rates of cells expressing Ssa1 and Ssa1-His(6X). 
Overnight cultures of cells expressing Ssa1 and Ssa-His(6X) were 
diluted from overnight 30oC cultures to an OD600 0.1. The OD600 of 
cultures was, measured every two hours for approximately ten hours 
(chapter 2.7.1). MGT expressed as a percentage of wildtype. 
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5.2.4 Affect of His (6X) tag on Ssa1 function 
 
Hsp70 functions as a heat shock protein, refolding misfolded or aggregated proteins at  
elevated temperatures. As previously observed fusing of a His (6X) tag to the N-
terminus of Ssa1 appears to have a larger affect on the PBD of Ssa1 in the presence of 
mutations (Figure 5.9). This may indicate the N-terminally fused His (6X) tag of Ssa1 
is having a specific affect on the PBD and may affect the ability of Ssa1 to rescue 
proteins at elevated temperatures. To analyze this we observed growth of cells solely 
expressing Ssa1 and Ssa1 His (6X) at 37oC.  Both [PSI+] and [psi-] cells expressing 
Ssa1-His (6X) were capable of growth at 37 oC, indicating that Ssa1 is still functional 
despite the presence of an N-terminal His (6X) tag. 
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Figure 5.11 Temperature sensitivity of cells expressing Ssa1 and Ssa1-His(6X).  Cells 
incubated at specific temperatures for 48 hours on YPD. Cells were diluted by a 1/5 serial 
dilution. Spots labeled accordingly. Ssa1 and Ssa1-His(6X) expressed in [PSI+] and [psi-] 
G402 as sole source of Ssa in strain. 
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5.3 Microarray analysis Ssa1-4 
We have observed that individually expressing the Hsp70 subfamily Ssa1-4 in S. 
cerevisiae, can lead to different phenotypes with regards to  prion propagation (Figure 
5.2) and cell growth (Figure 5.3) at elevated temperatures. It appears that each 
member of the Ssa family may functionally differ. To obtain a more complete view of 
functional relationships between the individual Ssa members we evaluated gene 
expression in cells expressing Ssa1-4, each as the sole source of Ssa in the cell by 
microarray analysis. Previous studies saw microarray analysis carried out on a 
∆ssa1/2 strain to investigate the genomic response at an mRNA to heat shock 
(Matsumoto et al., 2005).  Analysis revealed that genes involved in stress response, 
including chaperones, were up-regulated similarly in ∆ssa1/2 and wildtype strains 
(Matsumoto et al., 2005). Up-regulation of genes involved in protein synthesis was 
observed in ∆ssa1/2 but were suppressed in wildtype, also up-regulated in ∆ssa1/2 
were genes involved in ubiquitin-proteosome protein degradation, whereas genes 
encoding elements of the unfolded protein response were highly expressed in heat 
shocked wild-type (Matsumoto et al. 2005). These results suggest that recovery of 
denatured proteins in ∆ssa1/2 differs from wild-type. 
To gain further insight into the functional relationships between Ssa1-4, we compared 
the up and down-regulation of genes in [psi-] strains expressing Ssa2, 3 and 4. Strains 
expressing Ssa1 was used as a control to compare gene expression levels. RNA was 
extracted from individual strains and sent to Toray industries, Japan, for microarray 
analysis.  
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5.3.1 Microarray analysis of Ssa2-4 
We carried out analysis on microarray data by comparing genes that were up or down 
regulated in Ssa2-4 in comparison to Ssa1. To test the accuracy of microarray data we 
initially analyzed the expression of Ssa2-4 in each strain, for example, SSA2 
expression in the Ssa2 strain should be up-regulated in comparison to Ssa1, whereas 
Ssa2 expression should be down- regulated in strains expressing SSA3 and SSA4. 
Strains expressing Ssa2 and Ssa4 exhibit high levels of respective genes expressed in 
comparison to Ssa1 (Table 5.3). Unexpectedly the Ssa3 strain did not exhibit high 
levels of Ssa3 in comparison to Ssa1. As we have already confirmed Ssa3 is expressed 
in the strain (Figure 5.7-C), this result may be due to the high homology between Ssa3 
and Ssa1 (79%) (Sharma et al., 2009), as 70 mer probes were used in microarray 
analysis it is conceivable that the SSA3 probe could bind to SSA1 and give this 
inaccurate measurement. This analysis is currently being repeated to confirm results. 
 
 
 
 
 
 
 
 
Strain SSA2  SSA3 SSA4 
Ssa2 48.166 0.278 0.279 
Ssa3 0.958 0.653 0.966 
Ssa4 1.339 1.291 124.937 
Table 5.3 Accuracy of microarray analysis. Gene expression levels in Ssa2, 
Ssa3 and Ssa4 were compared to the Ssa1 control by microarray analysis.  Gene 
levels expressed as a ratio of Ssa1 gene levels, e.g. the reading for SSA4 from 
Ssa1 strain was 126.8 and 15838.6 from the Ssa4 strain, therefore SSA4 is 
expressed 124.937 times higher in Ssa4 strain. 
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To analyze the microarray data, we chose genes that were up or down-regulated by 
two fold or more in Ssa2-4 strains in comparison to Ssa1. There are eleven genes 
common to Ssa2-4 strains that were up-regulated by greater than three fold (Table 
5.4). The gene with the highest up-regulation in the three strains is LCB4. The Lcb4 
protein is involved in the production of sphingolipids in S.cerevisiae. Sphingolipids 
are essential components of the plasma membrane in all eukaryotic cells. S. cerevisiae 
cells make three complex sphingolipids: inositol-phosphoceramide (IPC), mannose-
inositol-phosphoceramide (MIPC), and mannose-(inositol phosphate) 2-ceramide 
(M(IP)2C). Lcb4 acts as a sphingoid long-chain base kinase, which is responsible for 
synthesis of long-chain base phosphates, which function as signaling molecules that 
regulate the synthesis of ceramide (Nagiec et al. 1998, Funato et al., 2003).  
Interestingly, sphingolipids  have been implicated as playing a role in the heat stress 
response (Jenkins et al., 1997). It is believed that ceramide and other sphingolipid 
metabolites accumulate during heat stress and signal yeast cells to activate 
transcription of the TBS2 gene and accumulate trehalose (Dickson et al., 1997). Along 
with the production of Hsp’s, yeast cells have many ways of coping with heat stress, 
another protective mechanism in S. cerevisiae is the accumulation of the disaccharide 
trehalose, which occurs rapidly following a shift from 25 to 37°C (Trehalose is known 
to protect proteins and biological membranes from heat denaturation) (Hottiger et al., 
1994). Previous microarray analysis carried out on heat shocked wildtype and a strain 
unable to produce sphingolipids, revealed approximately seventy genes that showed 
differential regulation during first fifteen minutes of heat shock in strain unable to 
produce sphingolipids (Cowart et al., 2003). These genes fell into the groups involved 
in stress sphingolipids (Cowart et al., 2003). These genes fell into the groups involved  
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ORF/Gene Gene Function Ssa2 Ssa3 Ssa4 
YOR171C/LCB4 
 
Sphingoid long-chain base kinase 8.2 8.4 9.2 
YOR064C/YNG1 Subunit of the NuA3 histone acetyltransferase 
complex 
6.4 5.5 5.9 
YBR120C/CBP6 Mitochondrial translational activator of the 
COB mRNA; phosphorylated 
5.3 3.8 4.2 
YBR179C/Unknown 
 
Unknown function-not essential 5.0 4.0 3.7 
YAL028W/FRT2 
 
Tail-anchored endoplasmic reticulum 
membrane protein, interacts with homolog 
Frt1p but is not a substrate of calcineurin 
(unlike Frt1p), promotes growth in conditions 
of high Na+, alkaline pH, or cell wall stress 
4.1 5.1 3.8 
YOL105C/WSC3 Partially redundant sensor-transducer of the 
stress activated PKC1-MPK1 signaling pathway 
3.9 5.2 5.1 
YKL195W/MIA40 Essential protein of the mitochondrial 
intermembrane space 
3.7 6.5 6.1 
YDR335W/MSN5 Karyopherin involved in nuclear import and 
export of proteins 
3.5 3.3 3.6 
YMR078C/CTF18 
 
Required for sister chromatid cohesion 3.1 3.8 5.0 
YDR202C/RAV2 Subunit of RAVE complex which promotes 
assembly and reassembly of the holoenzyme 
3.1 2.9 3.1 
YPL015C/HST2 Cytoplasmic member of the silencing 
information regulator 2 (Sir2) family of 
NAD(+)-dependent protein deacetylases  
3.0 2.3 2.2 
 
 
 
 
 
 
 
in stress response and cell cycle regulation. This is indicative that sphingolipid 
production broadly influences the expression of genes involved in diverse cellular 
pathways. However, previous results demonstrated that sphingoid bases do not induce 
the expression of Hsp70, Hsp90 or Hsp104 (Dickson et al. 1997). However, more 
recent microarray analysis revealed that several stress response genes are dependent 
Table 5.4 Up-regulation of genes common in Ssa2-4 strains. Analysis of microarray data 
revealed eleven genes that are commonly up-regulated in strains expressing Ssa2, Ssa3 or Ssa4. 
Expression of genes in each strain was compared to expression in Ssa1. Functions of genes 
were obtained from the Saccharomyces genome database (SGD). 
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on sphingolipid generation for their induction, including the Hsp70 member, Ssa4 
(Cowart et al., 2003). The up-regulation of LCB4 in strains expressing Ssa2, Ssa3 and 
Ssa4 may indicate that in the absence of Ssa1 or other Ssa members, S.cerevisiae 
utilizes other cellular components such as sphingolipids to deal with heat stress. 
 
Interestingly, genes involved in cell wall stress appear to be up- regulated in Ssa2, 
Ssa3 and Ssa4 in comparison to Ssa1. FRT2 and WSC3 are up-regulated by more than 
three fold in each strain. FRT2 is an endoplasmic reticulum membrane protein that 
promotes growth in conditions of high Na+, alkaline PH or cell wall stress. The WSC3 
gene is part of the WSC family in yeast, which has functions in maintenance of cell 
wall integrity and the stress response (Verna et al., 1997). It is thought that the WSC 
gene family may play a role in the Pkc1-Mpk1 pathway in yeast (Verna et al., 1997). 
This result may indicate that in the absence of Ssa1 or other Ssa family members, 
other components involved in response to cell wall stress are up-regulated within the 
cell. This may further implicate Ssa as playing a role in the cell wall integrity 
signaling pathway. 
There is only one ORF that is commonly down regulated in Ssa2, Ssa3 and Ssa4, 
YOR387C, which is uncharacterized. It is known that it is regulated by the metal-
responsive Aft1p transcription factor and is highly inducible in zinc-depleted 
conditions (Rutherford et al., 2003; Higgins et al., 2003). 
 
5.3.2 Microarray analysis of Ssa3-4 
We found a wide variety of genes up-regulated in Ssa2-4 in comparison to Ssa1, as 
Ssa3 and Ssa4 are 88% identical we analyzed genes that were commonly up-regulated 
in both in comparison to Ssa1. Interestingly, a majority of up-regulated genes appear 
to be involved in the yeast cell cycle (Table 5.5). Proliferation of cells is mediated 
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through the cell-division cycle. The cell division cycle consists of four stages; genome 
duplication (S phase) and nuclear division (M phase) which have intermediate gap 
phases G1 and G2. Periodic gene transcription regulates cell cycle phases. Many of 
the genes up-regulated in Ssa3 and Ssa4 (NRM1, PCL1, YOX1, CLB2, CLN1, CLN2, 
and ACE2 ), encode components involved in regulating the cell cycle (Table 5.5). The 
transcription control of G1/S phase is the most widely studied phase of the cell cycle. 
At the end of the G1 phase, cells decide whether to commit to cell division. DNA 
replication is initiated by increased transcript levels of several genes during late G1. 
In S.cerevisiae two transcription factor (TF) complexes activate expression of genes, 
the MBF TF complex is necessary for sufficient cell cycle regulated transcription 
(Lowndes et al.,1991) whereas the SBF TF complex is necessary to promote G1/S 
specific transcription in heterologous genes (Andrews and Herskowitz, 1989). The 
proteins Cln1, Cln2 and Clb2 are involved in regulating expression of both MBF and 
SBF TF complexes (Bähler 2005). Also up-regulated in Ssa3 and Ssa4 is the Ace2 
transcription factor, this is involved in regulating the M/G1 phase in conjunction with 
Swi5 and specifically is involved  in activating a number of genes with roles in cell 
separation (Dohrmann et al., 1992; Bidlingmaier et al., 2001). During the G1/S phase 
the SBF TF complex binds to promoters of several transcription factors, one of which 
is Yox1, which may play a role in regulating the periodic expression of genes during 
the G1/S phase that may be involved in expression of genes for proteolysis, spindle 
pole duplication, and DNA synthesis (Horak et al., 2002). The Nrm1 TF is also 
involved in the G1/S phase of the cell cycle, 
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it acts as a MBF specific co-repressor and is required for repression of MBF regulated 
transcription during exit from G1 phase (de Bruin et al., 2004). Increased expression 
of components involved in regulation of the cell cycle in S.cerevisiae in cells 
ORF/Gene Gene Function Ssa3 Ssa4 
YNL300W/TOS6 Glycosylphosphatidylinositol-dependent cell wall protein  11.3 3.9 
YNR009W/NRM1 Transcriptional co-repressor of MBF (MCB binding factor) 5.9 3.2 
YNL289W/PCL1 Cyclin, interacts with cyclin-dependent kinase Pho85p; 
member of the Pcl1,2-like subfamily, involved in the 
regulation of polarized growth and morphogenesis and 
progression through the cell cycle 
5.8 4.4 
YML027W/YOX1 Homeodomain-containing transcriptional repressor, binds to 
Mcm1p and to early cell cycle boxes (ECBs) in the 
promoters of cell cycle-regulated genes expressed in M/G1 
phase; expression is cell cycle-regulated 
5.6 2.4 
YDL227C/HO Site specific endonuclease required for gene conversion at 
MAT locus 
5.4 1.8 
YPR119W/CLB2 B-type cyclin involved in cell cycle progression 
 
4.9 2.0 
YMR199W/CLN1 G1 cyclin involved in regulation of the cell cycle 
 
4.1 3.1 
YPL256C/CLN2 G1 cyclin involved in regulation of the cell cycle 
 
3.8 4.9 
YDR309C/GIC2 Protein of unknown function involved in initiation of 
budding and cellular polarization 
3.8 2.7 
YBR136W/MEC1 Genome integrity checkpoint protein and PI kinase 
superfamily member 
3.6 2.7 
YGR108W/CLB1 B-type cyclin involved in cell cycle progression; 
 
3.3 1.0 
YBR088C/POL30 Proliferating cell nuclear antigen (PCNA), functions as the 
sliding clamp for DNA polymerase delta; may function as a 
docking site for other proteins required for mitotic and 
meiotic chromosomal DNA replication and for DNA repair 
3.2 2.7 
YLR131C/ACE2 Transcription factor that activates expression of early G1-
specific genes 
3.1 1.6 
YBR162C/TOS1 Covalently-bound cell wall protein of unknown function; 
identified as a cell cycle regulated SBF target gene 
3.1 1.5 
YER162C/RNR1 Major isoform of the large subunit of ribonucleotide-
diphosphate reductase; the RNR complex catalyzes rate-
limiting step in dNTP synthesis, regulated by DNA 
replication and DNA damage checkpoint pathways via 
localization of small subunits 
3.0 2.0 
Table 5.5 Up-regulation of genes common in Ssa3 and Ssa4 strains. Analysis of microarray data revealed 
eleven genes that are commonly up-regulated in strains expressing Ssa3 or Ssa4.  Functions of genes were 
obtained from the Saccharomyces genome database (SGD). 
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individually expressing Ssa3 and Ssa4, suggests that the expression of components 
that regulate the cell cycle require the presence of Ssa1 or a combination of other Ssa 
members in order to have regular expression. These results may also indicate why 
growth rates of cells individually expressing Ssa3 or Ssa4 have a reduced growth rate 
in comparison to cells expressing Ssa1 (Table 5.1). 
 
5.3.3 Up-regulation of genes involved in metal homeostasis  
 
In addition to the up-regulation of genes involved in the cell cycle, we also observed 
that that there was an up-regulation of genes involved in metal homeostasis common 
to strains expressing Ssa3 or Ssa4 (Table 5.6). Genes involved in Copper and Iron 
homeostasis appear to be most prominently up-regulated in strains solely expressing 
Ssa3 or Ssa4. In yeast, Copper is a necessary cofactor for several enzymes, however  
 
 
 
ORF/Gene Name Gene function SSA3 SSA4 
YPR124W/ CTR1 High-affinity copper transporter of the plasma 
membrane, mediates nearly all copper uptake under low 
copper conditions; transcriptionally induced at low 
copper levels and degraded at high copper levels. 
2.810 2.254 
YDL198C/ GGC1 Mitochondrial GTP/GDP transporter, essential for 
mitochondrial genome maintenance; has a role in 
mitochondrial iron transport. 
5.356 3.581 
YJL217W/ REE1 Cytoplasmic protein involved in the regulation of enolase 
(ENO1); mRNA expression is induced by calcium 
shortage, copper deficiency (via Mac1) and the presence 
of galactose (via Gal4). 
4.890 1.932 
YFR055W/ IRC7 Putative cystathionine beta-lyase; involved in copper ion 
homeostasis and sulfur metabolism 
3.400 2.952 
YOL152W/ FRE7 Putative ferric reductase with similarity to Fre2; 
expression induced by low copper levels. 
4.944 2.905 
 
 
Table 5.6 Up-regulation of genes involved in metal homeostasis. Analysis of microarray data 
revealed five genes that are commonly up-regulated in strains expressing Ssa3 or Ssa4. Genes 
are all involved in metal homeostasis. Expression of genes in each strain was compared to 
expression in Ssa1. Functions of genes were obtained from the Saccharomyces genome 
database (SGD). 
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excess accumulation of copper results in hydroxyl radicals that can damage the cell at 
the level of nucleic acids, proteins and lipids (Halliwell and Gutteridge, 1984). 
Therefore, cells have developed homeostatic mechanisms to control intracellular 
accumulation and distribution of copper (Askwith and Kaplan, 1998; Puig and Thiele, 
2002). In S. cerevisiae, copper ions regulate gene expression through the two 
transcriptional activators, Ace1 and Mac1. Mac1 activates the expression of genes 
such as CTR1, REE1 and FRE7 (which are both up-regulated in Ssa3 and Ssa4 
strains), under conditions of low copper levels. In yeast, the proteins Ctr1 and Ctr3 are 
transporters that regulate the import of copper. Ctr1 is specifically responsible for 
uptake of copper in low copper environments (Yonkovich et al., 2002). Expression of 
CTR1 is increased by more that two fold in both the Ssa3 and Ssa4 strain. Expression 
of FRE7 is also induced by the transcription factor Mac1 during periods of low 
Copper levels. Fre7 acts as a copper reductase (Martins et al., 1998).  
 
Iron is also an important nutrient for yeast, deficiency of Iron would have an affect on 
synthesis of ATP and DNA. In excess Iron is toxic, therefore its intracellular levels 
are tightly controlled. Normal Iron homeostasis relies on the presence of Copper. Two 
genes, FRE7 and GGC1, involved in Iron homeostasis are up-regulated in strains 
expressing Ssa or Ssa4. Ggc1 is a GTP transporter and recent studies have shown that 
GTP in the mitochondrial matrix is involved in organellar Iron homeostasis (Gordon 
et al., 2006). 
 
Interestingly, all genes involved in copper homeostasis that are up-regulated in Ssa3 
and Ssa4 strains are down-regulated in the Ssa2 strain. To analyze whether growth of 
strains expressing Ssa1, 2, 3 or 4 are affected we supplemented YPD agar with 
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Copper (CuSO4) or Iron (FeSO4) and analyzed affects. We used ranges of CuSO4 (10-
14mM) (Figure 5.12)
 
and FeSO4 (2-4mM) (Figure 5.13) (recommended to us by Dr. 
Simon Avery, personal communication). As genes involved in Copper and Iron 
homeostasis are up-regulated in strains expressing Ssa3 or Ssa4 and down-regulated 
in Ssa2, it is conceivable to think that plating these strains on various concentrations 
of CuSO4 and FeSO4  may produce different phenotypes. The various concentrations 
of CuSO4 and FeSO4 appeared to have no significant affect on the growth rates of any 
of the strains tested.   
 
5.5 Genome sequencing 
 
As we have utilized the same strain throughout this entire study (G402), we decided to 
extract and sequence genomic DNA from G402 to assess whether there are single-
nucleotide polymorphisms (SNPS) present in genes that may be related to results from 
this study. Using next generation sequencing, we have identified approximately 6,500 
high quality SNPs in G402 genomic DNA in comparison to the reference strain 
S288C. Using an Illumina GAII, we obtained approximately 40X genome coverage. 
From the isolated SNPs, there were approximately 1,500 non-synonymous amino acid 
changes. DNA sequencing was carried out in St James Hospital in conjunction with 
Trinity college, Dublin. A summary of the SNP data is presented in Table 5.7. 
Detailed sequence analysis  data are supplemented as a hard copy (CD).  
Inactivating stop codon mutations (ISCMs) were located in a number of genes in 
G402 (Table 5.8).  The ade2 nonsense mutation, which a cause a 507 amino acid 
truncation in Ade2 (catalyzes a step in the de novo purine nucleotide biosynthetic 
pathway) was correctly identified in the sequence data for G402, which provides us 
with confidence that data are correct. 
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YPD + Copper Sulphate 
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Figure 5.12. Investigation of Ssa1-4 growth on CuSO4.  YPD agar was 
supplemented with various concentrations of CuSO4 post autoclaving. Cells incubated 
at specific temperatures for 48 hours on YPD plus various concentrations of CuSO4. 
Cells were diluted by a 1/5 serial dilution. Spots labeled accordingly.  
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YPD + Iron Sulphate (FeSO4) 
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Figure 5.13. Investigation of Ssa1-4 growth on FeSO4.  YPD agar was supplemented 
with various concentrations of FeSO4 post autoclaving. Cells incubated at specific 
temperatures for 48 hours on YPD plus various concentrations of FeSO4. Cells were 
diluted by a 1/5 serial dilution. Spots labeled accordingly.  
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 The largest truncation, 653 amino acids was caused by a premature stop codon in 
YBR074W, which is a putative metalloprotease. The INP52 gene also contains a 532 
amino acids, caused by a premature stop codon. This gene is a member of a conserved 
family of phosphoinositides phosphatases, it is a 136kD membrane protein and its 
deletion is viable (Stolz. et al., 1998).  INP52, encode member of a conserved family 
of phophoinositde phosphatases that contain an inositol polyphosphate 5-phosphatase 
domain. This domain in this enzyme specifically hydrolyzes phosphates at position 5 
of inositol rings. The Afi1 protein acts as a docking factor for Arf3 and both  play 
roles in maintaining normal budding pattern and actin patch polarization (Tsai et al., 
2008). The Crt10 protein has a one amino acid truncation, caused by a premature stop 
codon. The Ctr10 protein is involved in the transcriptional regulation of RNR2 and 
RNR3. Ribonucleotide reductase (Rnr) catalyzes the rate-limiting steps in dNTP 
synthesis. In addition to the presence of ISCMs being present in G402, we also 
located alterations to natural stop codons (Table 5.9). Eight genes were found to have 
alterations to their natural stop codons in the G402 strain including Nat4 which is an 
acetyltransferase protein responsible for acetylation of the histones H4 and H2A 
(Song et al. 2003). In G402, a Nat4 stop codon is present at 286aa; this was identified 
as being an Arginine (R) resulting in an addition of 53 amino acids to the C-terminus 
of the protein. This could potentially alter yeast molecular and biological processes. 
Other genes containing alterations to natural stop codons are listed in Table 5.9. 
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Chromosome Size 
(bp)a 
ORFsa Total 
number 
of SNPs 
SNPs in 
ORFs 
Non- synonymous 
amino acid changes 
I 230,208 92 156 122 57 
II 813,178 400 885 518 212 
III 316,616 158 229 157 65 
IV 1,531,919 737 37 26 21 
V 576,869 272 44 30 21 
VI 270,148 124 34 15 7 
VII 1,090,947 515 624 342 121 
VIII 562,643 277 10 6 3 
IX 439,885 206 508 303 98 
X 745,741 351 379 267 91 
XI 666,454 312 518 312 117 
XII 1,078,175 500 649 459 151 
XIII 924,429 452 656 380 138 
XIV 784,333 390 670 396 177 
XV 1,091,289 528 967 614 225 
XVI 948,062 455 78 54 34 
mito 85,779 19 83 57 4 
Totals 12,070,897 5,788 6,527 4,058 1,542 
 
Table 5.7 SNPs present in G402 compared to reference strain S288C. Genomic 
DNA was extracted from G402 and seqeunced by an Illumina GAII by a sequencing 
group in Trinity college Dublin. A total of 6,527 SNPs were present in G402 with 
1,542 being non-synonymous changes. 
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Systematic 
name 
Gene 
name 
Biological function Chromosomal 
SNP position 
Nonsense change and 
consequence  
YBR074W - Putative metalloprotease 387,247 Q323TAA 
653 amino acid 
truncation 
YNL106C INP52 Polyphosphatidylinositol 
phosphatase, dephosphorylates a 
number of phosphatidylinositols 
(PIs) to PI 
422,546 W651TAG 
532 amino acid 
truncation 
YOL063C CRT10 Protein involved in 
transcriptional regulation of 
RNR2 and RNR3 
207,394 Q957TAA 
1 amino acid truncation 
YOR128C ADE2 Adenine Biosynthesis 566,003 E64TAA 
507 amino acid 
truncation 
YOR129C AFI1 Arf3 polarization-specific 
docking factor, required for the 
polarized distribution of the 
ADP-ribosylation factor 
566,898 E887TAA 
6 amino acid truncation 
 
Table 5.8 ORFs in G402 containing single internal nonsense mutations. 
Information obtained from Saccharomyces Genome Database (SGD). 
 
 
The presence of ISCMs and alterations to natural stop codons in genes may have 
implications to the strains molecular and biological activity.  
 From the isolated SNPs, there were approximately 1,500 non-synonymous amino 
acid changes in G402. To analyze whether any of these non-synonymous changes 
may have had an affect on our results we looked for the presence of non-synonymous 
changes in factors that may affect Ssa1 activity, prion propagation or the CWI 
signaling pathway. The components that influence regulate Ssa1 function and 
influence prion propagations such as Hsp104, Sti1, Cpr7, Ydj1, Fes1 and Sse1 do not 
appear to have any non-synonymous amino acid changes present. This indicates that 
Ssa1 mutant phenotypes in relation to Ssa1 function and prion propagation are most 
likely due to presence of the mutation in Ssa1 and not in any other factors affecting 
these functions. We also analyzed components of the CWI signaling pathway such a 
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Systematic 
name 
Gene 
name 
Biological function Chromosomal 
SNP position 
Nonsense 
change and 
consequence  
YGR067C Unknown Putative protein of unknown 
function 
622,405 TAA795K 
YKR103W NFT1 Putative transporter of the 
multidrug resistance-
associated protein (MRP) 
subfamily 
649,061 TAG1219Y 
YML062C MFT1 Subunit of the THO 
complex, which is a nuclear 
complex comprised of 
Hpr1p, Mft1p, Rlr1p, and 
Thp2p, that is involved in 
transcription elongation and 
mitotic recombination 
147,504 TGA393L 
YMR069W NAT4 N alpha-acetyl-transferase, 
involved in acetylation of 
the N-terminal residues of 
histones H4 and H2A 
406,850 TGA286R 
YNR066C Unknown Putative membrane-
localized protein of 
unknown function 
753,725 TAA437E 
YNR069C BSC5 Protein of unknown 
function, ORF exhibits 
genomic organization 
compatible with a 
translational readthrough-
dependent mode of 
expression 
761,123 TAG490Y 
YOR031W CRS5 Copper-binding 
metallothionein, required for 
wild-type copper resistance 
389,186 TAG9E 
YPR071W Unknown Putative membrane protein; 
YPR071W is not an 
essential gene 
687,533 TAG212Y 
Table 5.9 ORFS in G402 containing alterations to natural stop codons. Information 
obtained from Saccharomyces Genome Database (SGD) 
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Bck1, Pkc1, Rlm1, Mkk1 and 2 for non-synonymous amino acid changes. The only 
component of the CWI signaling pathway that contains non-synonymous amino acid 
changes is Pkc1, which contained four; F81C, K621R, S623P and P789A. The 
presence of these four amino acid changes may have an affect on the function of Pkc1 
in vivo and therefore may have influenced some of the phenotypes we observed in 
relation to the CWI signaling pathway. 
Utilizing the G402, sequencing data we were able to create a phylogenetic tree to gain 
knowledge of the relationship between the G402 yeast strain and other commonly 
yeast strains. Figure 5.15 illustrates the phylogenetic distribution of yeast strains that 
have been generated by the Saccharomyces Genome re-sequencing project. Analysis 
of this phylogeny was carried out by Dr David Fitzpatrick. This shows that G402 is 
closely related to the reference strain S288c that is a commonly used yeast strain in 
research. 
 
 
 
5.6 Discussion 
Due to the high conservation between the cytosolic Hsp70 Ssa family, it was 
postulated that the Ssa family were functionally redundant (Kabani and Martineau, 
2008). However, our results and several other reports suggest that there is functional 
specialization among the Ssa family. The Ssa family differs by expression patterns; 
Ssa2 is constitutively expressed at high levels, Ssa1 is also constitutively expressed 
but at lower levels than Ssa2, Ssa3 and Ssa4 are not expressed during vegetative 
growth but expression increases upon encounters with stress (Boorstein and Craig, 
1990b, Boorstein and Craig,1990a). We observed that deletion of all four members is 
lethal but can be complemented by over- expressing individual members, which 
suggests redundant functions. Ssa3 and Ssa4 do not seem to support growth as well as 
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Figure 5.15. Phylogenetic distribution of yeast species. 74D is another commonly 
used yeast strain for [PSI+] analysis. This phylogeny was generated by Liti et al., 
(2009).  
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Ssa1 and Ssa2 and both strains expressing Ssa3 or Ssa4 are non-functional at elevated 
temperatures suggesting that functions carried out by Ssa1/2 are not fully 
complemented by Ssa3/4. Individual Ssa’s also appear to vary in their ability to help 
refold proteins in vivo. 
Propagation of [PSI+] also appears to be affected differently by different members of 
the Ssa family with overexpression of Ssa3 being the most effective for [PSI+] 
maintenance and propagation, this agrees with previous results from the Masison 
group (Sharma et al., 2009). Other groups have also found different effects of Ssa 
members on [URE3] propagation; overproduction of Ssa1 but not Ssa2 cures [URE3] 
whereas a mutation in Ssa2 but not Ssa1 impairs [URE3] propagation (Schwimmer 
and Masison ,2002, Roberts et al., 2004). Individually expressing Ssa3 or Ssa4 
weakens [URE3] propagation. Differences with regard to prion propagation may be 
due to differences in sequence, which may determine how Ssa members interact with 
prions. For example a screen undertaken to find components that bind to the prion 
form of Sup35 found that Ssa1/2 efficiently bind to the prion domain of Sup35 in 
[PSI+] cells but had a weak interaction with Sup35 in [psi-] cells (Bagriantsev et 
al.,2008). Ssa3/Ssa4 were not isolated in the screen as binding to Sup35, indicating 
difference in binding to prions between Ssa members. Aside from degree in sequence 
specificity, it is possible that individual members of the Ssa family are regulated 
differently. Ssa proteins are recruited and activated by J proteins (Hsp40/DnaJ family) 
and regulated by nucleotide exchange factors such as Fes1 and Sse1. It is conceivable 
that Ssa isoforms have different preferences or affinities for particular J proteins and 
NEF’s which in turn may explain different prion phenotypes when members of the 
Ssa family are individually expressed. 
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Up and down regulation of numerous genes in cells individually expressing Ssa 
member’s further highlights functional specialization among individual Ssa members. 
Previous microarray screens on wildtype and ∆ssa1/∆ssa2 strains post a mild heat 
shock identified genes involved in up-regulation of genes involved in protein 
synthesis in ∆ssa1/∆ssa2  that were suppressed in wild-type (Matsumoto et al., 2005). 
Furthermore, genes involved in ubiquiton-proteosome protein degradation were up 
regulated in ∆ssa1/∆ssa2  strain whereas genes involved in the UPR were up 
regulated in the wild-type strain, suggesting that mechanism for denatured protein 
rescue differs in the absence of Ssa1 and Ssa2 (Matsumoto et al., 2005). Interestingly, 
we found the gene that had the highest up regulation and common in Ssa2, Ssa3 and 
Ssa4 is involved in the production of sphingolipids. Sphingolipids are thought to be 
involved in the heat stress response in yeast (Jenkins et al., 1997). It is believed that 
ceramide and other sphingolipid metabolites accumulate during heat stress and signal 
yeast cells to activate transcription of the TBS2 gene and accumulate trehalose 
(Dickson et al., 1997). Recent studies have shown that trehalose is required for the 
transcription and maintenance of Heat shock factor one (Hsf1) in a highly active state 
during response to heat shock (Conlin and Nelson, 2007). This may indicate that in 
the absence of Ssa1 or by individually expressing Ssa2, Ssa3 or Ssa4, cells may 
depend on alternative mechanisms to deal with heat stress. Groups of genes involved 
in regulation of the yeast cell cycle and metal homeostasis appear to be commonly up 
regulated in cells individually expressing Ssa3 and Ssa4. This adds further weight to 
the argument that there is functional specialization among cytosolic Hsp70 Ssa 
members.  
As we performed biochemical analysis throughout this project utilizing a His (6X) 
tagged version of Ssa1 and various Ssa1 mutants, we decided to analyze the affects of 
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fusing a His (6X) tag to the N-terminal of Ssa1 in vivo. Cells were viable when 
expressing Ssa1-His(6X) as the sole source of Ssa, growth rates seemed to be slightly 
affected indicating that the His(6X) tag has a slight affect on Ssa1 function although 
cells were not 37oC t.s  indicating Ssa1 still has the ability to recover proteins exposed 
to heat shock. Interestingly, cells expressing Ssa1 His (6X) appear to be able to 
maintain [PSI+] propagation better than cells expressing wildtype Ssa1. The presence 
of the His (6X) tag may affect binding of Ssa1 to substrates, for example if Ssa1- His 
(6X) binding to aggregated Sup35 is affected it may mean Hsp104 has more access to 
disaggregate Sup35 polymers resulting in the production of larger numbers of prion 
seeds. Fusing a His (6X) to Ssa1 in the presence of PBD mutations such as L483W 
and F475S appears to make the protein non-functional whereas fusing a His (6X) to 
Ssa1 in the presence of ATPase domain mutations appears not to affect cell viability. 
We carried out sequencing analysis of the G402 strain to investigate whether 
mutations present in the strain background may be affecting phenotypes of Ssa1 
mutants that we observed throughout the project. We observed five ISCMs, one of 
which is purposely present in the ADE2 gene, to detect the presence of the [PSI] prion 
and eight altered natural stop codons. Truncations or elongations of proteins may 
affect their molecular or biological function in G402, which then may have an affect 
on phenotypes observed in that strain. There are 1,500 non-synonymous amino acid 
changes present in G402. We found no changes present in any of the main 
components that may affect prion propagation, which leads us to conclude that 
phenotypes we observed are solely due to the presence of mutations in the ATPase 
domain, the PBD or truncations of the CTD in Ssa1. Interestingly we found four non-
synonymous amino acid changes in the CWI signaling component Pkc1. The CWI 
signaling pathway consists of a linear pathway in which activation of components is 
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dependent on phosphorylation by previous component in pathway. Pkc1 initiates the 
phosphorylation cascade that eventually results in the up regulation of genes involved 
in cell wall repair. In the presence of wild-type Ssa1 G402 exhibits no phenotypes 
related to the CWI signaling pathway, indicating that the four non-synonymous amino 
acids are not affecting phosphorylation of Bck1 by Pkc1.  
  
Investigation of the affects of individually expressing Ssa1, Ssa2, Ssa3 and Ssa4 has 
provided us with new insight into the functional specialization of each member of the 
Ssa family with regards Hsp70 function and prion propagation. Microarray analysis 
highlights specific genes that are regulated differently when members of the Ssa 
family are expressed individually further highlighting functional specialization. We 
also purpose that fusing an N-terminal His (6X) tag to Ssa1 has no major affects on 
Ssa1 function. 
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6.0 Final Discussion 
The de novo formation, propagation and maintenance of the [PSI+] prion in 
S.cerevisiae is dependent upon many cellular factors. By carrying out mutational 
analysis on the various domains of the cytosolic Hsp70 members Ssa1-4, we further 
implicate these chaperones and their co-chaperones as playing a crucial role in prion 
propagation. As Hsp70 is a highly conserved protein throughout eukaryotes, these 
results may be transferable to mammalian systems. 
 
Previous Ssa1 mutagenesis screens, highlighted the ATPase domain as being a highly 
important region for the propagation of the [PSI+] prion (Jung et al., 2000, Jones and 
Masison, 2003, Loovers et al.,2007). The previously isolated PBD mutant, SSA1-21 
(Jung et al., 2000), highlighted that mutations in PBD could affect prion propagation. 
By carrying out random mutagenesis on an Ssa1 construct lacking the ATPase 
domain, we successfully isolated a number of PBD mutations that impair [PSI+] 
propagation. The isolation of the Ssa1 PBD mutants highlights the importance of this 
domain with respect to prion propagation. Amongst PBD mutations isolated was the 
novel mutant Ssa1F475S, the first Ssa1 mutation to affect both prion propagation and 
Ssa1 function. From structural analysis we observed that the F475S mutation is 
closely located to the previously isolated PBD mutant SSA1-21 (Jung et al., 2000). 
 
There are a number of ways in which the Ssa1F475S mutation may be impairing [PSI+] 
propagation. Previous studies have shown that in cells expressing the SSA1-21 mutant, 
there is a 10-fold decrease in the number of transmissible prion seeds but only a two 
to three fold reduction in the amount of aggregated Sup35 (Jung et al., 2000). Further 
studies revealed that in cells expressing this mutant, aggregates are larger as there are 
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more polymers per aggregate; therefore, there are less free polymers available for 
efficient Sup35 recruitment, which may inhibit prion propagation (Song et al., 2005). 
The F475S may be having a similar affect on aggregate size. Another plausible reason 
Ssa1F475S may impair [PSI+] propagation, is that this mutation may cause Ssa1 to bind 
more avidly to its substrates. It has recently been shown that Ssa1/2 interacts with 
Sup35 resistant polymers (Bagriantsev et al., 2008). Increased binding may affect the 
Ssa1 function of binding to Sup35 and dismantling polymers from Sup35 aggregates, 
resulting in defective prion propagation. 
 
 The identification of second-site suppressor mutations of Ssa1F475S that suppress 
impairment of [PSI+] (P636S) and restore Ssa1 function (A394V, P432S and V477I), 
may provide us with further insight into how this mutation impairs these functions. 
The P636S mutation is located within a conserved CTD motif in Ssa1 that is involved 
in the binding of TPR co-chaperones such as Sti1 to Ssa1. Disruption to this motif in 
the presence of the PBD mutations Ssa1F475S and SSA1-21, restores [PSI+] 
propagation.  It therefore appears that a weak interaction between Ssa1 and Sti1 is 
needed in order for the prion to propagate. The A394V mutation is located in the 
linker region between the ATPase domain and the PBD, which is involved in inter-
domain communication, suggesting that the F475S mutation may have an affect on 
inter-domain communication that may cause it to become non-functional. 
 
As a majority of mutants that impair prion propagation, isolated from random 
mutagenesis screens are located in the ATPase domain, we decided to carry out 
further analysis on a subset of previously isolated mutants (G73D, G287D and T295I) 
(Loovers et al., 2007). Structural analysis of these mutants reveals that they are 
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located in regions of importance of Ssa1, the G73D mutant is located in a region for 
inter-domain communication in the E.coli Hsp70, DnaK (Revington et al., 2005). The 
G287D  and T295I mutants are located in regions important for the binding of NEFs  
Ssa1 that are important for the regulation of the Hsp70 ATPase cycle. Interference 
with the binding of Ssa1 and its NEFs may result in prolonged substrate binding of 
Ssa1. Prolonged substrate binding may result in Ssa1 binding more avidly to Sup35,  
restricting  access of Hsp104 to disaggregate Sup35 polymers or it may  affect the role 
of Ssa1 in dismantling polymers from Sup35 aggregates. This suggests that both inter-
domain communication and interactions of Ssa1 with NEF’s is essential for prion 
propagation. The presence of these mutations does not appear to have a significant 
affect on cellular functions of Ssa1 suggesting that these residues may be exclusively 
involved in prion propagation. 
Although numerous mutagenesis screen have identified mutations in the ATPase 
domain and PBD of Ssa1 that impair prion propagation, mutations in the CTD have 
not been isolated that have an effect on prion propagation. We therefore hypothesized 
that severe truncations may have an affect rather than single allele alterations. We 
found that truncations to the CTD of Ssa1 did not appear to affect prion propagation 
in [PSI+] cells, but had a severe affect on the function of Ssa1. The absence of the 
highly conserved TPR binding motif did not appear to have an affect on prion 
propagation further suggesting that interactions of Ssa1 with Sti1 and Hsp90 are not 
required for prion propagation. 
The cytosolic Hsp70 Ssa family is composed of four members, Ssa1-4, it was 
originally hypothesized that the members of this family were functionally redundant. 
By expressing each member individually as the sole source of Ssa, it is clear that 
members exhibit functional specialization with respect to growth and prion 
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propagation. This functional specialization between members of the Ssa family may 
be due to differences between members which may determine how they interact with 
Sup35. Alternatively, it is possible that individual members of the Ssa family are 
regulated differently. Ssa proteins are recruited and activated by J proteins 
(Hsp40/DnaJ family) and regulated by nucleotide exchange factors such as Fes1 and 
Sse1. It is conceivable that Ssa isoforms have different preferences or affinities for 
particular J proteins and NEF’s which in turn may explain different prion phenotypes 
when members of the Ssa family are individually expressed.  
Furthermore, by carrying out microarray analysis, it appears that numerous genes are 
regulated differently in the presence of individual members of the Ssa family. Groups 
of genes involved in regulation of the yeast cell cycle and metal homeostasis appear to 
be commonly up regulated in cells individually expressing Ssa3 and Ssa4.  
 
A common feature we found in a group of Ssa1 mutants (Ssa1G73D, Ssa1F475S, ∆20 and 
∆40), was a t.s phenotype at elevated temperatures that is rescued by growth on 1M 
sorbitol. This is a common phenotype present in mutations of components of the cell 
wall integrity signaling pathway. This result may implicate Ssa1 as playing either a 
direct or indirect role in this pathway. Other chaperones such as Hsp90, Sse1 and 
Hsp40 have previously been implicated as playing a crucial role in the pathway and it 
is plausible Ssa1 may be implicated into pathway through interactions with these 
chaperones. 
As Hsp70 is a highly conserved protein throughout eukaryotes, locating mutations 
that affect prion propagation without affecting the function of Hsp70 may be potential 
therapeutic and drug targets for the treatment of prion diseases. 
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6.1 Future work 
In order to decipher a mechanism of how Hsp70 mutants are affecting prion 
propagation further studies must be carried out. With respect to the PBD mutant 
Ssa1F475S, it may be necessary to carry out studies to determine prion seed numbers 
and Sup35-GFP studies to analyze the size of Sup35 polymers in cells expressing the 
mutant in comparison to wild-type. As the fusion of a His (6X) tag to the N-terminal 
of Ssa1 is non-functional, it is necessary to find an alternative protein purification 
method for the purification of this mutant. Previous studies have purified Ssa1 and 
mutants from the yeast strain G402 by anion exchange chromatography, ATP affinity 
chromatography, liquid chromatography and size exclusion chromatography 
(Needham and Masison, 2008). Once a purification system is established testing of 
substrate binding may be carried out by measuring equilibrium binding of fluorescein 
labeled A7 peptide. This would provide insight into whether the F475S mutation 
increases binding avidity of Ssa1 to substrates which would have an affect on prion 
propagation. Further analysis may also be carried out on second-site suppressors to 
assess whether they restore functions affected by F475S. For example if F475S 
increases binding of Ssa1 to substrates, does the second-site suppressors restore 
substrate binding to a normal level. The same theory could be applied to the ATPase 
activity  rate of Ssa. Binding assays may also be preformed on the ATPase mutants 
G73D, G287D and T295I to assess whether the presence of these mutations increase 
Ssa1 substrate binding.  
As previously discussed, we observed a number of mutants that are t.s at elevated 
temperatures and are rescued by growth on 1M sorbitol indicating that Ssa may play a 
part in the CWI signaling pathway. However, from genome sequencing data we 
discovered four mutations present in the Pkc1 protein, which is a major component of 
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this pathway. To test whether mutations are the cause of this phenotype and not strain 
background, mutants should be tested in the commonly used yeast strain BY4741. In 
order to achieve this, the Ssa family must be deleted in this background so mutants 
may be expressed as the sole source in the strain. Phenotypes of strains expressing Ssa 
mutants will then be tested at elevated temperatures and compared to phenotypes 
observed in the G402 background. Sensitivity of mutants may also be tested by 
growth on cell wall damaging drugs such as caffeine, SDS and congo red. Yeast-two 
hybrid assays may also be carried out to analyze whether Ssa1 or mutants bind any 
components involved in the CWI signaling pathway. 
From microarray analysis of strains individually expressing members of the Ssa 
family we observed increased expression of numerous genes including genes involved 
in sphingolipid synthesis, metal homeostasis and the yeast cell cycle. At present 
microarray analysis is being repeated on strains individually expressing Ssa1-4. RT-
PCR should be carried out on genes with varied expression to confirm results. To 
assess whether up-regulation of components involved in sphingolipid synthesis is 
indicative that this alternative pathway is up-regulated as an alternative mechanism to 
deal with stress, mutations to impair the sphingolipid biosynthesis pathway may result 
in cells individually expressing Ssa2-4 not being able to deal with stress as efficiently.  
As Hsp70 is a highly conserved protein, mutations that impair prion propagation in 
yeast could be introduced into the mammalian Hsp70 homologue Hsc70 and test their 
affects on Scrapie propagation in a mammalian system.    
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